10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED December 31, 2011

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM                    TO                    

COMMISSION FILE NUMBER: 001-11593

The Scotts Miracle-Gro Company

(Exact name of registrant as specified in its charter)

OHIO	31-1414921
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
14111 SCOTTSLAWN ROAD, MARYSVILLE, OHIO	43041
(Address of principal executive offices)	(Zip Code)

(937) 644-0011

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

	September 30,
Class	Outstanding at February 1, 2012
Common Shares, $0.01 stated value, no par value	60,827,981 common shares

THE SCOTTS MIRACLE-GRO COMPANY

INDEX

		PAGE NO.
PART I. FINANCIAL INFORMATION:
Item 1.	Financial Statements
	Condensed Consolidated Statements of Operations — Three months ended December 31, 2011 and January 1, 2011		3
	Condensed Consolidated Statements of Cash Flows — Three months ended December 31, 2011 and January 1, 2011		4
	Condensed Consolidated Balance Sheets — December 31, 2011, January 1, 2011 and September 30, 2011		5
	Notes to Condensed Consolidated Financial Statements		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		28
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		38
Item 4.	Controls and Procedures		38
PART II. OTHER INFORMATION:
Item 1.	Legal Proceedings		38
Item 1A.	Risk Factors		38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		39
Item 6.	Exhibits		40
Signatures			41
Index to Exhibits			42

2

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidated Statements of Operations

(In Millions, Except Per Common Share Data)

(Unaudited)

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net sales	$	211.2		$	230.2
Cost of sales		186.4			180.3
Cost of sales – product registration and recall matters		—			0.8
Gross profit		24.8			49.1
Operating expenses:
Selling, general and administrative		123.0			143.2
Impairment, restructuring and other charges		2.6			—
Product registration and recall matters		0.3			0.9
Other income, net		(0.9	)		(0.5	)
Loss from operations		(100.2	)		(94.5	)
Interest expense		15.3			9.5
Loss from continuing operations before income taxes		(115.5	)		(104.0	)
Income tax benefit from continuing operations		(41.6	)		(37.3	)
Loss from continuing operations		(73.9	)		(66.7	)
Loss from discontinued operations, net of tax		—			(1.2	)
Net loss	$	(73.9	)	$	(67.9	)
Basic loss per common share:
Loss from continuing operations	$	(1.21	)	$	(1.00	)
Loss from discontinued operations		—			(0.02	)
Basic loss per common share	$	(1.21	)	$	(1.02	)
Weighted-average common shares outstanding during the period		60.9			66.3
Diluted loss per common share:
Loss from continuing operations	$	(1.21	)	$	(1.00	)
Loss from discontinued operations		—			(0.02	)
Diluted loss per common share	$	(1.21	)	$	(1.02	)
Weighted-average common shares outstanding during the period plus dilutive potential common shares		60.9			66.3
Dividends declared per common share	$	0.30		$	0.25

See notes to condensed consolidated financial statements

3

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidated Statements of Cash Flows

(In Millions)

(Unaudited)

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
OPERATING ACTIVITIES
Net loss	$	(73.9	)	$	(67.9	)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense		1.6			4.3
Depreciation		12.9			12.2
Amortization		2.7			2.5
Loss on sale of long-lived assets		0.1			—
Changes in assets and liabilities, net of acquired businesses:
Accounts receivable		141.8			139.5
Inventories		(269.2	)		(225.3	)
Prepaid and other assets		—			(8.7	)
Accounts payable		76.4			80.0
Other current liabilities		(90.4	)		(113.7	)
Restructuring reserves		(3.0	)		—
Other non-current items		(0.7	)		11.6
Other, net		0.6			(4.2	)
Net cash used in operating activities		(201.1	)		(169.7	)
INVESTING ACTIVITIES
Investments in property, plant and equipment		(16.4	)		(28.1	)
Net cash used in investing activities		(16.4	)		(28.1	)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans		447.0			258.2
Repayments under revolving and bank lines of credit and term loans		(205.7	)		(234.0	)
Proceeds from issuance of 6.625% Senior Notes		—			200.0
Dividends paid		(18.9	)		(16.8	)
Purchase of common shares		(17.5	)		(25.0	)
Financing and issuance fees		—			(4.1	)
Excess tax benefits from share-based payment arrangements		3.8			1.5
Cash received from the exercise of stock options		5.6			6.5
Net cash provided by financing activities		214.3			186.3
Effect of exchange rate changes on cash		0.1			2.2
Net decrease in cash and cash equivalents		(3.1	)		(9.3	)
Cash and cash equivalents, beginning of period		130.9			88.1
Cash and cash equivalents, end of period	$	127.8		$	78.8
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	$	(13.0	)	$	(4.8	)
Income taxes paid		(10.0	)		(2.9	)

See notes to condensed consolidated financial statements

4

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidated Balance Sheets

(In Millions)

		September 30,			September 30,			September 30,
	DECEMBER 31, 2011			JANUARY 1, 2011			SEPTEMBER 30, 2011
	UNAUDITED
ASSETS
Current assets:
Cash and cash equivalents	$	127.8		$	78.8		$	130.9
Accounts receivable, less allowances of $12.4, $6.2 and $12.9, respectively		166.5			213.2			323.5
Accounts receivable pledged		14.3			—			—
Inventories		654.8			567.0			387.0
Assets held for sale		—			200.9			—
Prepaid and other current assets		148.8			136.1			151.1
Total current assets		1,112.2			1,196.0			992.5
Property, plant and equipment, net of accumulated depreciation of $520.1, $471.8 and $510.5 respectively		391.4			391.1			394.7
Goodwill		309.1			305.8			309.1
Intangible assets, net		316.2			326.7			319.6
Other assets		35.4			35.6			36.3
Total assets	$	2,164.3		$	2,255.2		$	2,052.2
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	8.1		$	168.5		$	3.2
Accounts payable		220.4			208.5			150.0
Liabilities held for sale		—			45.4			—
Other current liabilities		220.6			244.8			315.4
Total current liabilities		449.1			667.2			468.6
Long-term debt		1,026.1			687.4			791.8
Other liabilities		224.9			222.0			232.0
Total liabilities		1,700.1			1,576.6			1,492.4
Commitments and contingencies (notes 3 and 12)
Shareholders’ equity:
Common shares and capital in excess of $.01 stated value per share, 60.8, 66.5 and 60.8 shares issued and outstanding, respectively		410.3			428.6			427.1
Retained earnings		511.6			414.2			599.2
Treasury shares, at cost: 7.4 million shares, 1.9 million shares and 7.5 million shares, respectively		(377.5	)		(98.3	)		(388.5	)
Accumulated other comprehensive loss		(80.2	)		(65.9	)		(78.0	)
Total shareholders’ equity		464.2			678.6			559.8
Total liabilities and shareholders’ equity	$	2,164.3		$	2,255.2		$	2,052.2

See notes to condensed consolidated financial statements

5

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of consumer branded products for lawn and garden care. The Company’s primary customers include home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers and food and drug stores. The Company’s products are sold primarily in North America and the European Union. The Company also operates the Scotts LawnService^® business, which provides residential and commercial lawn care, tree and shrub care and limited pest control services in the United States.

On February 28, 2011, the Company completed the sale of a significant majority of the assets of its Global Professional business (excluding the non-European professional seed business, “Global Pro”) to Israel Chemicals Ltd. (“ICL”). As a result of the then-pending sale, effective in the Company’s first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations. See “NOTE 2. DISCONTINUED OPERATIONS” for additional details regarding the sale of Global Pro.

Organization and Basis of Presentation

The Company’s unaudited condensed consolidated financial statements for the three months ended December 31, 2011 and January 1, 2011 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this report should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

RECENT ACCOUNTING PRONOUNCEMENTS

Fair Value Measurement

In May 2011, the Financial Accounting Standards Board (the “FASB”) issued amended accounting guidance to improve comparability of fair value measures between GAAP and the International Financial Reporting Standards. The amended guidance clarifies how to apply the existing fair value measurement and disclosure requirements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

Comprehensive Income

In June 2011, the FASB issued amended accounting guidance on the presentation of comprehensive income. The amended guidance requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

6

Testing for Goodwill Impairment

In September 2011, the FASB issued new accounting guidance that permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. The entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that the reporting unit’s fair value is less than its carrying value. The guidance will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the guidance may have on its financial statements and related disclosures.

NOTE 2. DISCONTINUED OPERATIONS

On February 28, 2011, the Company completed the sale of Global Pro to ICL for $270 million. After agreed upon adjustments (including post-closing adjustments), the Company received $270.9 million net proceeds, or $253.6 million after transaction costs. Results from discontinued operations for fiscal 2011 include an after-tax gain on the sale of Global Pro of $39.5 million, which includes transaction costs.

Pursuant to the terms of the indenture governing the Company’s 7.25% Senior Notes due 2018 and the indenture governing the Company’s 6.625% Senior Notes due 2020, the Company has a period of 360 days to apply an amount equal to the net proceeds received from the sale of Global Pro to repay indebtedness, acquire equity interests in certain entities, make capital expenditures, acquire other assets useful in a related business and/or make investments in certain joint ventures. Any amount not so applied must be used to make an offer to repurchase the Senior Notes, provided that such repurchase offer may be deferred until such time as the unutilized proceeds exceed $50 million. As of December 31, 2011, the Company had applied all but approximately $45 million of the net proceeds to one or more of the uses permitted by the indentures.

The Company’s decision to exit the professional ornamental horticulture, turf and specialty agriculture markets and sell Global Pro was another step in its strategy to evolve its business portfolio to better leverage growth opportunities within its Global Consumer and Scotts LawnService^® business segments.

In conjunction with the transaction, The Scotts Company LLC (“Scotts LLC”), a wholly owned subsidiary of Scotts Miracle-Gro, and ICL entered into several product supply agreements which are generally up to five years in duration, as well as various trademark and technology licensing agreements with varying durations. The purpose of these agreements is to allow each party to continue leveraging existing production capabilities and intellectual property to meet customer demand for their respective products. Scotts LLC estimates that it will supply ICL with approximately $50 million of product under these agreements, as well as purchase approximately $15 million of materials from ICL, each on an annualized basis.

The Company’s continuing cash inflows and outflows related to these agreements are not considered to be significant in relation to the overall cash flows of Global Pro. Furthermore, none of these agreements permit the Company to influence the operating or financial policies of Global Pro under the ownership of ICL. Therefore, Global Pro met the criteria for presentation as discontinued operations. As such, effective in the first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations for all periods presented. The Global Pro results from discontinued operations include an allocation of interest expense relating to the amount of our then existing credit facilities that was required to be repaid from the sale proceeds.

The following table summarizes the results of Global Pro within discontinued operations for the three months ended January 1, 2011 (in millions):

		September 30,
Net sales	$	46.9
Operating costs		42.2
Other expense, net		5.3
Interest expense		1.0
Loss from discontinued operations before income taxes		(1.6	)
Income tax benefit from discontinued operations		(0.4	)
Loss from discontinued operations	$	(1.2	)

7

The major classes of assets and liabilities of Global Pro as held for sale at January 1, 2011 were as follows (in millions):

		September 30,
Cash and cash equivalents	$	1.0
Accounts receivable, net		54.9
Inventories		61.2
Prepaid and other assets		4.6
Property, plant and equipment, net		12.8
Goodwill		66.4
Assets held for sale	$	200.9
Accounts payable	$	16.4
Other current liabilities		15.6
Other liabilities		13.4
Liabilities held for sale	$	45.4

NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS

In April 2008, the Company became aware that a former associate apparently deliberately circumvented the Company’s policies and U.S. Environmental Protection Agency (“U.S. EPA”) regulations under the Federal Insecticide, Fungicide, and Rodenticide Act of 1947, as amended (“FIFRA”), by failing to obtain valid registrations for certain products and/or causing certain invalid product registration forms to be submitted to regulators. Since that time, the Company has been cooperating with both the U.S. EPA and the U.S. Department of Justice (the “U.S. DOJ”) in related civil and criminal investigations into the pesticide product registration issues as well as a state civil investigation into related allegations arising under state pesticide registration laws and regulations.

In late April 2008, in connection with the U.S. EPA’s investigation, the Company conducted a consumer-level recall of certain consumer lawn and garden products and a Scotts LawnService^® product. Subsequently, the Company and the U.S. EPA agreed upon a Compliance Review Plan for conducting a comprehensive, independent review of the Company’s product registration records. Pursuant to the Compliance Review Plan, an independent third-party firm, Quality Associates Incorporated (“QAI”), reviewed substantially all of the Company’s U.S. pesticide product registrations and associated advertisements, some of which were historical in nature and no longer related to sales of the Company’s products. The U.S. EPA investigation and the QAI review process resulted in the temporary suspension of sales and shipments of certain products. In addition, as the QAI review process or the Company’s internal review identified potential FIFRA registration issues (some of which appear unrelated to the actions of the former associate), the Company endeavored to stop selling or distributing the affected products until the issues could be resolved. QAI’s review of the Company’s U.S. pesticide product registrations and associated advertisements is now substantially complete. The results of the QAI review process did not materially affect the Company’s fiscal 2009, fiscal 2010 or fiscal 2011 sales and are not expected to materially affect the Company’s fiscal 2012 sales.

In fiscal 2008, the Company conducted a voluntary recall of certain of its wild bird food products due to a formulation issue. Certain wild bird food products had been treated with pest control additives to avoid insect infestation, especially at retail stores. While the pest control additives had been labeled for use on certain stored grains that can be processed for human and/or animal consumption, they were not labeled for use on wild bird food products. In October 2008, the U.S. Food & Drug Administration concluded that the recall had been completed and that there had been proper disposition of the recalled products. The results of the wild bird food recall did not materially affect the Company’s fiscal 2009, fiscal 2010 or fiscal 2011 financial condition, result of operations or cash flows.

Settlement discussions relating to potential fines and/or penalties are a frequent outgrowth of governmental investigations. In that regard, on or about June 30, 2011, the Company received a Notice of Intent to File Administrative Complaint (“Notice”) from the U.S. EPA Region 5 with respect to the alleged FIFRA violations. The Notice, which does not set forth a proposed penalty amount, offers the Company an opportunity to present any information that it believes the U.S. EPA should consider prior to filing the complaint and indicates that the U.S. EPA is prepared to meet with the Company to discuss the alleged violations. The Company made a timely response to the Notice and communications between the Company and the U.S. EPA are underway.

8

As previously disclosed, the Company has also been engaged in settlement discussions with the U.S. DOJ regarding its criminal investigation. On January 25, 2012, a plea agreement (the “Plea Agreement”), executed by both Scotts Miracle-Gro and the U.S. DOJ, was filed with the United States District Court for the Southern District of Ohio. Under the terms of the Plea Agreement, which must be approved by a federal judge, Scotts Miracle-Gro has agreed to plead guilty to 11 counts of violating FIFRA and the regulations promulgated thereunder, to pay a $4,000,000 penalty to the United States and to provide $100,000 to each of the following programs designed to enhance and protect the natural environment, particularly habitats for the bird populations that the U.S. EPA’s regulation of pesticides is designed to protect: (1) Ohio Audubon’s Important Bird Area Program; (2) Ohio Department of Natural Resources’ Urban Forestry Program; (3) Columbus Metro-Parks Bird Habitat Enhancement Program; (4) Cornell University Ornithology Laboratory; and (5) The Nature Conservancy of Ohio. In exchange for Scotts Miracle-Gro’s guilty plea and the other promises contained in the Plea Agreement, the U.S. DOJ has agreed not to criminally prosecute the Company for any other federal crimes relating to any potential FIFRA violations known to the government as of the date of the Plea Agreement. The Company’s previously established reserve covers the full amount of the proposed criminal penalty and other amounts payable under the Plea Agreement.

The U.S. EPA and related state investigations continue and the Plea Agreement between Scotts Miracle-Gro and the U.S. DOJ must still be approved by the United States District Court. In addition, the current investigations and proceedings may result in future state, federal or private rights of action as well as judgments, settlements, fines and/or penalties with respect to known or potential additional product registration issues. At this stage of the investigations, the Company cannot reasonably estimate the total scope or magnitude of all possible liabilities that could result from known or potential product registration issues. Based on the facts and circumstances known to the Company at this time (including settlement discussions that have taken place to date and the pending Plea Agreement), the Company has established what it believes to be an appropriate reserve. It is possible that any fines and/or penalties with respect to the investigations, as well as any judgments, litigation costs or other liabilities relating to such known or potential product registration issues, could exceed the amount of the reserve, possibly materially, and could have an adverse effect on the Company’s financial condition, results of operations or cash flows.

As a result of these registration and recall matters, the Company has recorded charges for affected inventory and other registration and recall-related costs. The Company expects that future charges will include costs associated with the rework of certain finished goods inventories, the potential disposal of certain products and ongoing third-party professional services related to the U.S. EPA, U.S. DOJ and state investigations. It may also be appropriate to establish additional reserves as settlement discussions continue or in connection with other actions or potential liabilities arising in connection with the product registration issues.

The following tables summarize the impact of the product registration and recall matters on the Company’s results of operations during the three months ended December 31, 2011 and January 1, 2011, and on accrued liabilities and inventory reserves as of December 31, 2011 (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Cost of sales — other charges	$	—		$	0.8
Gross loss		—			(0.8	)
Selling, general and administrative		0.3			0.9
Loss from operations		(0.3	)		(1.7	)
Income tax benefit		0.1			0.6
Net loss	$	(0.2	)	$	(1.1	)

		September 30,		September 30,		September 30,			September 30,
	RESERVES AT SEPTEMBER  30, 2011		ADDITIONAL COSTS AND CHANGES IN ESTIMATE		RESERVES USED			RESERVES AT DECEMBER  31, 2011
Inventory reserves	$	0.4	$	—	$	—		$	0.4
Other incremental costs of sales		0.3		—		—			0.3
Other general and administrative costs		7.8		0.3		(0.6	)		7.5
Accrued liabilities and inventory reserves	$	8.5	$	0.3	$	(0.6	)	$	8.2

NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES

On August 8, 2011, the Company announced a restructuring plan (the “2011 restructuring plan”) designed to streamline management decision making and continue the regionalization of the Company’s operating structure, with the objective of reinvesting the savings generated in innovation and growth initiatives. During fiscal 2011, the Company incurred $24.2 million in restructuring costs related to termination benefits provided to employees who were involuntarily terminated and special termination benefits provided to certain employees upon future separation, as well as $2.3 million related to curtailment charges for its U.S. defined benefit pension and U.S. retiree medical plans. A majority of these costs that were incurred were in relation to the Global Consumer and Corporate & Other segments. In continuation of the 2011 restructuring plan, during the three months ended December 31, 2011, the Company incurred an additional $2.4 million in restructuring costs related to termination benefits provided to employees who accepted voluntary retirement and special termination benefits provided to certain employees upon future separation as well as $0.2 million related to curtailment charges for its U.S. defined benefit pension and U.S retiree medical plans. A significant portion of the amounts reserved as of September 30, 2011 and December 31, 2011 will be paid out over the course of fiscal 2012. Included in the restructuring reserves is $7.2 million that is classified as long-term. Payments against the long-term reserves will start once the employees covered by the 2011 restructuring plan retire.

9

The following table summarizes the activity related to liabilities associated with the restructuring and other charges during the three months ended December 31, 2011:

		September 30,
	DECEMBER 31, 2011
Amounts reserved for restructuring and other charges at September 30, 2011	$	29.6
Restructuring and other charges		2.6
Payments and other		(5.6	)
Amounts reserved for restructuring and other charges at December 31, 2011	$	26.6

NOTE 5. INVENTORIES

Inventories, net of reserves of $12.2 million, $27.2 million and $22.0 million as of December 31, 2011, January 1, 2011 and September 30, 2011, respectively, consisted of the following (in millions):

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Finished goods	$	435.9	$	351.5	$	130.7
Work-in-process		52.0		37.4		34.3
Raw materials		166.9		178.1		222.0
Total inventories	$	654.8	$	567.0	$	387.0

NOTE 6. MARKETING AGREEMENT

The Company is Monsanto’s exclusive agent for the marketing and distribution of consumer Roundup^® herbicide products (with additional rights to new products containing glyphosate or other similar non-selective herbicides) in the consumer lawn and garden market within the United States and other specified countries, including Australia, Austria, Belgium, Canada, France, Germany, the Netherlands and the United Kingdom. Under the terms of the Marketing Agreement, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The annual gross commission under the Marketing Agreement is calculated as a percentage of the actual earnings before interest and income taxes (EBIT) of the consumer Roundup^® business in the markets covered by the Marketing Agreement and is based on the achievement of two earnings thresholds, as defined in the Marketing Agreement. The Marketing Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of the consumer Roundup^® business. The annual contribution payment is defined in the Marketing Agreement as $20 million.

In consideration for the rights granted to the Company under the Marketing Agreement for North America, the Company was required to pay a marketing fee of $32 million to Monsanto. The Company has deferred this amount on the basis that the payment will provide a future benefit through commissions that will be earned under the Marketing Agreement. The economic useful life over which the marketing fee is being amortized is 20 years, with a remaining amortization period of seven years as of December 31, 2011.

Under the terms of the Marketing Agreement, the Company performs certain functions, primarily manufacturing conversion, distribution and logistics, and selling and marketing support, on behalf of Monsanto in the conduct of the consumer Roundup^® business. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred under the Marketing Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in “Cost of sales” and the reimbursement of these costs in “Net sales,” with no effect on gross profit dollars or net income.

10

The gross commission earned under the Marketing Agreement, the contribution payments to Monsanto and the amortization of the initial marketing fee paid to Monsanto are included in the calculation of net sales in the Company’s Consolidated Statements of Operations. The elements of the net commission and reimbursements earned under the Marketing Agreement and included in “Net sales” are as follows (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Gross commission	$	—		$	—
Contribution expenses		(5.0	)		(5.0	)
Amortization of marketing fee		(0.2	)		(0.2	)
Net commission expense		(5.2	)		(5.2	)
Reimbursements associated with Marketing Agreement		17.9			15.2
Total net sales associated with Marketing Agreement	$	12.7		$	10.0

The Marketing Agreement has no definite term except as it relates to the European Union countries (the “EU term”). The EU term extends through September 30, 2013, with an automatic renewal period of two years, subject to non-renewal only upon the occurrence of certain performance defaults. Thereafter, the Marketing Agreement provides that the parties may agree to renew the EU term for an additional three years.

The Marketing Agreement provides Monsanto with the right to terminate the Marketing Agreement upon an event of default (as defined in the Marketing Agreement) by the Company, a change in control of Monsanto or the sale of the consumer Roundup^® business. The Marketing Agreement provides the Company with the right to terminate the Marketing Agreement in certain circumstances, including an event of default by Monsanto or the sale of the consumer Roundup^® business. Unless Monsanto terminates the Marketing Agreement due to an event of default by the Company, Monsanto is required to pay a termination fee to the Company that varies by program year. The termination fee is calculated as a percentage of the value of the Roundup^® business exceeding a certain threshold, but in no event will the termination fee be less than $16 million. If Monsanto were to terminate the Marketing Agreement for cause, the Company would not be entitled to any termination fee. Monsanto may also be able to terminate the Marketing Agreement within a given region, including North America, without paying a termination fee if unit volume sales to consumers in that region decline: (1) over a cumulative three-fiscal-year period; or (2) by more than 5% for each of two consecutive years. If the Marketing Agreement was terminated for any reason, the Company would also lose all, or a substantial portion, of the significant source of earnings and overhead expense absorption the Marketing Agreement provides.

Under the Marketing Agreement, Monsanto must provide the Company with notice of any proposed sale of the consumer Roundup business, allow the Company to participate in the sale process and negotiate in good faith with the Company with respect to any such proposed sale. In the event the Company acquires the consumer Roundup^® business in such a sale, the Company would receive as a credit against the purchase price the amount of the termination fee that would have been paid to the Company if Monsanto had exercised its right to terminate the Marketing Agreement in connection with a sale to another party. If Monsanto decides to sell the consumer Roundup^® business to another party, the Company must let Monsanto know whether the Company intends to terminate the Marketing Agreement and forfeit any right to a termination fee or whether it will agree to continue to perform under the Marketing Agreement on behalf of the purchaser.

NOTE 7. DEBT

The components of long-term debt are as follows (in millions):

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Credit Facilities:
Revolving loans	$	621.7	$	227.4	$	387.2
Term loans		—		208.5		—
Senior Notes – 7.25%		200.0		200.0		200.0
Senior Notes – 6.625%		200.0		200.0		200.0
MARP Agreement		5.4		—		—
Foreign borrowings (local facilities and term loans)		0.3		1.3		0.4
Contingent consideration		0.3		10.8		0.3
Other		6.5		7.9		7.1
		1,034.2		855.9		795.0
Less current portions		8.1		168.5		3.2
Total long-term debt	$	1,026.1	$	687.4	$	791.8

11

As of December 31, 2011, there was $1.05 billion of availability under the Company’s senior secured credit facility, including availability under letters of credit. Under the credit facility, the Company has the ability to issue letter of credit commitments up to $75 million. At December 31, 2011, the Company had letters of credit in the aggregate face amount of $26.3 million outstanding.

The Company was in compliance with the terms of all debt covenants at December 31, 2011. The credit facility contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio, calculated as average total indebtedness, as described in the Company’s credit facility, relative to the Company’s EBITDA, as adjusted pursuant to the terms of the credit facility (“Adjusted EBITDA”). Under the terms of the credit facility, the maximum leverage ratio was 3.50 as of December 31, 2011. The Company’s leverage ratio was 2.09 at December 31, 2011. The Company’s credit facility also includes an affirmative covenant regarding its interest coverage ratio. Interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the credit facility, and excludes costs related to refinancings. Under the terms of the credit facility, the minimum interest coverage ratio was 3.50 for the twelve months ended December 31, 2011. The Company’s interest coverage ratio was 6.79 for the twelve months ended December 31, 2011.

On September 21, 2011, the Company entered into a new Master Accounts Receivable Purchase Agreement (the “MARP Agreement”), with an initial stated termination date of September 21, 2012, or such later date as may be mutually agreed by the Company and the banks party thereto. The MARP Agreement, which is uncommitted, provides for the discretionary sale by the Company, and the discretionary purchase by the banks, on a revolving basis, of accounts receivable generated by sales to two specified account debtors in an aggregate amount not to exceed $325 million, with debtor sublimits ranging from $120 million to $250 million. Under the terms of the MARP Agreement, the banks have the opportunity to purchase those accounts receivable offered by the Company at a discount (from the agreed base value thereof) effectively equal to the greater of 7-day or 3-month LIBOR plus 1.05%. The MARP Agreement replaced the Company’s previous Master Accounts Receivable Purchase Agreement, which provided for the discounted sale, on an uncommitted, revolving basis, of accounts receivable generated by a single specified account debtor, with aggregate limits not to exceed $80 million and an interest rate that approximated the 7-day LIBOR rate plus 1.25%. The previous Master Accounts Receivable Purchase Agreement was scheduled to expire on September 30, 2011.

The Company accounts for the sale of receivables under the MARP Agreement as short-term debt and continues to carry the receivables on its Consolidated Balance Sheet, primarily as a result of the Company’s right to repurchase receivables sold. There were $5.4 million in borrowings under the MARP Agreement as of December 31, 2011.

Estimated Fair Values

A description of the methods and assumptions used to estimate the fair values of the Company’s debt instruments is as follows:

Credit Facility

The interest rate currently available to the Company fluctuates with the applicable LIBOR rate, prime rate or Federal Funds Effective Rate, and thus the carrying value is a reasonable estimate of fair value.

7.25% Senior Notes

The fair value of Scotts Miracle-Gro’s 7.25% Senior Notes due 2018 (the “7.25% Senior Notes”) can be determined based on the trading of the 7.25% Senior Notes in the open market. The difference between the carrying value and the fair value of the 7.25% Senior Notes represents the premium or discount on that date. Based on the trading value on or around December 31, 2011, the fair value of the 7.25% Senior Notes was approximately $212.0 million.

6.625% Senior Notes

The fair value of Scotts Miracle-Gro’s 6.625% Senior Notes due 2020 (the “6.625% Senior Notes”) can be determined based on the trading of the 6.625% Senior Notes. The difference between the carrying value and the fair value of the 6.625% Senior Notes represents the premium or discount on that date. Based on the trading value on or around December 31, 2011, the fair value of the 6.625% Senior Notes was approximately $203.3 million.

Accounts Receivable Pledged

The interest rate on the short-term debt associated with accounts receivable pledged under the MARP Agreement fluctuates with the applicable LIBOR rate, and thus the carrying value is a reasonable estimate of fair value.

12

NOTE 8. COMPREHENSIVE INCOME (LOSS)

The components of other comprehensive income (loss) (“OCI”) were as follows (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net loss	$	(73.9	)	$	(67.9	)
Other comprehensive income (loss):
Net unrealized gain (loss) on derivative instruments		(0.6	)		2.8
Net change in pension and other postretirement related items		1.9			6.2
Foreign currency translation adjustments		(3.5	)		2.2
Total comprehensive loss	$	(76.1	)	$	(56.7	)

NOTE 9. RETIREMENT AND RETIREE MEDICAL PLANS

The following summarizes the components of net periodic benefit cost for the retirement and retiree medical plans sponsored by the Company (in millions):

		September 30,			September 30,			September 30,		September 30,			September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011								JANUARY 1, 2011
	U.S. Pension			International Pension			U.S. Medical		U.S. Pension			International Pension			U.S. Medical
Service cost	$	—		$	0.3		$	0.1	$	—		$	0.4		$	0.1
Interest cost		1.1			2.4			0.4		1.2			2.7			0.4
Expected return on plan assets		(1.4	)		(2.2	)		—		(1.3	)		(2.6	)		—
Net amortization		1.3			0.2			0.1		1.2			0.4			—
Curtailment loss		0.2			—			—		—			—			—
Net periodic benefit cost	$	1.2		$	0.7		$	0.6	$	1.1		$	0.9		$	0.5

NOTE 10. SHAREHOLDERS’ EQUITY

During the three months ended December 31, 2011, Scotts Miracle-Gro repurchased 0.4 million of its common shares (the “Common Shares”) for $17.5 million. These repurchases were made pursuant to the $700 million share repurchase program approved by the Scotts Miracle-Gro Board of Directors. Since the inception of the program in the fourth quarter of fiscal 2010 through December 31, 2011, Scotts Miracle-Gro has repurchased approximately 7.9 million Common Shares for $401.2 million to be held in treasury.

Share-based awards

The following is a summary of the share-based awards granted over the periods indicated:

		September 30,		September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011		JANUARY 1, 2011
Performance shares		—		11,574
Restricted stock units (including deferred stock units)		1,134		2,721
Total share-based awards		1,134		14,295
Aggregate fair value at grant dates (in millions)	$	0.1	$	0.7

Total share-based compensation was $1.6 million and $4.3 million for the three months ended December 31, 2011 and January 1, 2011, respectively.

Subsequent to December 31, 2011, Scotts Miracle-Gro awarded stock options, performance share units, restricted stock units and deferred stock units covering 0.7 million Common Shares to employees and members of the Board of Directors with an estimated fair value of $16.7 million on the date of the grant.

13

NOTE 11. INCOME TAXES

The effective tax rate related to continuing operations for the three months ended December 31, 2011 was 36.0%, compared to 35.9% for the three months ended January 1, 2011. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year. An allocation of the income tax expense has been separately determined to report the discontinued operations, net of tax. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year end.

Scotts Miracle-Gro and/or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. With few exceptions, which are discussed below, the Company is no longer subject to examinations by these tax authorities for fiscal years prior to 2008. The Company is currently under examination by certain foreign and U.S. state and local tax authorities. In regard to the local German audit, the tax periods under investigation are limited to fiscal years 2004 through 2008. In regard to the U.S. state and local audits, the tax periods under investigation are limited to fiscal years 1997 through 2009. In addition to these aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company currently anticipates that few of its open and active audits will be resolved within the next 12 months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

NOTE 12. CONTINGENCIES

Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, its assessment of contingencies is reasonable and related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. The following are the more significant of the Company’s identified contingencies:

FIFRA Compliance and the Corresponding Governmental Investigations

For a description of the Company’s ongoing FIFRA compliance efforts and the corresponding governmental investigations, see “NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS.”

Other Regulatory Matters

At December 31, 2011, $4.0 million was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheet for non-FIFRA compliance-related environmental actions, the majority of which is for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.

Other

The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. The complaints in these cases are not specific about the plaintiffs’ contacts with the Company or its products. The Company in each case is one of numerous defendants and none of the claims seek damages from the Company alone. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no reserves have been recorded in the Company’s condensed consolidated financial statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

14

NOTE 13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

Exchange Rate Risk Management

The Company periodically uses foreign currency swap contracts to manage the exchange rate risk associated with intercompany loans with foreign subsidiaries that are denominated in local currencies. At December 31, 2011, the notional amount of outstanding foreign currency swap contracts was $306.3 million, with a fair value of $3.5 million. At January 1, 2011, the notional amount of outstanding foreign currency swap contracts was $330.7 million with a fair value of $5.0 million. The fair value of foreign currency swap contracts is determined based on changes in spot rates. The unrealized gain on the foreign currency swap contracts approximates the unrealized loss on the intercompany loans recognized by the Company’s lending subsidiaries. The contracts will mature over the next fiscal year.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. The fair values are reflected in the Company’s Condensed Consolidated Balance Sheets. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded as elements of accumulated other comprehensive loss (“AOCI”) within the Condensed Consolidated Balance Sheets. The fair value of the swap agreements is determined based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date.

At December 31, 2011 and January 1, 2011, the Company had outstanding interest rate swap agreements with major financial institutions that effectively converted a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a total U.S. dollar equivalent notional amount of $900 million and $800 million at December 31, 2011 and January 1, 2011, respectively. Included in the AOCI balance at December 31, 2011 was a loss of $5.2 million related to interest rate swap agreements that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

Commodity Price Risk Management

The Company had outstanding hedging arrangements at December 31, 2011 designed to fix the price of a portion of its projected future urea requirements. The contracts are designated as hedges of the Company’s exposure to future cash flow fluctuations associated with the cost of urea. The objective of the hedges is to mitigate the earnings and cash flow volatility attributable to the risk of changing prices. Unrealized gains or losses in the fair value of these contracts are recorded to the AOCI component of shareholders’ equity. Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at December 31, 2011 was a loss of $0.1 million related to urea derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

Periodically, the Company also uses derivatives to partially mitigate the effect of fluctuating diesel and gasoline costs on operating results. Any such derivatives that do not qualify for hedge accounting treatment in accordance with GAAP are recorded at fair value, with unrealized gains and losses on open contracts and realized gains or losses on settled contracts recorded as an element of cost of sales. Unrealized gains or losses in the fair value of contracts that do qualify for hedge accounting are recorded in OCI except for any ineffective portion of the change in fair value, which is immediately recorded in earnings. For the effective portion of the change in fair value, realized gains or losses remain as a component of AOCI until the related fuel is consumed. Upon consumption of the fuel, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at December 31, 2011 was a loss of $0.1 million related to fuel derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

15

As of December 31, 2011 and January 1, 2011, the Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

		September 30,		September 30,
	THREE MONTHS ENDED
Commodity	DECEMBER 31, 2011		JANUARY 1, 2011
Urea		40,500 tons		39,500 tons
Diesel		5,250,000 gallons		3,570,000 gallons
Gasoline		217,000 gallons		—
Heating Oil		2,268,000 gallons		—

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments were as follows (in millions):

	September 30,		September 30,			September 30,			September 30,
		ASSETS / (LIABILITIES)
DERIVATIVES DESIGNATED AS HEDGING		DECEMBER 31, 2011			JANUARY 1, 2011			SEPTEMBER 30, 2011
INSTRUMENTS	BALANCE SHEET LOCATION	FAIR VALUE
Interest rate swap agreements	Other assets	$	—		$	2.4		$	—
	Other current liabilities		(8.4	)		(12.3	)		(10.7	)
	Other liabilities		(18.9	)		(6.2	)		(17.4	)
Commodity hedging instruments	Prepaid and other assets		—			3.6			0.1
	Other current liabilities		(2.1	)		—			(0.3	)
Total derivatives designated as hedging instruments		$	(29.4	)	$	(12.5	)	$	(28.3	)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS (1)
Foreign currency swap contracts	Prepaid and other assets	$	3.5		$	5.3		$	2.7
	Other current liabilities		(0.6	)		(0.3	)		—
Commodity hedging instruments	Prepaid and other assets		—			0.8			—
	Other current liabilities		(0.2	)		—			(0.5	)
Total derivatives not designated as hedging instruments (1)		$	(2.7	)	$	5.8		$	2.2
Total derivatives		$	(26.7	)	$	(6.7	)	$	(26.1	)

(1) See discussion above for additional information regarding the Company’s purpose for entering into derivatives not designated as hedging instruments and its overall risk management strategy.

16

The effect of derivative instruments on OCI and the Condensed Consolidated Statements of Operations for the three months ended December 31, 2011 and January 1, 2011 was as follows (in millions):

		September 30,			September 30,
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS	AMOUNT OF GAIN / (LOSS) RECOGNIZED IN OCI
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Interest rate swap agreements	$	(2.2	)	$	2.5
Commodity hedging instruments		(1.4	)		2.1
Total	$	(3.6	)	$	4.6

	September 30,		September 30,			September 30,
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS	LOCATION OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO EARNINGS	AMOUNT OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO EARNINGS
		THREE MONTHS ENDED
		DECEMBER 31, 2011			JANUARY 1, 2011
Interest rate swap agreements	Interest expense	$	(3.1	)	$	(3.1	)
Commodity hedging instruments	Cost of sales		0.1			0.1
Total		$	(3.0	)	$	(3.0	)

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS	LOCATION OF GAIN RECOGNIZED IN EARNINGS	AMOUNT OF GAIN RECOGNIZED IN EARNINGS
		THREE MONTHS ENDED
		DECEMBER 31, 2011		JANUARY 1, 2011
Foreign currency swap contracts	Interest expense	$	6.7	$	8.8
Commodity hedging instruments	Cost of sales		0.4		0.8
Total		$	7.1	$	9.6

NOTE 14. FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

Derivatives

Derivatives consist of foreign currency, interest rate and commodity derivative instruments. Foreign currency swap contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Commodity contracts are measured using observable commodity exchange prices in active markets.

These derivative instruments are classified within Level 2 of the valuation hierarchy and are included within other assets and other liabilities in the Company’s Condensed Consolidated Balance Sheets, except for derivative instruments expected to be settled within the next 12 months, which are included within prepaid and other assets and other current liabilities.

17

Cash equivalents

Cash equivalents consist of highly liquid investments purchased with a maturity of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

Other

Other financial assets consist of investment securities in non-qualified retirement plan assets. These securities are valued using observable market prices in active markets.

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at December 31, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Cash equivalents	$	83.5	$	—		$	—	$	83.5
Derivatives
Foreign currency swap contracts		—		3.5			—		3.5
Other		6.5		—			—		6.5
Total	$	90.0	$	3.5		$	—	$	93.5
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(27.3	)	$	—	$	(27.3	)
Foreign currency swap contracts		—		(0.6	)		—		(0.6	)
Commodity hedging instruments		—		(2.3	)		—		(2.3	)
Total	$	—	$	(30.2	)	$	—	$	(30.2	)

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at January 1, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Derivatives
Interest rate swap agreements	$	—	$	2.4		$	—	$	2.4
Foreign currency swap contracts		—		5.3			—		5.3
Commodity hedging instruments		—		4.4			—		4.4
Other		7.8		—			—		7.8
Total	$	7.8	$	12.1		$	—	$	19.9
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(18.5	)	$	—	$	(18.5	)
Foreign currency swap contracts		—		(0.3	)		—		(0.3	)
Total	$	—	$	(18.8	)	$	—	$	(18.8	)

18

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at September 30, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Cash equivalents	$	83.6	$	—		$	—	$	83.6
Derivatives
Commodity hedging instruments		—		0.1			—		0.1
Foreign currency swap contracts		—		2.7			—		2.7
Other		6.3		—			—		6.3
Total	$	89.9	$	2.8		$	—	$	92.7
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(28.1	)	$	—	$	(28.1	)
Commodity hedging instruments		—		(0.8	)		—		(0.8	)
Total	$	—	$	(28.9	)	$	—	$	(28.9	)

NOTE 15. SEGMENT INFORMATION

The Company divides its business into the following segments—Global Consumer and Scotts LawnService^®. This division of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company.

Segment performance is evaluated based on several factors, including income from continuing operations before amortization, product registration and recall costs, and impairment, restructuring and other charges, which is not a GAAP measure. Senior management of the Company uses this measure of operating profit to gauge segment performance because the Company believes this measure is the most indicative of performance trends and the overall earnings potential of each segment.

Corporate & Other consists of the Company’s non-European professional seed business, revenues and expenses associated with the Company’s supply agreements with ICL and the amortization related to the Roundup^® Marketing Agreement, as well as corporate, general and administrative expenses and certain other income/expense items not allocated to the business segments. Corporate & Other assets primarily include deferred financing and debt issuance costs and corporate intangible assets, as well as deferred tax assets. For capital expenditures and total assets, Corporate & Other also includes Smith & Hawken, which is classified as discontinued operations on the Consolidated Statements of Operations.

The following tables present summarized financial information concerning the Company’s reportable segments for the periods indicated (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net sales:
Global Consumer	$	149.1		$	188.8
Scotts LawnService®		37.6			37.1
Segment total		186.7			225.9
Corporate & Other		24.5			4.3
Consolidated	$	211.2		$	230.2
Loss from continuing operations before income taxes:
Global Consumer	$	(69.4	)	$	(55.1	)
Scotts LawnService®		(4.6	)		(4.5	)
Segment total		(74.0	)		(59.6	)
Corporate & Other		(20.8	)		(30.9	)
Intangible asset amortization		(2.5	)		(2.3	)
Product registration and recall matters		(0.3	)		(1.7	)
Restructuring and other charges		(2.6	)		—
Interest expense		(15.3	)		(9.5	)
Consolidated	$	(115.5	)	$	(104.0	)

19

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Total assets:
Global Consumer	$	1,723.8	$	1,584.2	$	1,552.4
Scotts LawnService®		162.2		155.4		184.3
Corporate & Other		278.3		314.7		315.5
Assets held for sale		—		200.9		—
Consolidated	$	2,164.3	$	2,255.2	$	2,052.2

NOTE 16. FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS

The 7.25% and 6.625% Senior Notes (collectively, the “Senior Notes”) issued by Scotts Miracle-Gro on January 14, 2010 and December 16, 2010, respectively, are guaranteed by certain of its domestic subsidiaries and, therefore, the Company has disclosed condensed consolidating financial information in accordance with SEC Regulation S-X Rule 3-10, Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered. The following 100% directly or indirectly owned subsidiaries fully and unconditionally guarantee the Senior Notes on a joint and several basis: EG Systems, Inc., dba Scotts LawnService^®; Gutwein & Co., Inc.; Hyponex Corporation; Miracle-Gro Lawn Products, Inc.; OMS Investments, Inc.; Rod McLellan Company; Sanford Scientific, Inc.; Scotts Temecula Operations, LLC; Scotts Manufacturing Company; Scotts Products Co.; Scotts Professional Products Co.; Scotts-Sierra Investments, Inc.; SMG Brands, Inc.; SMG Growing Media, Inc.; Swiss Farms Products, Inc.; and The Scotts Company LLC (collectively, the “Guarantors”). SMG Brands, Inc. was added as a Guarantor of the Senior Notes on September 28, 2011. Accordingly, SMG Brands, Inc. has been classified as a Guarantor for all periods presented in the condensed consolidating financial information accompanying this Note 16.

The following information presents condensed consolidating Statements of Operations for the three months ended December 31, 2011 and January 1, 2011, condensed consolidating Statements of Cash Flows for the three months ended December 31, 2011 and January 1, 2011, and condensed consolidating Balance Sheets as of December 31, 2011, January 1, 2011 and September 30, 2011. The condensed consolidating financial information presents, in separate columns, financial information for: Scotts Miracle-Gro on a Parent-only basis, carrying its investment in subsidiaries under the equity method; Guarantors on a combined basis, carrying their investments in subsidiaries which do not guarantee the debt (collectively, the “Non-Guarantors”) under the equity method; Non-Guarantors on a combined basis; and eliminating entries. The eliminating entries primarily reflect intercompany transactions, such as interest expense, accounts receivable and payable, short and long-term debt, and the elimination of equity investments and income in subsidiaries. Because the Parent is obligated to pay the unpaid principal amount and interest on all amounts borrowed by the Guarantors or Non-Guarantors under the credit facility (and was obligated to pay the unpaid principal amount and interest on all amounts borrowed by the Guarantors and Non-Guarantors under the previous senior secured five-year revolving loan facility), the borrowings and related interest expense for the loans outstanding of the Guarantors and Non-Guarantors are also presented in the accompanying Parent-only financial information, and are then eliminated.

20

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Operations

for the three months ended December 31, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,			September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations			Consolidated
Net sales	$	—		$	157.1		$	54.1		$	—		$	211.2
Cost of sales		—			144.8			41.6			—			186.4
Gross profit		—			12.3			12.5			—			24.8
Operating expenses:
Selling, general and administrative		—			95.5			27.5			—			123.0
Impairment, restructuring and other charges		—			2.6			—			—			2.6
Product registration and recall matters		—			0.3			—			—			0.3
Other income, net		(2.8	)		(0.5	)		(0.4	)		2.8			(0.9	)
Income (loss) from operations		2.8			(85.6	)		(14.6	)		(2.8	)		(100.2	)
Equity loss in subsidiaries		66.2			9.8			—			(76.0	)		—
Interest expense		10.8			6.6			0.7			(2.8	)		15.3
Loss from continuing operations before income taxes		(74.2	)		(102.0	)		(15.3	)		76.0			(115.5	)
Income tax benefit from continuing operations		(0.3	)		(35.8	)		(5.5	)		—			(41.6	)
Loss from continuing operations		(73.9	)		(66.2	)		(9.8	)		76.0			(73.9	)
Loss from discontinued operations, net of tax		—			—			—			—			—
Net loss	$	(73.9	)	$	(66.2	)	$	(9.8	)	$	76.0		$	(73.9	)

21

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Cash Flows

for the three months ended December 31, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,		September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations		Consolidated
NET CASH USED IN OPERATING ACTIVITIES	$	(8.0	)	$	(144.7	)	$	(48.4	)	$	—	$	(201.1	)
INVESTING ACTIVITIES
Investments in property, plant and equipment		—			(13.3	)		(3.1	)		—		(16.4	)
Net cash used in investing activities		—			(13.3	)		(3.1	)		—		(16.4	)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit		—			321.9			125.1			—		447.0
Repayments under revolving and bank lines of credit		—			(30.7	)		(175.0	)		—		(205.7	)
Dividends paid		(18.9	)		—			—			—		(18.9	)
Purchase of common shares		(17.5	)		—			—			—		(17.5	)
Excess tax benefits from share-based payment arrangements		—			3.8			—			—		3.8
Cash received from the exercise of stock options		5.6			—			—			—		5.6
Intercompany financing		38.8			(131.3	)		92.5			—		—
Net cash provided by financing activities		8.0			163.7			42.6			—		214.3
Effect of exchange rate changes on cash		—			—			0.1			—		0.1
Net increase (decrease) in cash and cash equivalents		—			5.7			(8.8	)		—		(3.1	)
Cash and cash equivalents, beginning of period		—			4.3			126.6			—		130.9
Cash and cash equivalents, end of period	$	—		$	10.0		$	117.8		$	—	$	127.8

22

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Balance Sheet

As of December 31, 2011

(in millions)

		September 30,		September 30,		September 30,			September 30,			September 30,
			Subsidiary		Non-
	Parent		Guarantors		Guarantors			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	10.0	$	117.8		$	—		$	127.8
Accounts receivable, net		—		92.7		73.8			—			166.5
Accounts receivable pledged		—		14.3		—			—			14.3
Inventories		—		543.6		111.2			—			654.8
Prepaid and other current assets		—		102.2		46.6			—			148.8
Total current assets		—		762.8		349.4			—			1,112.2
Property, plant and equipment, net		—		343.2		48.2			—			391.4
Goodwill		—		308.4		0.7			—			309.1
Intangible assets, net		—		269.6		46.6			—			316.2
Other assets		32.1		13.3		27.6			(37.6	)		35.4
Equity investment in subsidiaries		699.2		—		—			(699.2	)		—
Intercompany assets		788.3		207.7		—			(996.0	)		—
Total assets	$	1,519.6	$	1,905.0	$	472.5		$	(1,732.8	)	$	2,164.3
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	—	$	7.8	$	0.3		$	—		$	8.1
Accounts payable		—		165.6		54.8			—			220.4
Other current liabilities		15.3		118.6		86.7			—			220.6
Total current liabilities		15.3		292.0		141.8			—			449.1
Long-term debt		1,021.7		547.4		78.7			(621.7	)		1,026.1
Other liabilities		18.4		200.5		43.6			(37.6	)		224.9
Equity investment in subsidiaries		—		336.1		—			(336.1	)		—
Intercompany liabilities		—		—		374.3			(374.3	)		—
Total liabilities		1,055.4		1,376.0		638.4			(1,369.7	)		1,700.1
Shareholders’ equity		464.2		529.0		(165.9	)		(363.1	)		464.2
Total liabilities and shareholders’ equity	$	1,519.6	$	1,905.0	$	472.5		$	(1,732.8	)	$	2,164.3

23

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Operations

for the three months ended January 1, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,			September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations			Consolidated
Net sales	$	—		$	176.8		$	53.4		$	—		$	230.2
Cost of sales		—			143.3			37.0			—			180.3
Cost of sales—product registration and recall matters		—			0.8			—			—			0.8
Gross profit		—			32.7			16.4			—			49.1
Operating expenses:
Selling, general and administrative		—			115.1			28.1			—			143.2
Product registration and recall matters		—			0.9			—			—			0.9
Other (income) loss, net		—			0.2			(0.7	)		—			(0.5	)
Loss from operations		—			(83.5	)		(11.0	)		—			(94.5	)
Equity loss in subsidiaries		63.6			8.4			—			(72.0	)		—
Other non-operating income		(3.8	)		—			—			3.8			—
Interest expense		8.7			4.3			0.3			(3.8	)		9.5
Loss from continuing operations before income taxes		(68.5	)		(96.2	)		(11.3	)		72.0			(104.0	)
Income tax benefit from continuing operations		(0.6	)		(32.7	)		(4.0	)		—			(37.3	)
Loss from continuing operations		(67.9	)		(63.5	)		(7.3	)		72.0			(66.7	)
Loss from discontinued operations, net of tax		—			—			(1.2	)		—			(1.2	)
Net loss	$	(67.9	)	$	(63.5	)	$	(8.5	)	$	72.0		$	(67.9	)

24

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Cash Flows

for the three months ended January 1, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,		September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations		Consolidated
NET CASH USED IN OPERATING ACTIVITIES	$	(0.6	)	$	(125.0	)	$	(44.1	)	$	—	$	(169.7	)
INVESTING ACTIVITIES
Investments in property, plant and equipment		—			(25.2	)		(2.9	)		—		(28.1	)
Net cash used in investing activities		—			(25.2	)		(2.9	)		—		(28.1	)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans		—			205.2			53.0			—		258.2
Repayments under revolving and bank lines of credit and term loans		—			(94.0	)		(140.0	)		—		(234.0	)
Proceeds from issuance of 6.625% Senior Notes		200.0			—			—			—		200.0
Dividends paid		(16.8	)		—			—			—		(16.8	)
Purchase of common shares		(25.0	)		—			—			—		(25.0	)
Financing and issuance fees		(4.1	)		—			—			—		(4.1	)
Excess tax benefits from share-based payment arrangements		—			1.5			—			—		1.5
Cash received from the exercise of stock options		6.5			—			—			—		6.5
Intercompany financing		(160.0	)		43.2			116.8			—		—
Net cash provided by financing activities		0.6			155.9			29.8			—		186.3
Effect of exchange rate changes on cash		—			—			2.2			—		2.2
Net increase (decrease) in cash and cash equivalents		—			5.7			(15.0	)		—		(9.3	)
Cash and cash equivalents, beginning of period		—			5.1			83.0			—		88.1
Cash and cash equivalents, end of period	$	—		$	10.8		$	68.0		$	—	$	78.8

25

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Balance Sheet

As of January 1, 2011

(in millions)

		September 30,		September 30,		September 30,			September 30,			September 30,
			Subsidiary		Non-
	Parent		Guarantors		Guarantors			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	10.8	$	68.0		$	—		$	78.8
Accounts receivable, net		—		137.0		76.2			—			213.2
Inventories		—		474.0		93.0			—			567.0
Assets held for sale		—		—		200.9			—			200.9
Prepaid and other current assets		—		97.9		38.2			—			136.1
Total current assets		—		719.7		476.3			—			1,196.0
Property, plant and equipment, net		—		344.5		46.6			—			391.1
Goodwill		—		305.1		0.7			—			305.8
Intangible assets, net		—		273.9		52.8			—			326.7
Other assets		13.6		23.1		28.8			(29.9	)		35.6
Equity investment in subsidiaries		919.3		—		—			(919.3	)		—
Intercompany assets		578.1		—		—			(578.1	)		—
Total assets	$	1,511.0	$	1,666.3	$	605.2		$	(1,527.3	)	$	2,255.2
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	164.7	$	2.4	$	1.4		$	—		$	168.5
Accounts payable		—		161.0		47.5			—			208.5
Liabilities held for sale		—		—		45.4			—			45.4
Other current liabilities		7.3		142.4		95.1			—			244.8
Total current liabilities		172.0		305.8		189.4			—			667.2
Long-term debt		657.4		230.0		13.7			(213.7	)		687.4
Other liabilities		3.0		198.1		50.8			(29.9	)		222.0
Equity investment in subsidiaries		—		173.3		—			(173.3	)		—
Intercompany liabilities		—		10.0		354.4			(364.4	)		—
Total liabilities		832.4		917.2		608.3			(781.3	)		1,576.6
Shareholders’ equity		678.6		749.1		(3.1	)		(746.0	)		678.6
Total liabilities and shareholders’ equity	$	1,511.0	$	1,666.3	$	605.2		$	(1,527.3	)	$	2,255.2

26

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Balance Sheet

As of September 30, 2011

(in millions)

		September 30,		September 30,		September 30,			September 30,			September 30,
			Subsidiary		Non-
	Parent		Guarantors		Guarantors			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	4.3	$	126.6		$	—		$	130.9
Accounts receivable, net		—		248.2		75.3			—			323.5
Inventories		—		313.7		73.3			—			387.0
Prepaid and other current assets		—		107.9		43.2			—			151.1
Total current assets		—		674.1		318.4			—			992.5
Property, plant and equipment, net		—		347.3		47.4			—			394.7
Goodwill		—		308.4		0.7			—			309.1
Intangible assets, net		—		270.3		49.3			—			319.6
Other assets		33.1		13.3		27.6			(37.7	)		36.3
Equity investment in subsidiaries		794.3		—		—			(794.3	)		—
Intercompany assets		553.7		115.4		—			(669.1	)		—
Total assets	$	1,381.1	$	1,728.8	$	443.4		$	(1,501.1	)	$	2,052.2
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	—	$	2.8	$	0.4		$	—		$	3.2
Accounts payable		—		103.9		46.1			—			150.0
Other current liabilities		17.2		202.5		95.7			—			315.4
Total current liabilities		17.2		309.2		142.2			—			468.6
Long-term debt		787.2		261.3		130.5			(387.2	)		791.8
Other liabilities		16.9		205.6		47.2			(37.7	)		232.0
Equity investment in subsidiaries		—		328.7		—			(328.7	)		—
Intercompany liabilities		—		—		281.9			(281.9	)		—
Total liabilities		821.3		1,104.8		601.8			(1,035.5	)		1,492.4
Shareholders’ equity		559.8		624.0		(158.4	)		(465.6	)		559.8
Total liabilities and shareholders’ equity	$	1,381.1	$	1,728.8	$	443.4		$	(1,501.1	)	$	2,052.2

27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The purpose of this discussion is to provide an understanding of the financial condition and results of operations of The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company,” “we” or “us”) by focusing on changes in certain key measures from year-to-year. Management’s Discussion and Analysis is divided into the following sections:

• Executive summary

• Results of operations

• Segment results

• Management’s outlook

• Liquidity and capital resources

• Regulatory matters

• Critical accounting policies and estimates

This discussion and analysis should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011.

EXECUTIVE SUMMARY

We are dedicated to delivering strong, long-term financial results and outstanding shareholder returns by providing products of superior quality and value to enhance consumers’ outdoor lawn and garden environments. We are a leading manufacturer and marketer of consumer branded products for lawn and garden care in North America and Europe. We are Monsanto’s exclusive agent for the marketing and distribution of consumer Roundup^® non-selective herbicide products within the United States and other contractually specified countries. We have a presence in similar consumer branded products in Australia, the Far East and Latin America. We also operate Scotts LawnService^®, the second largest lawn care service business in the United States. Our operations are divided into the following reportable segments: Global Consumer and Scotts LawnService^®.

On February 28, 2011, we completed the sale of a significant majority of the assets of our Global Professional business (excluding our non-European professional seed business, “Global Pro”) to Israel Chemicals Ltd. (“ICL”) for $270 million in an all-cash transaction, subject to certain adjustments, resulting in $270.9 million net proceeds.

Effective in our first quarter of fiscal 2011, we classified Global Pro as discontinued operations. Prior to being reported as discontinued operations, Global Pro was included as part of our former Global Professional business segment. Results for our non-European professional seed business have been classified to Corporate & Other.

As a leading consumer branded lawn and garden company, our product development and marketing efforts are largely focused on providing innovative and differentiated products and on continually increasing brand and product awareness to inspire consumers and create retail demand. We have successfully applied this model for a number of years by focusing on research and development and investing approximately 4 - 5% of our annual net sales in advertising to support and promote our products and brands. We continually explore new and innovative ways to communicate with consumers. We believe that we receive a significant return on these expenditures and anticipate a similar commitment to research and development, advertising and marketing investments in the future, with the continuing objective of driving category growth and increasing market share.

Our sales in any one year are susceptible to weather conditions in the markets in which our products are sold. For instance, periods of abnormally wet or dry weather can adversely impact sales of certain products, while increasing demand for other products. We believe that our diversified product line and our broad geographic diversification reduce this risk, although to a lessor extent in a year where unfavorable weather is geographically wide-spread and extends across a significant portion of the lawn and garden season. We also believe that weather conditions in any one year, positive or negative, do not materially alter longer-term category growth trends.

28

Due to the nature of the lawn and garden business, significant portions of our products ship to our retail customers during our second and third fiscal quarters, as noted in the chart below. Our annual sales are further concentrated in the second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products, thereby reducing retailers’ pre-season inventories.

		September 30,			September 30,			September 30,
	Percent of Net Sales from Continuing Operations by Quarter
	2011			2010			2009
First Quarter		8.1	%		8.7	%		8.5	%
Second Quarter		39.9	%		36.2	%		32.0	%
Third Quarter		37.3	%		40.5	%		42.5	%
Fourth Quarter		14.7	%		14.6	%		17.0	%

Management focuses on a variety of key indicators and operating metrics to monitor the financial condition and performance of the continuing operations of our business. These metrics include consumer purchases (point-of-sale data), market share, category growth, net sales (including unit volume, pricing, product mix and foreign exchange movements), gross profit margins, advertising to net sales ratios, income from operations, income from continuing operations, net income and earnings per share. To the extent applicable, these measures are evaluated with and without impairment, restructuring and other charges as well as product registration and recall matters, which management believes are not indicative of the earnings capabilities of our businesses. We also focus on measures to optimize cash flow and return on invested capital, including the management of working capital and capital expenditures.

The Scotts Miracle-Gro Board of Directors has authorized the repurchase of up to $700 million of our Common Shares through September 30, 2014. Further, on August 8, 2011, we announced that the Scotts Miracle-Gro Board of Directors increased our quarterly dividend from $0.25 to $0.30 per Common Shares. The decisions to increase the amount of cash we intend to return to our shareholders reflect our continued confidence in the long-term performance of our business, which should allow us to return cash to shareholders while also investing to sustain and grow our key competitive advantages. During the first quarter of fiscal 2012, we repurchased approximately 0.4 million of our Common Shares in open market transactions for $17.5 million. From the inception of this program in the fourth quarter of fiscal 2010 through the first quarter of fiscal 2012, we have repurchased approximately 7.9 million of our Common Shares for $401.2 million.

Product Registration and Recall Matters

In April 2008, we became aware that a former associate apparently deliberately circumvented our policies and U.S. EPA regulations under FIFRA by failing to obtain valid registrations for certain products and/or causing certain invalid product registration forms to be submitted to regulators. Since that time, we have been cooperating with both the U.S. EPA and the U.S. DOJ in related civil and criminal investigations into the pesticide product registration issues as well as a state civil investigation into related allegations arising under state pesticide registration laws and regulations.

In late April of 2008, in connection with the U.S. EPA’s investigation, we conducted a consumer-level recall of certain consumer lawn and garden products and a Scotts LawnService^® product. Subsequently, the Company and the U.S. EPA agreed upon a Compliance Review Plan for conducting a comprehensive, independent review of our product registration records. Pursuant to the Compliance Review Plan, an independent third-party firm, QAI, reviewed substantially all of our U.S. pesticide product registrations and associated advertisements, some of which were historical in nature and no longer related to sales of our products. The U.S. EPA investigation and the QAI review process resulted in the temporary suspension of sales and shipments of certain products. In addition, as the QAI review process or our internal review identified potential FIFRA registration issues (some of which appear unrelated to the actions of the former associate), we endeavored to stop selling or distributing the affected products until the issues could be resolved. QAI’s review of our U.S. pesticide product registrations and associated advertisements is now substantially complete. The results of the QAI review process did not materially affect our fiscal 2009, fiscal 2010 or fiscal 2011 sales and are not expected to materially affect our fiscal 2012 sales.

In fiscal 2008, we conducted a voluntary recall of certain of our wild bird food products due to a formulation issue. Certain wild bird food products had been treated with pest control additives to avoid insect infestation, especially at retail stores. While the pest control additives had been labeled for use on certain stored grains that can be processed for human and/or animal consumption, they were not labeled for use on wild bird food products. In October 2008, the U.S. Food & Drug Administration concluded that the recall had been completed and that there had been proper disposition of the recalled products. The results of the wild bird food recall did not materially affect our fiscal 2009, fiscal 2010 or fiscal 2011 financial condition, results of operations or cash flows.

Settlement discussions relating to potential fines and/or penalties are a frequent outgrowth of governmental investigations. In that regard, on or about June 30, 2011, we received a Notice of Intent to File Administrative Complaint from the U.S. EPA Region 5 with respect to the alleged FIFRA violations. The Notice, which does not set forth a proposed penalty amount, offers us an opportunity to present any information that we believe the U.S. EPA should consider prior to filing the complaint and indicates that the U.S. EPA is prepared to meet with us to discuss the alleged violations. We made a timely response to the Notice and communications between us and the U.S. EPA are underway.

29

As previously disclosed, we have also been engaged in settlement discussions with the U.S. DOJ regarding its criminal investigation. On January 25, 2012, a Plea Agreement, executed by us and the U.S. DOJ, was filed with the United States District Court for the Southern District of Ohio. Under the terms of the Plea Agreement, which must be approved by a federal judge, we have agreed to plead guilty to 11 counts of violating FIFRA and the regulations promulgated thereunder, to pay a $4,000,000 penalty to the United States and to provide $100,000 to each of the following programs designed to enhance and protect the natural environment, particularly habitats for the bird populations that the U.S. EPA’s regulation of pesticides is designed to protect: (1) Ohio Audubon’s Important Bird Area Program; (2) Ohio Department of Natural Resources’ Urban Forestry Program; (3) Columbus Metro-Parks Bird Habitat Enhancement Program; (4) Cornell University Ornithology Laboratory; and (5) The Nature Conservancy of Ohio. In exchange for our guilty plea and the other promises contained in the Plea Agreement, the U.S. DOJ has agreed not to criminally prosecute us for any other federal crimes relating to any potential FIFRA violations known to the government as of the date of the Plea Agreement. Our previously established reserve covers the full amount of the proposed criminal penalty and other amounts payable under the Plea Agreement.

The U.S. EPA and related state investigations continue and the Plea Agreement between us and the U.S. DOJ must still be approved by the United States District Court. In addition, the current investigations and proceedings may result in future state, federal or private rights of action as well as judgments, settlements, fines and/or penalties with respect to known or potential additional product registration issues. At this stage of the investigations, we cannot reasonably estimate the total scope or magnitude of all possible liabilities that could result from known or potential product registration issues. Based on the facts and circumstances known to us at this time (including settlement discussions that have taken place to date and the pending Plea Agreement), we have established what we believe to be an appropriate reserve. It is possible that any fines and/or penalties with respect to the investigations, as well as any judgments, litigation costs or other liabilities relating to such known or potential product registration issues, could exceed the amount of the reserve, possibly materially, and could have an adverse effect on our financial condition, results of operations or cash flows.

As a result of these registration and recall matters, we have recorded charges for affected inventory and other registration and recall-related costs. The effects of these adjustments were pre-tax charges of $0.3 million and $1.7 million for the three-month periods ended December 31, 2011 and January 1, 2011, respectively. We expect that future charges will include costs associated with the rework of certain finished goods inventories, the potential disposal of certain products and ongoing third-party professional services related to the U.S. EPA, U.S. DOJ and state investigations. It may also be appropriate to establish additional reserves as settlement discussions continue or in connection with other actions or potential liabilities arising in connection with the product registration issues.

We are committed to providing our customers and consumers with products of superior quality and value to enhance their lawns, gardens and overall outdoor living environments. We believe consumers have come to trust our brands based on the superior quality and value they deliver, and that trust is highly valued. We also are committed to conducting business with the highest degree of ethical standards and in adherence to the law. While we are disappointed in these events, we believe we have made significant progress in addressing the issues and restoring customer and consumer confidence in our products.

RESULTS OF OPERATIONS

We classified Global Pro as discontinued operations, for all periods presented, beginning in our first quarter of fiscal 2011. As a result, and unless specifically stated, all discussions regarding results for the three months ended December 31, 2011 and January 1, 2011 reflect results from our continuing operations.

30

The following table sets forth the components of income and expense as a percentage of net sales for the three months ended December 31, 2011 and January 1, 2011:

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
	(UNAUDITED)
Net sales		100.0	%		100.0	%
Cost of sales		88.3			78.3
Cost of sales – product registration and recall matters		—			0.4
Gross profit		11.7			21.3
Operating expenses:
Selling, general and administrative		58.2			62.2
Impairment, restructuring and other charges		1.2			—
Product registration and recall matters		0.1			0.4
Other income, net		(0.4	)		(0.2	)
Loss from operations		(47.4	)		(41.1	)
Interest expense		7.3			4.1
Loss from continuing operations before income taxes		(54.7	)		(45.2	)
Income tax benefit from continuing operations		(19.7	)		(16.2	)
Loss from continuing operations		(35.0	)		(29.0	)
Loss from discontinued operations, net of tax		—			(0.5	)
Net loss		(35.0	)%		(29.5	)%

Net Sales

Net sales for the three months ended December 31, 2011 were $211.2 million, a decrease of 8.3% from net sales of $230.2 million for the three months ended January 1, 2011. The change in net sales for the three months ended December 31, 2011 was attributable to the following:

	September 30,
Volume	(9.5	)%
Pricing	0.9
Foreign exchange rates	(0.2	)
Acquisitions	0.5
Net sales decline	(8.3	)%

As the foregoing table indicates, the decrease in net sales was primarily the result of a decline in sales volume due to our customers purchasing product closer to the lawn and garden season, partially offset by increased net pricing and the impact of acquisitions within our Scotts LawnService^® and growing media businesses.

Cost of Sales

The following table shows the major components of cost of sales (in millions):

		September 30,		September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011		JANUARY 1, 2011
	(UNAUDITED)
Materials	$	103.1	$	98.3
Manufacturing labor and overhead		29.0		29.0
Distribution and warehousing		36.4		37.8
Roundup reimbursements		17.9		15.2
		186.4		180.3
Product registration and recall matters		—		0.8
	$	186.4	$	181.1

31

Factors contributing to the change in cost of sales for the three months ended December 31, 2011 are outlined in the following table (in millions):

		September 30,
Foreign exchange rates	$	0.4
Material costs		8.9
Volume and product mix		(5.9	)
Roundup® reimbursements		2.7
		6.1
Product registration and recall matters		(0.8	)
Change in cost of sales	$	5.3

The increase in cost of sales, excluding product registration and recall matters, was the result of an increase in material costs primarily related to wild bird food grains, higher input costs in our growing media business and higher reimbursements attributable to our marketing agreement with Monsanto, partially offset by the impact of decreased net sales.

Gross Profit

As a percentage of net sales, our gross profit rate was 11.7% and 21.3% for the three months ended December 31, 2011 and January 1, 2011, respectively. Factors contributing to the change in gross profit rate for the three months ended December 31, 2011 are outlined in the following table:

	September 30,
Pricing	1.1	%
Material costs	(4.3	)
Product mix and volume:
Roundup® commissions	(0.3	)
Corporate & Other	(1.3	)
Global Consumer mix and volume	(5.1	)
Total product mix and volume	(6.7	)
Product registration and recall matters	0.3
Change in gross profit rate	(9.6	)%

Gross profit rates for our first fiscal quarter are lower than the full year as a result of proportionally higher fixed overhead costs in relation to seasonally low sales volumes. The decrease in the gross profit rate, excluding product registration and recall matters, for the three months ended December 31, 2011 was primarily driven by:

• decreased net sales and negative product mix driven primarily by reduced fertilizer net sales; and

• increased material costs attributable primarily to our wild bird food business;

• partially offset by increased net pricing.

Selling, General and Administrative Expenses

The following table sets forth the components of selling, general and administrative expenses (in millions):

		September 30,		September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011		JANUARY 1, 2011
	(UNAUDITED)
Advertising	$	9.2	$	11.2
Share-based compensation		1.6		4.3
Research and development		12.1		12.4
Amortization of intangibles		2.1		2.3
Other selling, general and administrative		98.0		113.0
	$	123.0	$	143.2

32

Selling, general and administrative (“SG&A”) expenses decreased $20.2 million, or 14.1%, to $123.0 million for the first quarter of fiscal 2012 compared to the first quarter of fiscal 2011. Approximately $7.4 million of the decrease related to severance costs that were incurred in the first quarter of fiscal 2011. Other factors contributing to the decrease in SG&A during the quarter included $5.6 million of lower compensation expense primarily as a result of the Company’s restructuring plan initiated in fiscal 2011, lower year-over-year variable compensation expense of $4.5 million and lower advertising expense of $2.0 million.

We recorded $0.3 million and $0.9 million of SG&A-related product registration and recall costs during the first quarters of fiscal 2012 and fiscal 2011, respectively, which primarily related to third-party compliance review, legal and consulting fees.

Impairment, Restructuring and Other Charges

In continuation of the restructuring plan we initiated in fiscal 2011, the Company incurred $2.6 million in restructuring costs in the first quarter of fiscal 2012. These costs consisted primarily of $1.3 million of termination benefits provided to employees who accepted voluntary retirement, $0.5 million of special termination benefits to be provided to certain employees upon future separation and $0.2 million related to curtailment charges for our U.S. defined benefit pension and U.S retiree medical plans.

Other (Income) Expense, net

Other income was $0.9 million for the first quarter of fiscal 2012, compared to $0.5 million for the first quarter of fiscal 2011. Other income/expense is comprised of activities outside our normal business operations, such as royalty income from the licensing of certain of our brand names, franchise fee income from our Scotts LawnService^® business, foreign exchange gains/losses and gains/losses from the sale of non-inventory assets. The change from fiscal 2011 was not significant.

Interest Expense

Interest expense in continuing operations for the first quarter of fiscal 2012 was $15.3 million, compared to $9.5 million for the first quarter of fiscal 2011. The increase in interest expense was attributable to an increase in average borrowings and the impact of higher rates associated with the Company’s new financing structure. Excluding the impact of foreign exchange rates, average borrowings during the first quarter of fiscal 2012 increased by approximately $147.0 million as compared to the prior year period, primarily due to higher debt levels entering the period as compared to the prior year as we work to navigate within our 2.0 to 2.5 times debt leverage objective for fiscal 2012. Weighted average interest rates increased by approximately 115 basis points, which was primarily attributable to the full quarter impact of the 6.625% Senior Notes issued on December 16, 2010 and our new credit facility, with margin rates in excess of our previous credit facility.

Income Tax Benefit

The first quarter income tax benefit from continuing operations was 36.0% for the three months ended December 31, 2011, compared to 35.9% for the same period of fiscal 2011. The effective tax rate used for interim purposes was based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year. Factors affecting the estimated effective tax rate include assumptions as to income by jurisdiction (domestic and foreign), the availability and utilization of tax credits and the existence of elements of income and expense that may not be taxable or deductible. The estimated effective tax rate is subject to revision in later interim periods and at fiscal year end as facts and circumstances change during the course of the fiscal year. There can be no assurances that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year end.

Loss from Continuing Operations

We reported a loss from continuing operations of $73.9 million for the first quarter of fiscal 2012, compared to a loss from continuing operations of $66.7 million for the first quarter of fiscal 2011. We anticipated a loss in our first fiscal quarter due to the seasonal nature of our business, in which sales are heavily weighted to the spring and summer selling seasons. The increase in our first quarter loss in fiscal 2012 was primarily attributable to lower net sales, higher cost of sales and increased interest expense, partially offset by a decrease in SG&A and an increased income tax benefit. Average common shares outstanding decreased to 60.9 million for the three months ended December 31, 2011 from 66.3 million for the three months ended January 1, 2011, primarily due to common share repurchases, partially offset by common shares issued as a result of stock option exercises.

Loss from Discontinued Operations

We reported a loss from discontinued operations, net of tax, of $1.2 million for the first quarter of fiscal 2011, primarily due to $5.2 million of transaction-related costs associated with the then pending sale of Global Pro to ICL, partially offset by income generated from Global Pro’s operations during the first quarter of fiscal 2011.

33

SEGMENT RESULTS

Our continuing operations are divided into the following reportable segments: Global Consumer and Scotts LawnService^®. This division of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company. Corporate & Other consists of our non-European professional seed business, revenues and expenses associated with our supply agreements with ICL and the amortization related to the Roundup^® Marketing Agreement, as well as corporate, general and administrative expenses and certain other income/expense items not allocated to the business segments.

Segment performance is evaluated based on several factors, including income from continuing operations before amortization, product registration and recall costs, and impairment, restructuring and other charges, which is not a measure recognized under GAAP. Senior management uses this measure of operating profit to gauge segment performance because we believe this measure is the most indicative of performance trends and the overall earnings potential of each segment.

The following table sets forth net sales by segment (in millions):

		September 30,		September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011		JANUARY 1, 2011
	(UNAUDITED)
Global Consumer	$	149.1	$	188.8
Scotts LawnService®		37.6		37.1
Segment total		186.7		225.9
Corporate & Other		24.5		4.3
Consolidated	$	211.2	$	230.2

The following table sets forth segment loss from continuing operations before income taxes (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
	(UNAUDITED)
Global Consumer	$	(69.4	)	$	(55.1	)
Scotts LawnService®		(4.6	)		(4.5	)
Segment total		(74.0	)		(59.6	)
Corporate & Other		(20.8	)		(30.9	)
Amortization of intangibles		(2.5	)		(2.3	)
Product registration and recall matters		(0.3	)		(1.7	)
Impairment, restructuring and other charges		(2.6	)		—
Interest expense		(15.3	)		(9.5	)
Consolidated	$	(115.5	)	$	(104.0	)

Global Consumer

Global Consumer segment net sales were $149.1 million in the first quarter of fiscal 2012, a decrease of 21.0% from net sales of $188.8 million for the first quarter of fiscal 2011. Excluding the impact of changes in foreign exchange rates, the decrease was 20.7%, primarily driven by a decrease in unit volume of 21.9% as a result of our customers purchasing product closer to the lawn and garden season, partially offset by a 1.0% increase in net pricing.

Net sales in the United States decreased $34.7 million, or 25.1%, in the first quarter of fiscal 2012, which included a favorable impact from increased pricing of 2.2%. The decrease was driven primarily by an anticipated delay of shipments until closer to peak consumer seasonal demand. Consumer purchases of our products at our largest U.S. retailers (retail point-of-sale, or “POS”) decreased by 5.1% for the quarter, against higher comparable prior year POS that had increased 10.7% during the first quarter of fiscal 2011 relative to 2010. The primary drivers were a decrease in retail sales of lawn fertilizer, grass seed and control products, partially offset by an increase in retail sales of Roundup^®. Excluding the impact of changes in foreign exchange rates, net sales internationally decreased by $4.5 million, or 8.9%. The decrease was primarily driven by approximately $3.9 million of lower net sales in France that was anticipated due to a planned change in distribution method from utilizing certain distributors to selling direct to more customers, which will result in a shifting of net sales to the second and third fiscal quarters of 2012.

Global Consumer segment operating loss increased by $14.3 million, or 26.0%, in the first quarter of fiscal 2012. Excluding the impact of changes in foreign exchange rates, the decrease was 26.5%. The change in seasonal operating loss was primarily the result of lower net sales and a decline in the gross profit rate from 18.1% in the first quarter of fiscal 2011 to 7.0% in the first quarter of fiscal 2012. The decline in the gross profit rate was due to lower net sales and increased material costs, partially offset by an increase in net pricing. The overall decline was partially offset by lower SG&A spending of $8.8 million primarily due to decreases in advertising expense timing, marketing and compensation expenses.

34

Scotts LawnService^®

Scotts LawnService^® revenues increased by $0.5 million, or 1.3%, in the first quarter of fiscal 2012, primarily due to a 2.5% increase in customer count from the same period of fiscal 2011.

The operating loss for Scotts LawnService^® increased by $0.1 million in the first quarter of fiscal 2012 compared to the first quarter of fiscal 2011, driven by a lower gross margin of $1.2 million, offset by $1.1 million of lower SG&A spending.

Corporate & Other

The net operating loss for Corporate & Other decreased by $10.1 million in the first quarter of fiscal 2012 compared to the first quarter of fiscal 2011, primarily related to lower severance as well as variable compensation and benefits realized from the fiscal 2011 restructuring plan.

MANAGEMENT’S OUTLOOK

We believe the long-term fundamentals of our business are strong, and our broad strategies for value accretion remain substantially unchanged. However, in light of the challenges and overall disappointing results of fiscal 2011, we re-examined our strategies and tactics and determined certain adjustments were required to give us greater confidence in our ability to increase consumer participation, category growth and our market share. As we are focused on long-term value creation, we do not expect all of our actions in fiscal 2012 to have short-term benefits.

The following are general themes that help shape our financial expectations for 2012:

• We expect at least 6 percent top line growth in our Global Consumer and Scotts LawnService^® reportable segments on the basis of modest category growth supported by more normal weather relative to fiscal 2011, increased commitment to marketing and media, innovation and modest net pricing.

• We expect commodity inflation of approximately $80 million, with only about half recovered through pricing and adjustments to trade programs. We expect a modest benefit from improved product mix as the unfavorable weather in fiscal 2011 disproportionately impacted our higher margin product categories.

• We are planning to significantly step up our media and marketing initiatives, with increases in advertising of up to $40 million. We plan on reinstating some form of variable compensation for over 1,800 associates who participate in incentive programs globally, the majority of whom received no payout in fiscal 2011. We typically budget $30 to $35 million for this expenditure. Partially offsetting these increases will be benefits accruing from the fiscal 2011 restructuring programs of about $17 million, as well as savings from other long-term indirect purchasing initiatives.

• We expect interest expense to increase about $10 to $12 million based on the combined full year effect of our new credit facility and the bonds issued last December, as well as a projected increase in average debt as we work to navigate within our 2.0 to 2.5 times debt leverage objective.

• We expect a benefit from shares repurchased during fiscal 2011. While shares repurchased in fiscal 2011 were influenced by proceeds from the divestiture of Global Pro, we expect to significantly moderate our share repurchase activity in fiscal 2012 in the context of our broader capital deployment strategy. Over the longer-term, we plan to target one-third of our operating cash flow for return to shareholders, including our dividend, with the remaining two-thirds targeted to fund capital expenditures for organic as well as acquisitive growth. Absent appropriate acquisition opportunities, we intend to return excess cash to shareholders, though we will balance this with our objective of maintaining debt leverage of 2.0 to 2.5 times. We expect our fiscal 2012 fully diluted share count to be approximately 62.0 million.

For certain information concerning our risk factors, see “PART II. OTHER INFORMATION: ITEM 1A. RISK FACTORS” of this Quarterly Report on Form 10-Q.

35

LIQUIDITY AND CAPITAL RESOURCES

Operating Activities

Cash used in operating activities totaled $201.1 million and $169.7 million for the three months ended December 31, 2011 and January 1, 2011, respectively. The use of cash in the first fiscal quarter is primarily due to the seasonal nature of our operations. The first quarter is historically the lowest net sales period of our fiscal year, while at the same time we are building inventories in preparation for the spring selling season that begins in our second fiscal quarter. The increase in cash outflows was primarily the result of lower net sales and an increase in cash used for working capital purposes of $16.2 million. The increase in working capital was due to the impact of additional cash used for inventory of $43.9 million and an increase in taxes paid of $7.1 million, partially offset by a $44.8 million decrease in variable compensation payouts for fiscal 2011. Inventory has increased due to higher commodity costs and planned build in anticipation of substantially higher demand in fiscal 2012.

Investing Activities

Cash used in investing activities totaled $16.4 million and $28.1 million for the three months ended December 31, 2011 and January 1, 2011, respectively. The decrease in capital spending in the first three months of fiscal 2012 was primarily due to capital investments associated with a new liquids manufacturing and bottling plant in Pearl, Mississippi that occurred during the first three months of fiscal 2011.

Financing Activities

Financing activities provided cash of $214.3 million and $186.3 million for the three months ended December 31, 2011 and January 1, 2011, respectively. The increase in cash provided by financing activities in the first quarter of fiscal 2012 compared to the same period in fiscal 2011 was primarily due to higher net borrowings under our credit facility of $217.1 million and a $7.5 million decrease in repurchases of our common shares, partially offset by $200 million in proceeds received from the issuance of the 6.625% Senior Notes that occurred in the first quarter of fiscal 2011 and an increase in dividends paid of $2.1 million.

Cash and Cash Equivalents

Our cash and cash equivalents were held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments with a balance of $127.8 million as of December 31, 2011, compared to $78.8 million as of January 1, 2011. The cash and cash equivalents balance at December 31, 2011 included $115.5 million held by foreign subsidiaries and foreign corporate joint ventures. Our current plans do not demonstrate a need to, nor do we have plans to, repatriate the retained earnings from these subsidiaries as the earnings are indefinitely reinvested. However, in the future, if we determine it is necessary to repatriate these funds, or we sell or liquidate any of these subsidiaries, we may be required to pay associated taxes on the repatriation.

Borrowing Agreements

Our primary sources of liquidity are cash generated by operations and borrowings under our credit agreement which is guaranteed by substantially all of Scotts Miracle-Gro’s domestic subsidiaries. On June 30, 2011, Scotts Miracle-Gro and certain of its subsidiaries entered into a second amended and restated senior secured credit facility, providing for revolving loans in the aggregate principal amount of up to $1.7 billion over a five-year term. Borrowings may be made in various currencies including U.S. dollars, Euros, British pounds, Australian dollars and Canadian dollars. Under this credit facility, we may request up to an additional $450 million in revolving and/or term commitments, subject to certain specified conditions, including approval from our lenders. The credit facility replaced our previous senior secured credit facilities, which were comprised of: (a) a senior secured revolving loan facility in the aggregate principal of up to $1.59 billion and (b) a senior secured term loan facility totaling $560 million. The previous credit facilities were scheduled to expire in February 2012.

Under our credit facility, we have the ability to issue letter of credit commitments up to $75 million. At December 31, 2011, we had letters of credit in the aggregate face amount of $26.3 million outstanding and $1.1 billion of availability under our credit facility.

On September 21, 2011, we entered into a new Master Accounts Receivable Purchase Agreement (the “MARP Agreement”), with an initial stated termination date of September 21, 2012, or such later date as may be mutually agreed by us and the banks party thereto. The MARP Agreement, which is uncommitted, provides for the discretionary sale by us, and the discretionary purchase by the banks, on a revolving basis, of accounts receivable generated by sales to two specified account debtors in an aggregate amount not to exceed $325 million, with debtor sublimits ranging from $120 million to $250 million. Under the terms of the MARP Agreement, the banks have the opportunity to purchase those accounts receivable offered by us at a discount (from the agreed base value thereof) effectively equal to the greater of 7-day or 3-month LIBOR plus 1.05%. The MARP Agreement replaced our previous Master Accounts Receivable Purchase Agreement, which provided for the discounted sale, on an uncommitted, revolving basis, of accounts receivable generated by a single specified account debtor, with aggregate limits not to exceed $80 million and an interest rate that approximated the 7-day LIBOR rate plus 1.25%.

36

We account for the sale of receivables under the MARP Agreement as short-term debt and continue to carry the receivables on our Consolidated Balance Sheet, primarily as a result of our right to repurchase receivables sold. There were $5.4 million in borrowings under the MARP Agreement as of December 31, 2011.

As of December 31, 2011, we were in compliance with all debt covenants. Our credit facility contains, among other obligations, an affirmative covenant regarding our leverage ratio, calculated as indebtedness relative to our earnings before interest, taxes, depreciation and amortization. Under the terms of the credit facility, the maximum leverage ratio was 3.50 as of December 31, 2011. Our leverage ratio was 2.09 at December 31, 2011. Our credit facility also includes an affirmative covenant regarding our interest coverage. Under the terms of the credit facility, the minimum interest coverage ratio was 3.50 for the twelve months ended December 31, 2011. Our interest coverage ratio was 6.79 for the twelve months ended December 31, 2011.

We continue to monitor our compliance with the leverage ratio, interest coverage ratio and other covenants contained in the credit facility and, based upon our current operating assumptions, we expect to remain in compliance with the permissible leverage ratio and interest coverage ratio throughout fiscal 2012. However, an unanticipated charge to earnings, an increase in debt or other factors could materially affect our ability to remain in compliance with the financial or other covenants of our credit facility, potentially causing us to have to seek an amendment or waiver from our lending group which could result in repricing of our credit facility. While we believe we have good relationships with our banking group, we can provide no assurance that such a request would result in a modified or replacement credit facility on reasonable terms, if at all.

Liquidity

In our opinion, cash flows from operations and capital resources will be sufficient to meet debt service and working capital needs during fiscal 2012, and thereafter for the foreseeable future. However, we cannot ensure that our business will generate sufficient cash flow from operations or that future borrowings will be available under our credit facilities in amounts sufficient to pay indebtedness or fund other liquidity needs. Actual results of operations will depend on numerous factors, many of which are beyond our control.

Judicial and Administrative Proceedings

Apart from the proceedings surrounding the FIFRA compliance matters, which are discussed separately, we are party to various pending judicial and administrative proceedings arising in the ordinary course of business, including, among others, proceedings based on accidents or product liability claims and alleged violations of environmental laws. We have reviewed these pending judicial and administrative proceedings, including the probable outcomes, reasonably anticipated costs and expenses, and the availability and limits of our insurance coverage, and have established what we believe to be appropriate reserves. We do not believe that any liabilities that may result from these pending judicial and administrative proceedings are reasonably likely to have a material effect on our financial condition, results of operations or cash flows; however, there can be no assurance that future quarterly or annual operating results will not be materially affected by final resolution of these matters.

REGULATORY MATTERS

We are subject to local, state, federal and foreign environmental protection laws and regulations with respect to our business operations and believe we are operating in substantial compliance with, or taking actions aimed at ensuring compliance with, such laws and regulations. Apart from the proceedings surrounding the FIFRA compliance matters, which are discussed separately, we are involved in several legal actions with various governmental agencies related to environmental matters. While it is difficult to quantify the potential financial impact of actions involving these environmental matters, particularly remediation costs at waste disposal sites and future capital expenditures for environmental control equipment, in the opinion of management, the ultimate liability arising from such environmental matters, taking into account established reserves, should not have a material effect on our financial condition, results of operations or cash flows. However, there can be no assurance that the resolution of these matters will not materially affect our future quarterly or annual results of operations, financial condition or cash flows. Additional information on environmental matters affecting us is provided in Scotts Miracle Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011, under “ITEM 1. BUSINESS — Regulatory Considerations” and “ITEM 3. LEGAL PROCEEDINGS.”

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The preceding discussion and analysis of our consolidated results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q. Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011 includes additional information about us, our operations, our financial condition, our critical accounting policies and accounting estimates, and should be read in conjunction with this Quarterly Report on Form 10-Q.

37

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risks have not changed significantly from those disclosed in Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011.

ITEM 4. CONTROLS AND PROCEDURES

The Scotts Miracle-Gro Company (the “Registrant”) maintains “disclosure controls and procedures,” as such term is defined under Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed in the Registrant’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Registrant’s management, including its principal executive officer and its principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, the Registrant’s management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance, the Registrant’s management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

With the participation of the principal executive officer and principal financial officer of the Registrant, the Registrant’s management has evaluated the effectiveness of the Registrant’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the fiscal quarter covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, the Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures were effective at the reasonable assurance level.

In addition, there were no changes in the Registrant’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the Registrant’s fiscal quarter ended December 31, 2011 that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Other than as discussed in “NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS” and “NOTE 12. CONTINGENCIES” of the Notes to Condensed, Consolidated Financial Statements, pending material legal proceedings have not changed significantly since those disclosed in Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011.

ITEM 1A. RISK FACTORS

The Company’s risk factors as of December 31, 2011 have not changed materially from those described in “ITEM IA. RISK FACTORS” in Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q, including the exhibits hereto and the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to risks and uncertainties. Other than statements of historical fact, information regarding activities, events and developments that we expect or anticipate will or may occur in the future, including, but not limited to, information relating to our future growth and profitability targets and strategies designed to increase total shareholder value, are forward-looking statements based on management’s estimates, assumptions and projections. Forward-looking statements also include, but are not limited to, statements regarding our future economic and financial condition and results of operations, the plans and objectives of management and our assumptions regarding our performance and such plans and objectives, as well as the amount and timing of repurchases of Scotts Miracle-Gro common shares. These forward-looking statements generally can be identified through the use of words such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” and other similar words and variations.

Forward-looking statements contained in this Quarterly Report on Form 10-Q are predictions only and actual results could differ materially from management’s expectations due to a variety of factors, including those described in “ITEM 1A. RISK FACTORS” in Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011. All forward-looking statements attributable to us or persons working on our behalf are expressly qualified in their entirety by such risk factors.

38

The forward-looking statements that we make in this Quarterly Report on Form 10-Q are based on management’s current views and assumptions regarding future events and speak only as of their dates. We disclaim any obligation to update developments of these risk factors or to announce publicly any revisions to any of the forward-looking statements that we make, or to make corrections to reflect future events or developments, except as required by the federal securities laws.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The payment of future dividends, if any, on the Common Shares will be determined by the Board of Directors in light of conditions then existing, including the Company’s earnings, financial condition and capital requirements, restrictions in financing agreements, business conditions and other factors. The Company’s credit facility restricts future dividend payments to an aggregate of $125 million annually through fiscal 2013 and $150 million annually beginning in fiscal 2014 if our leverage ratio, after giving effect to any such annual dividend payment, exceeds 2.50. Our leverage ratio was 2.09 at December 31, 2011. See “NOTE 7. DEBT” of the Notes to Condensed Consolidated Financial Statements for further discussion regarding the restrictions on dividend payments.

(c) Issuer Purchases of Equity Securities

The following table shows the purchases of common shares of Scotts Miracle-Gro (“Common Shares”) made by or on behalf of Scotts Miracle-Gro or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of Scotts Miracle-Gro for each fiscal month in the three months ended December 31, 2011:

		September 30,		September 30,		September 30,		September 30,
Period	Total Number of Common Shares Purchased(1)		Average Price  Paid per Common Share(2)		Total Number of Common Shares Purchased as Part of Publicly Announced Plans or Programs(3)		Approximate Dollar Value  of Common Shares That May Yet be Purchased Under the Plans or Programs(3)
October 1 through October 29, 2011		175,750	$	45.51		175,425	$	308,301,215
October 30 through November 26, 2011		198	$	41.86		—	$	308,301,215
November 27 through December 31, 2011		215,616	$	44.29		214,200	$	298,816,786
Total		391,564	$	44.83		389,625

(1) All of the Common Shares purchased during the quarter were purchased in open market transactions. The total number of Common Shares purchased during the quarter includes 1,939 Common Shares purchased by the trustee of the rabbi trust established by the Company as permitted pursuant to the terms of The Scotts Company LLC Executive Retirement Plan (the “ERP”). The ERP is an unfunded, non-qualified deferred compensation plan which, among other things, provides eligible employees the opportunity to defer compensation above specified statutory limits applicable to The Scotts Company LLC Retirement Savings Plan and with respect to any Executive Management Incentive Pay (as defined in the ERP), Performance Award (as defined in the ERP) or other bonus awarded to such eligible employees. Pursuant to the terms of the ERP, each eligible employee has the right to elect an investment fund, including a fund consisting of Common Shares (the “Scotts Miracle-Gro Common Stock Fund”), against which amounts allocated to such employee’s account under the ERP, including employer contributions, will be benchmarked (all ERP accounts are bookkeeping accounts only and do not represent a claim against specific assets of the Company). Amounts allocated to employee accounts under the ERP represent deferred compensation obligations of the Company. The Company established the rabbi trust in order to assist the Company in discharging such deferred compensation obligations. When an eligible employee elects to benchmark some or all of the amounts allocated to such employee’s account against the Scotts Miracle-Gro Common Stock Fund, the trustee of the rabbi trust purchases the number of Common Shares equivalent to the amount so benchmarked. All Common Shares purchased by the trustee are purchased on the open market and are held in the rabbi trust until such time as they are distributed pursuant to the terms of the ERP. All assets of the rabbi trust, including any Common Shares purchased by the trustee, remain, at all times, assets of the Company, subject to the claims of its creditors. The terms of the ERP do not provide for a specified limit on the number of Common Shares that may be purchased by the trustee of the rabbi trust.

39

(2) The average price paid per Common Share is calculated on a settlement basis and includes commissions.

(3) In August 2010, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to $500 million of the Common Shares over a four-year period (through September 30, 2014). On May 4, 2011, the Scotts Miracle-Gro Board of Directors authorized the repurchase of up to an additional $200 million of the Common Shares, resulting in authority to repurchase up to a total of $700 million of the Common Shares through September 30, 2014. The dollar amounts in the “Approximate Dollar Value” column reflect the total $700 million authorized repurchase program.

ITEM 6. EXHIBITS

See Index to Exhibits at page 42 for a list of the exhibits included herewith.

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	THE SCOTTS MIRACLE-GRO COMPANY
Date: February 8, 2012	/s/ DAVID C. EVANS
	David C. Evans
	Chief Financial Officer and Executive Vice President,
	Strategy and Business Development
	(Principal Financial and Principal Accounting Officer)
	(Duly Authorized Officer)

41

THE SCOTTS MIRACLE-GRO COMPANY

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2011

INDEX TO EXHIBITS

EXHIBIT NO.	DESCRIPTION	LOCATION
10.1	Specimen form of Performance Unit Award Agreement for Employees (with Related Dividend Equivalents) used to evidence grants of Performance Units which may be made under The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (post-January 19, 2012 version)	*
10.2	Specimen form of Restricted Stock Unit Award Agreement for Employees (with Related Dividend Equivalents) used to evidence grants of Restricted Stock Units which may be made under The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (post-January 19, 2012 version)	*
10.3	Specimen form of Nonqualified Stock Option Award Agreement for Employees used to evidence grants of Nonqualified Stock Options which may be made under The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (post-January 19, 2012 version)	*
10.4	Specimen form of Deferred Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) used to evidence grants of Deferred Stock Units which may be made under The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (post-January 19, 2012 version)	*
10.5	Specimen form of Deferred Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) used to evidence grants of Deferred Stock Units made on January 20, 2012 to Adam Hanft and William G. Jurgensen under The Scotts Miracle-Gro Company Amended and Restated Long-Term Incentive Plan	*
10.6	Specimen form of Deferred Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) used to evidence grants of Deferred Stock Units which may be made under The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (Deferral of Cash Retainer – post-January 19, 2012 version)	*
14.1	The Scotts Miracle-Gro Company Code of Business Conduct & Ethics (as revised effective January 18, 2012)	Incorporated herein by reference to the Registrant’s Current Report on Form 8-K filed January 24, 2012 (File No. 1-11593) [Exhibit 14.1]
31.1	Rule 13a-14(a)/15d-14(a) Certifications (Principal Executive Officer)	*

42

EXHIBIT NO.	DESCRIPTION	LOCATION
31.2	Rule 13a-14(a)/15d-14(a) Certifications (Principal Financial Officer)	*
32	Section 1350 Certifications (Principal Executive Officer and Principal Financial Officer)	*
101.INS**	XBRL Instance Document	*
101.SCH**	XBRL Taxonomy Extension Schema	*
101.CAL**	XBRL Taxonomy Extension Calculation Linkbase	*
101.DEF**	XBRL Taxonomy Extension Definition Linkbase	*
101.LAB**	XBRL Taxonomy Extension Label Linkbase	*
101.PRE**	XBRL Taxonomy Extension Presentation Linkbase	*

* Included herewith

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

43

EX-10.1

Exhibit 10.1

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

PERFORMANCE UNIT AWARD AGREEMENT FOR EMPLOYEES

(with related dividend equivalents)

PERFORMANCE UNITS GRANTED TO

[Grantee’s Name] ON [Grant Date]

This Award Agreement describes the type of Award that you have been granted and the terms and conditions of your Award.

1. DESCRIPTION OF YOUR PERFORMANCE UNITS. You have received a grant of [Number] Performance Units (“Performance Units”), based on a target level of performance, and an equal number of related dividend equivalents. If the minimum performance is achieved (and if all other service and vesting requirements are met), the Performance Units and related dividend equivalents that will actually be awarded to you may be more or less than the number of Performance Units granted. See Sections 3, 6 and Exhibit A for more details.

The “Grant Date” of your Award is [Grant Date]. To accept this Award Agreement, you must return a signed copy of this Award Agreement no later than [Date 30 Days After Grant Date], to [Third Party Administrator] (the “Third Party Administrator”) as follows:

[Third Party Administrator]

Attention: [TPA Contact’s Name]

[TPA Contact’s Address]

[TPA Telephone Number]

2. INCORPORATION OF PLAN AND DEFINITIONS.

(a) This Award Agreement and your Performance Units are granted pursuant to the terms and conditions of the Company’s 2006 Long-Term Incentive Plan (the “Plan”) and this Award Agreement. All provisions of the Plan are incorporated herein by reference, and your Performance Units and related dividend equivalents are subject to the terms of the Plan. To the extent there is a conflict between this Award Agreement and the Plan, the Plan will govern.

(b) Capitalized terms that are not defined in this Award Agreement have the same meanings as in the Plan.

3.        PERFORMANCE UNIT ACHIEVEMENT. The number of Performance Units Achieved will be calculated as follows: Performance Units Achieved = Performance Units * Payout Percentage. The number of Performance Units Achieved is subject to satisfaction of the performance criteria set forth on Exhibit A over the period beginning on [Beginning Date] and ending on [Ending Date] (the “Performance Period”), and will be determined at the end of the Performance Period. If actual performance is below the Minimum performance level indicated, no Performance Units will be achieved. Each whole Performance Unit Achieved represents the right to receive one full Share at the time and in the manner described in this Award Agreement.

4.        VESTING. Except as provided in Section 7 of this Award Agreement, the Performance Units Achieved, as described in Section 3 of this Award Agreement, are also subject to achieving the vesting criteria as follows:

(a) General Vesting. If your employment continues from the Grant Date until [Third Anniversary of Grant Date] (the “Vesting Date”) the number of Performance Units Achieved shall become 100% vested on the Vesting Date; or

(b) Accelerated Vesting. Under the following circumstances, the Performance Units Achieved will be deemed to become 100% vested, even if you Terminate prior to the Vesting Date (subject to the performance criteria as described in Section 3 and Exhibit A):

(i) If you die or you Terminate because you become Disabled (as defined below), the number of Performance Units Achieved, as described in this Award Agreement, will be deemed to become 100% vested as of the Vesting Date. For purposes of this Award Agreement, “Disabled” means (A) you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, (B) you are, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering Employees of your employer, or (C) you are determined to be totally disabled by the Social Security Administration or Railroad Retirement Board; or

(ii) If you Terminate for a reason other than Cause after reaching age 55 and completing at least 10 years of employment with the Company, its Affiliates and/or its Subsidiaries, the number of Performance Units Achieved, as described in this Award Agreement, will be deemed to become 100% vested as of the Vesting Date.

2

5. SETTLEMENT.

(a) Subject to the terms of the Plan and this Award Agreement, the number of vested Performance Units Achieved, minus any shares that are withheld for taxes as provided under Section 5(c), shall be settled in a lump sum as soon as administratively practicable, but no later than 90 days following the Vesting Date (the “Settlement Date”). Your whole Performance Units Achieved shall be settled in full Shares, and any fractional Performance Unit Achieved shall be settled in cash, determined based upon the Fair Market Value of a Share on the Settlement Date.

(b) Except as provided in Section 6 of this Award Agreement, you will have none of the rights of a shareholder with respect to Shares underlying the Performance Units unless and until you become the record holder of such Shares.

(c) You may use one of the following methods to pay the required withholding taxes related to the settlement of your Performance Units Achieved. You will decide on the method at the time prescribed by the Company. If you do not elect one of these methods, the Company will apply the Net Settlement method described below:

(i) CASH PAYMENT: If you elect this alternative, you will be responsible for paying the Company through the Third Party Administrator cash equal to the minimum statutory withholding requirements applicable on your Performance Units.

(ii) NET SETTLEMENT: If you elect this alternative, the Company will retain the number of shares with a Fair Market Value equal to the minimum statutory withholding requirements applicable on your Performance Units.

(d) Normally, the number of Performance Units Achieved will vest and be settled only under the circumstances described above. However, if there is a Change in Control, your Performance Units will become 100% vested on the date of the Change in Control and will be settled as described in the Plan. See the Plan for further details.

6.        DIVIDEND EQUIVALENTS. Each dividend equivalent represents the right to receive an amount equal to the dividends that are declared and paid during the period beginning on the Grant Date and ending on the Settlement Date (as described in Section 5(a) of this Award Agreement) with respect to the Share represented by the related Performance Unit Achieved, subject to the same terms and conditions. Any dividend equivalents described in this Section 6 will be distributed to you in accordance with Section 5 of this Award Agreement or forfeited, depending on whether or not you have met the conditions described in this Award Agreement and the Plan. Any such distributions will be made in (i) cash, for any dividend equivalents relating to cash dividends and/or (ii) Shares, for any dividend equivalents relating to Share dividends.

3

7. FORFEITURE.

(a) Except as otherwise provided in Section 4 or Section 5(d) of this Award Agreement, you will forfeit your unvested Performance Units if you Terminate prior to the Vesting Date, whether the performance criteria are achieved or not.

(b) If you engage in “Conduct That Is Harmful To The Company” (as described below), you will forfeit your Performance Units and related dividend equivalents and must return to the Company all Shares and other amounts you have received through the Plan or this Award Agreement if, without the Company’s written consent, you do any of the following within 180 days before and 730 days after you Terminate:

(i) You breach any confidentiality, nondisclosure, and/or noncompetition obligations under any agreement or plan with the Company or any Affiliate or Subsidiary;

(ii) You fail or refuse to consult with, supply information to or otherwise cooperate with the Company or any Affiliate or Subsidiary after having been requested to do so;

(iii) You deliberately engage in any action that the Company concludes has caused substantial harm to the interests of the Company or any Affiliate or Subsidiary;

(iv) You fail to return all property (other than personal property), including vehicles, computer or other equipment or electronic devices, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data, formulae or any other tangible property or document and any and all copies, duplicates or reproductions that you have produced or received or have otherwise been provided to you in the course of your employment with the Company or any Affiliate or Subsidiary; or

(v) You engaged in conduct that the Committee reasonably concludes would have given rise to a Termination for Cause had it been discovered before you Terminated.

8.        AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or terminate this Award Agreement or the Plan at any time.

9.        BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any vested Performance Units and related dividend equivalents that may be achieved under this Award Agreement but are settled after you die. This may be done only on the attached Beneficiary Designation Form and by following the rules described in that Form. The Beneficiary Designation Form does not need to be completed now and is not required as a condition of receiving your Award. However, if you die without completing a Beneficiary Designation Form or if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.

4

10.        TRANSFERRING YOUR PERFORMANCE UNITS AND RELATED DIVIDEND EQUIVALENTS. Except as described in Section 9, your Performance Units and related dividend equivalents may not be transferred to another person. Also, the Committee may allow you to place your Performance Units and related dividend equivalents into a trust established for your benefit or the benefit of your family. Contact the Third Party Administrator for further details.

11.        GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

12.        OTHER AGREEMENTS. Your Performance Units and related dividend equivalents, whether achieved or not, will be subject to the terms of any other written agreements between you and the Company or any Affiliate or Subsidiary to the extent that those other agreements do not directly conflict with the terms of the Plan or this Award Agreement.

13.        ADJUSTMENTS TO YOUR PERFORMANCE UNITS. Subject to the terms of the Plan, your Performance Units and related dividend equivalents will be adjusted, if appropriate, to reflect any change to the Company’s capital structure (e.g., the number of Shares underlying your Performance Units will be adjusted to reflect a stock split).

14.        YOUR ACKNOWLEDGMENT OF AND AGREEMENT TO AWARD CONDITIONS.

By signing below, you acknowledge and agree that:

(a) A copy of the Plan has been made available to you;

(b) You understand and accept the terms and conditions of your Award;

(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees and without any further consideration) to any necessary change to your Award or this Award Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those changes affect the terms of your Award and reduce its value or potential value; and

(d) You must return a signed copy of this Award Agreement to the address given above before [Date 30 Days After Grant Date].

5

[Grantee’s Name]	THE SCOTTS MIRACLE-GRO COMPANY
By:	By:

Date signed:	[Name of Company Representative]
	[Title of Company Representative]
	Date signed:

6

EXHIBIT A

PERFORMANCE CRITERIA

EX-10.2

Exhibit 10.2

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT FOR EMPLOYEES

(with related dividend equivalents)

RESTRICTED STOCK UNITS GRANTED TO

[Grantee’s Name] ON [Grant Date]

This Award Agreement describes the type of Award that you have been granted and the terms and conditions of your Award.

1. DESCRIPTION OF YOUR RESTRICTED STOCK UNITS. You have been granted [Number] Restricted Stock Units (“RSUs”) and an equal number of related dividend equivalents. The “Grant Date” of your Award is [Grant Date]. Each whole RSU represents the right to receive one full Share at the time and in the manner described in this Award Agreement. Subject to Section 5 of this Award Agreement, each dividend equivalent represents the right to receive an amount equal to the dividends that are declared and paid during the period beginning on the Grant Date and ending on the Settlement Date (as described in Section 4(a) of this Award Agreement) with respect to the Share represented by the related RSU. To accept this Award Agreement, you must return a signed copy of this Award Agreement no later than [Date 30 Days After Grant Date], to [Third Party Administrator] (the “Third Party Administrator”) as follows:

[Third Party Administrator]

Attention: [TPA Contact’s Name]

[TPA Contact’s Address]

[TPA Telephone Number]

2. INCORPORATION OF PLAN AND DEFINITIONS.

(a) This Award Agreement and your RSUs are granted pursuant to and in accordance with the Company’s 2006 Long-Term Incentive Plan (the “Plan”). All provisions of the Plan are incorporated herein by reference, and your RSUs and related dividend equivalents are subject to the terms of the Plan and this Award Agreement. To the extent there is a conflict between this Award Agreement and the Plan, the Plan will govern.

(b) Capitalized terms that are not defined in this Award Agreement have the same meanings as in the Plan.

3. VESTING. Except as provided in Section 6 of this Award Agreement, the RSUs described in this Award Agreement will vest as follows:

(a) General Vesting. If your employment continues from the Grant Date until the third anniversary of the Grant Date, in this case [Vesting Date] (the “Vesting Date”), your RSUs described in this Award Agreement will become 100% vested on the Vesting Date; or

(b) Accelerated Vesting. Under the following circumstances, your RSUs described in this Award Agreement will become 100% vested earlier than the Vesting Date:

(i) If you die or you Terminate because you become Disabled (as defined below), your RSUs described in this Award Agreement will become 100% vested as of the date of such event and will be settled in accordance with Section 4 of this Award Agreement. For purposes of this Award Agreement, “Disabled” means (A) you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, (B) you are, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering Employees of your employer, or (C) you are determined to be totally disabled by the Social Security Administration or Railroad Retirement Board; or

(ii) If you Terminate for a reason other than Cause after reaching age 55 and completing at least 10 years of employment with the Company, its Affiliates and/or its Subsidiaries, your RSUs described in this Award Agreement will become 100% vested as of the date of such event and will be settled in accordance with Section 4 of this Award Agreement.

4. SETTLEMENT.

(a) Subject to the terms of the Plan and this Award Agreement, your vested RSUs, minus any shares that are withheld for taxes as provided under Section 4(c), shall be settled in a lump sum as soon as administratively practicable, but no later than 90 days following the earliest date to occur of: (i) your death; (ii) the date you become Disabled (as defined above); or (iii) the third anniversary of the Grant Date (the “Settlement Date”). Your whole RSUs shall be settled in full Shares, and any fractional RSU shall be settled in cash, determined based upon the Fair Market Value of a Share on the Settlement Date.

(b) Except as provided in Section 5 of this Award Agreement, you will have none of the rights of a shareholder with respect to Shares underlying the RSUs unless and until you become the record holder of such Shares.

(c) You may use one of the following methods to pay the required withholding taxes related to the vesting of your RSUs. You will decide on the method at the time prescribed by the Company. If you do not elect one of these methods, the Company will apply the Net Settlement method described below:

2

(i) CASH PAYMENT: If you elect this alternative, you will be responsible for paying the Company through the Third Party Administrator cash equal to the minimum statutory withholding requirements applicable on your RSUs.

(ii) NET SETTLEMENT: If you elect this alternative, the Company will retain the number of shares with a Fair Market Value equal to the minimum statutory withholding requirements applicable on your RSUs.

(d) Normally, your RSUs will vest and be settled only under the circumstances described above. However, if there is a Change in Control, your RSUs will become 100% vested on the date of the Change in Control and will be settled as described in the Plan. See the Plan for further details.

5. DIVIDEND EQUIVALENTS. You will be entitled to receive a dividend equivalent equal to any dividends declared and paid on each Share represented by a related RSU, subject to the same terms and conditions as the related RSU. Any dividend equivalents described in this Section 5 will be distributed to you in accordance with Section 4 of this Award Agreement or forfeited, depending on whether or not you have met the conditions described in this Award Agreement and the Plan. Any such distributions will be made in (i) cash, for any dividend equivalents relating to cash dividends and/or (ii) Shares, for any dividend equivalents relating to Share dividends.

6. FORFEITURE.

(a) Except as otherwise provided in Section 3 or Section 4(d) of this Award Agreement, you will forfeit your unvested RSUs if you Terminate prior to the Vesting Date.

(b) If you engage in “Conduct That Is Harmful To The Company” (as described below), you will forfeit your RSUs and related dividend equivalents and must return to the Company all Shares and other amounts you have received through the Plan or this Award Agreement if, without the Company’s written consent, you do any of the following within 180 days before and 730 days after you Terminate:

(i) You breach or threaten breach of any confidentiality, nondisclosure, and/or noncompetition obligations under any agreement or plan with the Company or any Affiliate or Subsidiary;

(ii) You fail or refuse to consult with, supply information to or otherwise cooperate with the Company or any Affiliate or Subsidiary after having been requested to do so;

(iii) You deliberately engage in any action that the Company concludes has caused substantial harm to the interests of the Company or any Affiliate or Subsidiary;

3

(iv) You fail to return all property (other than personal property), including vehicles, computer or other equipment or electronic devices, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data, formulae or any other tangible property or document and any and all copies, duplicates or reproductions that you have produced or received or have otherwise been provided to you in the course of your employment with the Company or any Affiliate or Subsidiary; or

(v) You engaged in conduct that the Committee reasonably concludes would have given rise to a Termination for Cause had it been discovered before you Terminated.

7. AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or terminate this Award Agreement or the Plan at any time.

8. BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any RSUs and related dividend equivalents that vest before you die but are settled after you die. This may be done only on the attached Beneficiary Designation Form and by following the rules described in that Form. The Beneficiary Designation Form does not need to be completed now and is not required as a condition of receiving your Award. However, if you die without completing a Beneficiary Designation Form or if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.

9. TRANSFERRING YOUR RSUs AND RELATED DIVIDEND EQUIVALENTS. Except as described in Section 8, your RSUs and related dividend equivalents may not be transferred to another person. Also, the Committee may allow you to place your RSUs and related dividend equivalents into a trust established for your benefit or the benefit of your family. Contact the Third Party Administrator for further details.

10. GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

11. OTHER AGREEMENTS. Your RSUs and related dividend equivalents will be subject to the terms of any other written agreements between you and the Company or any Affiliate or Subsidiary to the extent that those other agreements do not directly conflict with the terms of the Plan or this Award Agreement.

12. ADJUSTMENTS TO YOUR RSUs. Subject to the terms of the Plan, your RSUs and related dividend equivalents will be adjusted, if appropriate, to reflect any change to the Company’s capital structure (e.g., the number of Shares underlying your RSUs will be adjusted to reflect a stock split).

4

13. YOUR ACKNOWLEDGMENT OF AND AGREEMENT TO AWARD CONDITIONS.

By signing below, you acknowledge and agree that:

(a) A copy of the Plan has been made available to you;

(b) You understand and accept the terms and conditions of your Award;

(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees and without any further consideration) to any necessary change to your Award or this Award Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those changes affect the terms of your Award and reduce its value or potential value; and

(d) You must return a signed copy of this Award Agreement to the address given above before [Date 30 Days After Grant Date].

[Grantee’s Name]	THE SCOTTS MIRACLE-GRO COMPANY
By:	By:
Date signed:	[Name of Company Representative]
	[Title of Company Representative]
	Date signed:_________________________________

5

EX-10.3

Exhibit 10.3

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT FOR EMPLOYEES

NONQUALIFIED STOCK OPTION GRANTED

TO [Grantee’s Name] ON [Grant Date]

This Award Agreement describes the type of Award that you have been granted and the terms and conditions of your Award.

1. DESCRIPTION OF YOUR NONQUALIFIED STOCK OPTION. You have been granted a Nonqualified Stock Option (“NSO”) to purchase [Number of Common Shares] Shares at an exercise price of $[Exercise Price] for each Share (“Exercise Price”) on or before [Day Prior to Tenth Anniversary of Grant Date] (“Expiration Date”). The Grant Date of the NSO is [Grant Date]. To accept this Award Agreement, you must return a signed copy of this Award Agreement no later than [Date 30 Days After Grant Date], to [Third Party Administrator] (the “Third Party Administrator”) as follows:

[Third Party Administrator]

Attention: [TPA Contact’s Name]

[TPA Contact’s Address]

[TPA Telephone Number]

2. INCORPORATION OF PLAN AND DEFINITIONS.

(a) This Award Agreement and your NSO are granted pursuant to and in accordance with the Company’s 2006 Long-Term Incentive Plan (the “Plan”). All provisions of the Plan are incorporated herein by reference, and your NSO is subject to the terms of the Plan. To the extent there is a conflict between this Award Agreement and the Plan, the Plan will govern.

(b) Capitalized terms that are not defined in this Award Agreement have the same meanings as in the Plan.

3. VESTING. Except as provided in Section 6 of this Award Agreement, the NSO described in this Award Agreement will vest as follows:

(a) General Vesting. If your employment continues from the Grant Date until the third anniversary of the Grant Date, in this case [Vesting Date] (the “Vesting Date”), your NSO described in this Award Agreement will vest (and become exercisable) on the Vesting Date;

(b) Accelerated Vesting. Under the following circumstances, the NSO described in this Award Agreement will vest earlier than the Vesting Date:

(i) If you die or you Terminate due to your Disability (as defined below), your NSO described in this Award Agreement will become fully vested and expire on the Expiration Date. For purposes of this Award Agreement, “Disabled” means (A) you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, (B) you are, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering Employees of your employer, or (C) you are determined to be totally disabled by the Social Security Administration or Railroad Retirement Board;

(ii) If you Terminate for a reason other than Cause after reaching age 55 and completing at least 10 years of employment with the Company, its Affiliates and/or its Subsidiaries, your NSO described in this Award Agreement will become fully vested and expire on the Expiration Date; or

(iii) If there is a Change in Control, your NSO may vest earlier. See the Plan for further details.

4. RIGHTS BEFORE YOUR NSO IS EXERCISED. You may not vote, or receive any dividends associated with, the Shares underlying your NSO before your NSO is exercised with respect to such Shares.

5. EXERCISING YOUR NSO.

(a) After your NSO vests, you may exercise the NSO at any time prior to the Expiration Date. To exercise the NSO you must complete an Exercise Notice on the form provided by the Company, which is available from Third Party Administrator. At any one time, you must exercise your NSO to buy no fewer than 100 Shares, or, you must exercise the balance of your NSO if the value is less than 100 Shares.

(b) You may use one of the following three methods to exercise your NSO and to pay any taxes related to that exercise. You will decide on the method at the time of exercise. If you do not elect one of these methods, the Company will apply the Broker-Assisted Cashless Exercise and Sell method described below:

(i) BROKER-ASSISTED CASHLESS EXERCISE AND SELL: If you elect this alternative, you will be deemed to have simultaneously exercised the NSO and to have sold the Shares underlying the portion of the NSO you exercised. When the transaction is complete, you will receive cash (but no Shares) from the broker equal to the difference between the aggregate Fair Market Value of the Shares deemed to have been acquired through the exercise minus the aggregate Exercise Price and related taxes.

2

(ii) COMBINATION EXERCISE: If you elect this alternative, you will be deemed to have simultaneously exercised the NSO and to have sold a number of those Shares with a Fair Market Value equal to the aggregate Exercise Price and for taxes that are required to be withheld on account of the exercise. When the transaction is complete, the balance of the Shares subject to the portion of the NSO you exercised will be transferred to you.

(iii) EXERCISE AND HOLD: If you elect this alternative, you must pay the full Exercise Price plus related taxes (in cash, a cash equivalent or in Shares having a Fair Market Value equal to the Exercise Price and which you have owned for at least six months before the exercise date). When the transaction is complete, you will receive the number of Shares purchased.

(c) You may never exercise your NSO to purchase a fractional Share. Any fractional Share shall be redeemed for cash equal to the Fair Market Value of such fractional Share.

6. EXPIRATION AND FORFEITURE. It is your responsibility to keep track of when your NSO expires. Your NSO will expire and/or you will forfeit your NSO (i.e. you will no longer have the right to exercise any portion of your NSO) under each of the following circumstances:

(a) General Expiration Rules. In general, your NSO will expire on the Expiration Date.

(b) Forfeiture Rules. In the following instances, your NSO will expire and you will forfeit your NSO prior to the Expiration Date:

(i) If you Terminate before the Vesting Date, except as provided in Section 3 above, you will forfeit your NSO in its entirety;

(ii) If you engage in “Conduct That Is Harmful To The Company” (as described below), you will forfeit your NSO and must return to the Company all Shares and other amounts you have received through the Plan or this Award Agreement if, without the Company’s written consent, you do any of the following within 180 days before and 730 days after you Terminate:

1) You breach of any confidentiality, nondisclosure, and/or noncompetition obligations under any agreement or plan with the Company or any Affiliate or Subsidiary;

2) You fail or refuse to consult with, supply information to or otherwise cooperate with the Company or any Affiliate or Subsidiary after having been requested to do so;

3

3) You deliberately engage in any action that the Company concludes has caused substantial harm to the interests of the Company or any Affiliate or Subsidiary;

4) You fail to return all property (other than personal property), including vehicles, computer or other equipment or electronic devices, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data, formulae or any other tangible property or document and any and all copies, duplicates or reproductions that you have produced or received or have otherwise been provided to you in the course of your employment with the Company or any Affiliate or Subsidiary; or

5) You engaged in conduct that the Committee reasonably concludes would have given rise to a Termination for Cause had it been discovered before you Terminated.

(iii) If you Terminate for Cause after the Vesting Date, the portion of your NSO that has not been exercised will be forfeited (whether or not then vested) on the date you Terminate; or

(iv) If you Terminate for any other reason after the Vesting Date, the portion of your NSO that is vested but has not been exercised will expire on the earlier of the Expiration Date or 90 days after you Terminate.

7. AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or terminate this Award Agreement or the Plan at any time.

8. BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive or to exercise the vested portion of your NSO that is unexercised when you die. This may be done only on the attached Beneficiary Designation Form and by following the rules described in that Form. The Beneficiary Designation Form need not be completed now and is not required as a condition of receiving your Award. If you die without completing a Beneficiary Designation Form or if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.

9. TRANSFERRING YOUR NSO. Except as described in Section 8, your NSO may not be transferred to another person. The Committee may allow you to place your NSO into a trust established for your benefit or for the benefit of your family. Contact the Third Party Administrator for further details.

10. GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

4

11. OTHER AGREEMENTS. Your NSO will be subject to the terms of any other written agreements between you and the Company or any Affiliate or Subsidiary to the extent that those other agreements do not directly conflict with the terms of the Plan or this Award Agreement.

12. ADJUSTMENTS TO YOUR NSO. Subject to the terms of the Plan, your NSO and the terms of this Award Agreement will be adjusted, if appropriate, to reflect any change to the Company’s capital structure (e.g., the number of Shares underlying your NSO and the Exercise Price will be adjusted to reflect a stock split).

13. YOUR ACKNOWLEDGMENT OF AND AGREEMENT TO AWARD CONDITIONS

By signing below, you acknowledge and agree that:

(a) A copy of the Plan has been made available to you;

(b) You understand and accept the terms and conditions of your NSO;

(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees and without any further consideration) to any necessary change to your NSO or this Award Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those changes affect the terms of your NSO and reduce its value or potential value; and

(d) You must return a signed copy of this Award Agreement to the address given above before [Date 30 Days After Grant Date].

[Grantee’s Name]	THE SCOTTS MIRACLE-GRO COMPANY
BY:	BY:
Date signed: ________________________	[Name of Company representative] [Title of Company representative] Date signed:______________________

5

EX-10.4

Exhibit 10.4

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

DEFERRED STOCK UNIT AWARD AGREEMENT

FOR NONEMPLOYEE DIRECTORS

(WITH RELATED DIVIDEND EQUIVALENTS)

DEFERRED STOCK UNITS GRANTED TO

[Director’s Name] ON [Grant Date]

This Award Agreement describes the type of Award that you have been granted and the terms and conditions of your Award.

1. DESCRIPTION OF YOUR DEFERRED STOCK UNITS. You have been granted [insert Number] deferred stock units (“DSUs”) and an equal number of related dividend equivalents, subject to the terms and conditions of the Company’s 2006 Long-Term Incentive Plan (the “Plan”) and this Award Agreement. The “Grant Date” of your Award is [Grant Date]. Each whole DSU represents the right to receive one full Share at the time and in the manner described in this Award Agreement. Each dividend equivalent represents the right to receive additional DSUs (determined in accordance with Section 5) in respect of the dividends that are declared and paid during the period beginning on the Grant Date and ending on the Settlement Date (as described in Section 4(a)) with respect to the Share represented by the related DSU. To accept this Award Agreement, you must return a signed copy of this Award Agreement no later than [Date 30 Days After Grant Date], to [Third Party Administrator] (the “Third Party Administrator”) as follows:

[Third Party Administrator]

Attention: [TPA Contact’s Name]

[TPA Contact’s Address]

[TPA Telephone Number]

2. INCORPORATION OF PLAN AND DEFINITIONS.

(a) This Award Agreement and your DSUs are granted pursuant to and in accordance with the terms of the Plan. All provisions of the Plan are incorporated herein by reference, and your DSUs are subject to the terms of the Plan. To the extent there is a conflict between this Award Agreement and the Plan, the Plan will govern.

(b) Capitalized terms that are not defined in this Award Agreement have the same meanings as in the Plan.

3. VESTING. The DSUs described in this Award Agreement will vest as follows:

(a) General Vesting. If your Board services continue from the Grant Date until the third anniversary of the Grant Date, in this case [Vesting Date] (the “Vesting Date”), your DSUs described in this Award Agreement will become 100% vested on the Vesting Date, including any DSUs received pursuant to Section 5 on or prior to the Vesting Date. Any DSUs received pursuant to Section 5 following the Vesting Date will be 100% vested on the date they are credited to you.

(b) Accelerated Vesting. Under the following circumstances, your DSUs described in this Award Agreement will vest earlier than the Vesting Date:

(i) If you die or you Terminate because you become Disabled (as defined below), all of your DSUs will become 100% vested as of the date of such event. For purposes of this Award Agreement, “Disabled” means that you have been determined to be totally disabled by the Social Security Administration; or

(ii) If you Terminate for a reason other than Cause after completing at least five full years of continuous service and are at least age 50, all DSUs will become 100% vested as of the date of such event.

4. SETTLEMENT.

(a) Subject to the terms of the Plan and this Award Agreement, your vested DSUs shall ordinarily be settled in a lump sum as soon as administratively practicable, but no later than 90 days following the earliest date to occur of: (i) your Termination; (ii) your death; (iii) the date you become Disabled (as defined above); or (iv) the third anniversary of the Grant Date (the “Settlement Date”). Your whole DSUs shall be settled in full Shares, and any fractional DSU shall be settled in cash, determined based upon the Fair Market Value of a Share on the Settlement Date.

(b) Except as provided in Section 5 below, you will have none of the rights of a shareholder with respect to Shares underlying the DSUs unless and until you become the record holder of such Shares.

(c) Normally, your DSUs will vest and be settled only under the circumstances described above. However, if there is a Change in Control, your DSUs will become 100% vested on the date of the Change in Control and will be settled as described in the Plan. See the Plan for further details.

5. DIVIDEND EQUIVALENTS. With respect to each dividend equivalent:

(a) If a cash dividend is declared and paid on the Shares underlying the DSUs, you will receive an additional number of DSUs equal to the quotient of:

(i) The product of (I) the number of DSUs granted under this Award Agreement (including additional DSUs previously received in accordance with this Section 5) that have not been settled as of the dividend payment date, multiplied by (II) the amount of the cash dividend paid per Share; divided by

2

(ii) The Fair Market Value (which shall be equal to the closing price) of a Share on the date such cash dividend is paid.

(b) If a Share dividend is declared and paid on the Shares underlying the DSUs, you will receive an additional number of DSUs equal to the product of:

(i) The number of DSUs granted under this Award Agreement (including additional DSUs previously received in accordance with this Section 5) that have not been settled as of the dividend payment date, multiplied by

(ii) The dividend paid per Share.

(c) Any additional DSUs credited pursuant to this Section 5 shall be subject to the same terms and conditions as the DSUs granted pursuant to Section 1 above.

(d) Any fractional number of DSUs resulting from the calculations under this Section 5 shall be rounded to the nearest whole Share.

6. FORFEITURE. Except as otherwise provided in Section 3 or Section 4(c), if you Terminate prior to the Vesting Date your unvested DSUs will be forfeited immediately.

7. AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or terminate this Award Agreement or the Plan at any time.

8. BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any DSUs and related dividend equivalents that vest before you die but are settled after you die. This may be done only on a Beneficiary Designation Form and by following the rules described in that Form. The Beneficiary Designation Form does not need to be completed now and is not required as a condition of receiving your Award. However, if you die without completing a Beneficiary Designation Form or if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.

9. TRANSFERRING YOUR DSUs AND RELATED DIVIDEND EQUIVALENTS. Except as described in Section 8, your DSUs and related dividend equivalents may not be transferred to another person. Also, the Committee may allow you to place your DSUs and related dividend equivalents into a trust established for your benefit or the benefit of your family. Contact the Third Party Administrator for further details.

10. GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

11. OTHER AGREEMENTS. Your DSUs and the related dividend equivalents will be subject to the terms of any other written agreements between you and the Company or any Affiliate or Subsidiary to the extent that those other agreements do not directly conflict with the terms of the Plan or this Award Agreement.

3

12. ADJUSTMENTS TO YOUR DSUs. Subject to the terms of the Plan, your DSUs and the related dividend equivalents will be adjusted, if appropriate, to reflect any change to the Company’s capital structure (e.g., the number of Shares underlying your DSUs will be adjusted to reflect a stock split).

13. YOUR ACKNOWLEDGMENT OF AND AGREEMENT TO AWARD CONDITIONS.

By signing below, you acknowledge and agree that:

(a) A copy of the Plan has been made available to you;

(b) You understand and accept the terms and conditions of your Award;

(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees and without any further consideration) to any necessary change to your Award or this Award Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those changes affect the terms of your Award and reduce its value or potential value; and

(d) You must return a signed copy of this Award Agreement to the address given above before [Date 30 Days After Grant Date].

[Director’s Name]	THE SCOTTS MIRACLE-GRO COMPANY
By:	By:
Date signed:	[Name of Company Representative]
	[Title of Company Representative]
	Date signed:

4

EX-10.5

Exhibit 10.5

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

DEFERRED STOCK UNIT AWARD AGREEMENT

FOR NONEMPLOYEE DIRECTORS (WITH RELATED DIVIDEND EQUIVALENTS)

DEFERRED STOCK UNITS GRANTED TO

[Director’s Name] ON [Grant Date]

The Scotts Miracle-Gro Company (“Company”) believes that its business interests are best served by ensuring that you have an opportunity to share in the Company’s business success. To this end, the Company adopted The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (“Plan”) through which members of its Board of Directors, like you, may acquire (or share in the appreciation of) common shares, without par value, of the Company (“Shares”). Capitalized terms that are not defined in this Award Agreement have the same meanings as in the Plan.

This Award Agreement describes the type of Award that you have been granted and the terms and conditions of your Award. To ensure you fully understand these terms and conditions, you should:

• Read the Plan and this Award Agreement carefully; and

• Contact [Title] at [Telephone Number] if you have any questions about your Award. Or, you may send a written inquiry to the address shown below:

The Scotts Miracle-Gro Company

Attention: [Title]

14111 Scottslawn Road

Marysville, Ohio 43041

Also, no later than [Date 30 Days After Grant Date], you must return a signed copy of this Award Agreement to:

[Third Party Administrator]

Attention: [TPA Contact’s Name]

[TPA Contact’s Address]

[TPA Telephone Number]

The Company intends that this Award satisfy the requirements of Section 409A of the Code and that this Award Agreement be so administered and construed. You agree that the Company may modify this Award Agreement, without any further consideration, to fulfill this intent, even if those modifications change the terms of your Award and reduce its value or potential value.

1. DESCRIPTION OF YOUR DEFERRED STOCK UNITS

You have been granted [insert Number] of deferred stock units (“DSUs”) and an equal number of related dividend equivalents, subject to the terms and conditions of the Plan and this Award Agreement. The “Grant Date” of your Award is [insert Grant Date]. Each whole DSU represents the right to receive one full Share at the time and in the manner described in this Award Agreement. Each dividend equivalent represents the right to receive additional DSUs (determined in accordance with Section 3(e)) in respect of the dividends that are declared and paid during the period beginning on the Grant Date and ending on the Settlement Date (as described in Section 2(b)) with respect to the Share represented by the related DSU.

2. VESTING AND SETTLEMENT

(a) Vesting. Subject to Sections 3(a) and 3(b), your DSUs will become 100% vested on [insert third anniversary of the Grant Date] (“Vesting Date”), including any DSUs received pursuant to Section 3(e) on or prior to the Vesting Date. Any DSUs received pursuant to Section 3(e) following the Vesting Date will be 100% vested on the date they are credited to you.

(b) Settlement. Subject to the terms of the Plan, your vested DSUs shall be settled in a lump sum as soon as administratively practicable, but no later than 90 days, following the earliest to occur of: (i) your Termination; (ii) your death; (iii) the date you become Disabled (as defined below); or (iv) the third anniversary of the Grant Date (the “Settlement Date”). Your whole DSUs shall be settled in full Shares, and any fractional DSU shall be settled in cash, determined based upon the Fair Market Value of a Share on the Settlement Date. For purposes of this Award Agreement, “Disabled” means that you have been determined to be totally disabled by the Social Security Administration.

3. GENERAL TERMS AND CONDITIONS

(a) YOU MAY FORFEIT YOUR DSUs IF YOU TERMINATE. Except as otherwise provided in this Section 3(a) and Section 3(b), you will forfeit your DSUs if you Terminate prior to the Vesting Date:

(i) If you Terminate for Cause (as defined below) prior to the Vesting Date, your DSUs will be forfeited immediately. For purposes of this Award Agreement, “Cause” means your conviction of, or plea of guilty or nolo contendere to, a felony.

(ii) If you (A) Terminate (other than for Cause) after completing at least one full term of continuous service on the Board of Directors, (B) die or (C) become Disabled, the DSUs granted during your first term will become 100% vested as of the date of such event.

(iii) If you Terminate for any reason not described in Section 3(a)(i) or 3(a)(ii) prior to the Vesting Date, your DSUs will be forfeited immediately.

(b) CHANGE IN CONTROL. Normally, your DSUs will vest and be settled only under the circumstances described in Sections 2 and 3(a). However, if there is a Change in Control, your DSUs will become 100% vested on the date of the Change in Control and will be settled as described in the Plan. You should read the Plan carefully to ensure that you understand how this may happen.

2

(c) AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or terminate this Award Agreement or the Plan at any time.

(d) RIGHTS BEFORE YOUR DSUs ARE SETTLED. Except as provided in Section 3(e) below, you will have none of the rights of a shareholder with respect to Shares underlying the DSUs unless and until you become the record holder of such Shares.

(e) DIVIDEND EQUIVALENTS. With respect to each dividend equivalent:

(i) If a cash dividend is declared and paid on the Shares underlying the DSUs, you will receive an additional number of DSUs equal to the quotient of:

(A) the product of (I) the number of DSUs granted under this Award Agreement (including additional DSUs previously received in accordance with this Section 3(e)) that have not been settled as of the dividend payment date, multiplied by (II) the amount of the cash dividend paid per Share; divided by

(B) the Fair Market Value (which shall be equal to the closing price) of a Share on the date such cash dividend is paid.

Any additional DSU credited pursuant to this Section 3(e)(i) shall be subject to the same terms and conditions as the DSUs granted pursuant to Section 1 above.

(ii) If a Share dividend is declared and paid on the Shares underlying the DSUs, you will receive an additional number of DSUs equal to the product of (A) the number of DSUs granted under this Award Agreement (including additional DSUs previously received in accordance with this Section 3(e)) that have not been settled as of the dividend payment date, multiplied by (B) the dividend paid per Share. Any additional DSUs credited pursuant to this Section 3(e)(ii) shall be subject to the same terms and conditions as the DSUs granted pursuant to Section 1 above.

(iii) Any fractional number of DSUs resulting from the calculations under this Section 3(e) shall be rounded to the nearest whole Share.

(f) BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any DSUs and related dividend equivalents that vest before you die but are settled after you die. This may be done only on a Beneficiary Designation Form and by following the rules described in that Form. The Beneficiary Designation Form does not need to be completed now and is not required as a condition of receiving your Award. However, if you die without completing a Beneficiary Designation Form or if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.

3

(g) TRANSFERRING YOUR DSUs AND RELATED DIVIDEND EQUIVALENTS. Normally your DSUs and the related dividend equivalents may not be transferred to another person. However, as described in Section 3(f), you may complete a Beneficiary Designation Form to name the person to receive any DSUs and related dividend equivalents that vest before you die but are settled after you die. Also, the Committee may allow you to place your DSUs and dividend equivalents into a trust established for your benefit or the benefit of your family. Contact [Third Party Administrator] at [TPA Telephone Number] or at the address given above if you are interested in doing this.

(h) GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

(i) OTHER AGREEMENTS. Your DSUs and the related dividend equivalents will be subject to the terms of any other written agreements between you and the Company or any Affiliate or Subsidiary to the extent that those other agreements do not directly conflict with the terms of the Plan or this Award Agreement.

(j) ADJUSTMENTS TO YOUR DSUs. Subject to the terms of the Plan, your DSUs and the related dividend equivalents will be adjusted, if appropriate, to reflect any change to the Company’s capital structure (e.g., the number of Shares underlying your DSUs will be adjusted to reflect a stock split).

(k) OTHER RULES. Your DSUs and dividend equivalents are subject to more rules described in the Plan. You should read the Plan carefully to ensure you fully understand all the terms and conditions of the grant of DSUs and the related dividend equivalents under this Award Agreement.

4. YOUR ACKNOWLEDGMENT OF AWARD CONDITIONS

By signing below, you acknowledge and agree that:

(a) A copy of the Plan has been made available to you;

(b) You understand and accept the terms and conditions of your Award;

(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees and without any further consideration) to any necessary change to your Award or this Award Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those changes affect the terms of your Award and reduce its value or potential value; and

(d) You must return a signed copy of this Award Agreement to the address given above before [Date 30 Days After Grant Date].

4

[Director’s Name]	THE SCOTTS MIRACLE-GRO COMPANY
By:	By:
Date signed:	[Name of Company Representative]
	[Title of Company Representative]
	Date signed:

5

EX-10.6

Exhibit 10.6

Deferral of 2012 Cash Retainer

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

DEFERRED STOCK UNIT AWARD AGREEMENT

FOR NONEMPLOYEE DIRECTORS

(WITH RELATED DIVIDEND EQUIVALENTS)

DEFERRED STOCK UNITS CREDITED TO

[Director’s Name]

The Scotts Miracle-Gro Company (“Company”) believes that its business interests are best served by ensuring that you have an opportunity to share in the Company’s business success. To this end, the Company adopted The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan (“Plan”) through which members of its Board of Directors, like you, may acquire (or share in the appreciation of) common shares, without par value, of the Company (“Shares”). Capitalized terms that are not defined in this Deferred Stock Unit Award Agreement (“Award Agreement”) have the same meanings as in the Plan.

This Award Agreement describes the deferred stock units (“DSUs”) which you will be credited with upon conversion of quarterly installments of the annual cash retainer payable to you by the Company and the terms and conditions of your DSUs. To ensure you fully understand these terms and conditions, you should:

• Read the Plan and this Award Agreement carefully; and

• Contact [Title] at [Telephone Number] if you have any questions about your Award. Or, you may send a written inquiry to the address shown below:

The Scotts Miracle-Gro Company

Attention: [Title]

14111 Scottslawn Road

Marysville, Ohio 43041

Also, no later than [Insert Date], you must return a signed copy of this Award Agreement to:

[Third Party Administrator]

Attention: [TPA Contact’s Name]

[TPA Contact’s Address]

[TPA Telephone Number]

The Company intends that the DSUs credited under this Award Agreement satisfy the requirements of Section 409A of the Code and that this Award Agreement be so administered and construed. You agree that the Company may modify this Award Agreement, without any further consideration, to fulfill this intent, even if those modifications change the terms of your DSUs and reduce their value or potential value.

1. DESCRIPTION OF YOUR DEFERRED STOCK UNITS

You have elected to convert [$dollar amount] of each quarterly installment of the annual cash retainer paid to you by the Company (“Amount Deferred”) into DSUs, subject to the terms and conditions of the Plan and this Award Agreement. As of each date on which the Amount Deferred would otherwise be paid (each a “Conversion Date”), you will be credited with a number of DSUs and an equal number of related dividend equivalents, determined by dividing the Amount Deferred by the Fair Market Value of a Share. The number of DSUs credited to you each quarter will be reflected on Schedule A, as updated by the Company after each Conversion Date during 2012.

Each whole DSU represents the right to receive one full Share at the time and in the manner described in this Award Agreement. Each dividend equivalent represents the right to receive additional DSUs (determined in accordance with Section 3(c)) in respect of the dividends that are declared and paid during the period beginning on the relevant Conversion Date and ending on the Settlement Date (as described in Section 2(b)) with respect to the Shares represented by the related DSU.

2. VESTING AND SETTLEMENT

(a) Vesting. Your DSUs (and any related dividend equivalents received pursuant to Section 3(c) following the Conversion Date) will be 100% vested on the date they are credited to you.

(b) Settlement. Subject to the terms of the Plan, your vested DSUs shall be settled in a lump sum as soon as administratively practicable, but no later than 90 days, following the earliest to occur of: (i) your Termination (as defined below); (ii) your death; (iii) the date you become Disabled (as defined below); or (iv) [January 31, 2017] (the “Settlement Date”). Your whole DSUs shall be settled in full Shares, and any fractional DSU shall be settled in cash, determined based upon the Fair Market Value of a Share on the Settlement Date.

(c) Definitions. For purposes of this Award Agreement:

(i) “Disabled” means that you have been determined to be totally disabled by the Social Security Administration.

(ii) “Termination” (or any form thereof) means your “separation from service” from the Company, as defined in Section 409A of the Code.

3. GENERAL TERMS AND CONDITIONS

(a) AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or terminate this Award Agreement or the Plan at any time.

(b) RIGHTS BEFORE YOUR DSUs ARE SETTLED. Except as provided in Section 3(c) below, you will have none of the rights of a shareholder with respect to Shares underlying the DSUs credited to you under this Award Agreement unless and until you become the record holder of such Shares.

2

(c) DIVIDEND EQUIVALENTS. With respect to each dividend equivalent:

(i) If a cash dividend is declared and paid on the Shares underlying the DSUs credited to you under this Award Agreement, you will receive an additional number of DSUs equal to the quotient of:

(A) the product of (I) such number of DSUs (including additional DSUs previously received in accordance with this Section 3(c)) that have not been settled as of the dividend payment date, multiplied by (II) the amount of the cash dividend paid per Share; divided by

(B) the Fair Market Value (which shall be equal to the closing price) of a Share on the date such cash dividend is paid.

Any additional DSUs credited pursuant to this Section 3(c)(i) shall be subject to the same terms and conditions as the DSUs credited to you pursuant to Section 1 above.

(ii) If a Share dividend is declared and paid on the Shares underlying the DSUs credited under this Award Agreement, you will receive an additional number of DSUs equal to the product of (A) such number of DSUs (including additional DSUs previously received in accordance with this Section 3(c)) that have not been settled as of the dividend payment date, multiplied by (B) the dividend paid per Share. Any additional DSUs credited pursuant to this Section 3(c)(ii) shall be subject to the same terms and conditions as the DSUs credited pursuant to Section 1 above.

(iii) Any fractional number of DSUs resulting from the calculations under this Section 3(c) shall be rounded to the nearest whole Share.

(d) BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any DSUs and related dividend equivalents that are settled after you die. This may be done only on a Beneficiary Designation Form and by following the rules described in that Form. The Beneficiary Designation Form does not need to be completed now and is not required as a condition of receiving DSUs upon conversion of the Amount Deferred. However, if you die without completing a Beneficiary Designation Form or if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.

(e) TRANSFERRING YOUR DSUs AND RELATED DIVIDEND EQUIVALENTS. Normally your DSUs and related dividend equivalents may not be transferred to another person. However, as described in Section 3(d), you may complete a Beneficiary Designation Form to name the person to receive any DSUs and related dividend equivalents that are settled after you die. Also, the Committee may allow you to place your DSUs and dividend equivalents into a trust established for your benefit or the benefit of your family. Contact [Third Party Administrator] at [TPA Telephone Number] or at the address given above if you are interested in doing this.

(f) GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

3

(g) OTHER AGREEMENTS. Your DSUs and the related dividend equivalents will be subject to the terms of any other written agreements between you and the Company or any Affiliate or Subsidiary to the extent that those other agreements do not directly conflict with the terms of the Plan or this Award Agreement.

(h) ADJUSTMENTS TO YOUR DSUs. Subject to the terms of the Plan, your DSUs and the related dividend equivalents will be adjusted, if appropriate, to reflect any change to the Company’s capital structure (e.g., the number of Shares underlying your DSUs will be adjusted to reflect a stock split).

(i) OTHER RULES. Your DSUs and dividend equivalents are subject to more rules described in the Plan. You should read the Plan carefully to ensure you fully understand all the terms and conditions of the crediting of DSUs and the related dividend equivalents under this Award Agreement.

4. YOUR ACKNOWLEDGMENT OF AWARD CONDITIONS

By signing below, you acknowledge and agree that:

(a) A copy of the Plan has been made available to you;

(b) You understand and accept the terms and conditions of your DSUs;

(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees and without any further consideration) to any necessary change to your DSUs or this Award Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those changes affect the terms of your DSUs and reduce their value or potential value; and

(d) You must return a signed copy of this Award Agreement to the address given above before [Insert Date]. By signing below you acknowledge that the DSUs credited to you on each Conversion Date (as reflected on Schedule A for each Conversion Date) will be subject to the terms of the Plan and this Award Agreement.

[Director’s Name]	THE SCOTTS MIRACLE-GRO COMPANY
By:	By:
Date signed:	[Name of Company Representative]
	[Title of Company Representative]
	Date signed:

4

THE SCOTTS MIRACLE-GRO COMPANY

AMENDED AND RESTATED

2006 LONG-TERM INCENTIVE PLAN

DEFERRED STOCK UNIT AWARD AGREEMENT

FOR NONEMPLOYEE DIRECTORS

(WITH RELATED DIVIDEND EQUIVALENTS)

DEFERRED STOCK UNITS CREDITED TO

[Director’s Name]

SCHEDULE A

Conversion Date	Amount Deferred	Applicable Share Price	Number of Deferred Stock Units
January [ ], 2012	$[amount]	$[price]	[# TBD]
April [ ], 2012	$[amount]	$[price]	[# TBD]
July [ ], 2012	$[amount]	$[price]	[# TBD]
October [ ], 2012	$[amount]	$[price]	[# TBD]

Note: the Company will update Schedule A each quarter to reflect the number of additional DSUs to be credited to you on the applicable Conversion Date.

5

EX-31.1

Exhibit 31.1

Rule 13a-14(a)/15d-14(a) Certifications

(Principal Executive Officer)

CERTIFICATIONS

I, James Hagedorn, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The Scotts Miracle-Gro Company for the quarterly period ended December 31, 2011;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2012	By:	/s/ JAMES HAGEDORN
		Printed Name: James Hagedorn
		Title: Chief Executive Officer and Chairman of the Board

EX-31.2

Exhibit 31.2

Rule 13a-14(a)/15d-14(a) Certifications

(Principal Financial Officer)

CERTIFICATIONS

I, David C. Evans, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of The Scotts Miracle-Gro Company for the quarterly period ended December 31, 2011;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2012	By:	/s/ DAVID C. EVANS
		Printed Name: David C. Evans
		Title: Chief Financial Officer and Executive Vice President,           Strategy and Business Development

EX-32

Exhibit 32

SECTION 1350 CERTIFICATIONS*

In connection with the Quarterly Report on Form 10-Q of The Scotts Miracle-Gro Company (the “Company”) for the quarterly period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned James Hagedorn, Chief Executive Officer and Chairman of the Board of the Company, and David C. Evans, Chief Financial Officer and Executive Vice President, Strategy and Business Development of the Company, certify, pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:

1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company and its subsidiaries.

/s/ JAMES HAGEDORN	/s/ DAVID C. EVANS
James Hagedorn	David C. Evans
Chief Executive Officer	Chief Financial Officer and Executive Vice President,
and Chairman of the Board	Strategy and Business Development
February 8, 2012	February 8, 2012

* THESE CERTIFICATIONS ARE BEING FURNISHED AS REQUIRED BY RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”) AND SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE, AND SHALL NOT BE DEEMED “FILED” FOR PURPOSES OF SECTION 18 OF THE EXCHANGE ACT OR OTHERWISE SUBJECT TO THE LIABILITY OF THAT SECTION. THESE CERTIFICATIONS SHALL NOT BE DEEMED TO BE INCORPORATED BY REFERENCE INTO ANY FILING UNDER THE SECURITIES ACT OF 1933 OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT THAT THE COMPANY SPECIFICALLY INCORPORATES THESE CERTIFICATIONS BY REFERENCE.

XML

Impact of Product Registration and Recall Matters on Company's Results of Operations (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Product Liability Contingency [Line Items]
Cost of sales - other charges		$ 0.8
Gross profit (loss)	24.8	49.1
Selling, general and administrative	123.0	143.2
Loss from operations	(100.2)	(94.5)
Income tax benefit	(41.6)	(37.3)
Net loss	(73.9)	(67.9)
Product registration and recall matter
Product Liability Contingency [Line Items]
Cost of sales - other charges		0.8
Gross profit (loss)		(0.8)
Selling, general and administrative	0.3	0.9
Loss from operations	(0.3)	(1.7)
Income tax benefit	0.1	0.6
Net loss	$ (0.2)	$ (1.1)

XML

INCOME TAXES - Additional Information (Detail)	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Income Taxes [Line Items]
Effective income tax rate-continuing operations	36.00%	35.90%
German audit
Income Taxes [Line Items]
Tax years under examination	Fiscal years 2004 through 2008
U.S. state and local tax authorities
Income Taxes [Line Items]
Tax years under examination	Fiscal years 1997 through 2009

XML

Components of Long-Term Debt (Parenthetical) (Detail)	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Senior Notes - 7.25%
Debt Instrument [Line Items]
Interest rate	7.25%	7.25%	7.25%
Senior Notes - 6.625%
Debt Instrument [Line Items]
Interest rate	6.625%	6.625%	6.625%

XML

CONTINGENCIES - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011
Commitments and Contingencies Disclosure [Line Items]
Accrued liabilities related to other regulatory matters which are accounted for in the "Other liabilities"	$ 4.0

XML

Net Commission Earned Under Marketing Agreement (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Long-term Purchase Commitment [Line Items]
Gross commission
Contribution expenses	(5.0)	(5.0)
Amortization of marketing fee	(0.2)	(0.2)
Net commission expense	(5.2)	(5.2)
Reimbursements associated with Marketing Agreement	17.9	15.2
Total net sales associated with Marketing Agreement	$ 12.7	$ 10.0

XML

FAIR VALUE MEASUREMENTS (Tables)

15 Months Ended

Dec. 31, 2011

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at December 31, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Cash equivalents	$	83.5	$	—		$	—	$	83.5
Derivatives
Foreign currency swap contracts		—		3.5			—		3.5
Other		6.5		—			—		6.5
Total	$	90.0	$	3.5		$	—	$	93.5
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(27.3	)	$	—	$	(27.3	)
Foreign currency swap contracts		—		(0.6	)		—		(0.6	)
Commodity hedging instruments		—		(2.3	)		—		(2.3	)
Total	$	—	$	(30.2	)	$	—	$	(30.2	)

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at January 1, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Derivatives
Interest rate swap agreements	$	—	$	2.4		$	—	$	2.4
Foreign currency swap contracts		—		5.3			—		5.3
Commodity hedging instruments		—		4.4			—		4.4
Other		7.8		—			—		7.8
Total	$	7.8	$	12.1		$	—	$	19.9
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(18.5	)	$	—	$	(18.5	)
Foreign currency swap contracts		—		(0.3	)		—		(0.3	)
Total	$	—	$	(18.8	)	$	—	$	(18.8	)

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at September 30, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Cash equivalents	$	83.6	$	—		$	—	$	83.6
Derivatives
Commodity hedging instruments		—		0.1			—		0.1
Foreign currency swap contracts		—		2.7			—		2.7
Other		6.3		—			—		6.3
Total	$	89.9	$	2.8		$	—	$	92.7
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(28.1	)	$	—	$	(28.1	)
Commodity hedging instruments		—		(0.8	)		—		(0.8	)
Total	$	—	$	(28.9	)	$	—	$	(28.9	)

XML

Outstanding Commodity Contracts that Hedge Forecasted Purchases (Detail)	Dec. 31, 2011 ton	Jan. 01, 2011 ton
Urea
Derivative [Line Items]
Outstanding commodity contracts	40,500	39,500
Diesel
Derivative [Line Items]
Outstanding commodity contracts	5,250,000	3,570,000
Gasoline
Derivative [Line Items]
Outstanding commodity contracts	217,000
Heating Oil
Derivative [Line Items]
Outstanding commodity contracts	2,268,000

XML

IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES (Tables)

15 Months Ended

Dec. 31, 2011

Summary of Activities Related to Liabilities Associated with Restructuring and Other Charges

The following table summarizes the activity related to liabilities associated with the restructuring and other charges during the three months ended December 31, 2011:

		September 30,
	DECEMBER 31, 2011
Amounts reserved for restructuring and other charges at September 30, 2011	$	29.6
Restructuring and other charges		2.6
Payments and other		(5.6	)
Amounts reserved for restructuring and other charges at December 31, 2011	$	26.6

XML

Components of Other Comprehensive Income (Expense) ("OCI") (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Comprehensive Income (Loss) [Line Items]
Net loss	$ (73.9)	$ (67.9)
Other comprehensive income (loss):
Net unrealized gain (loss) on derivative instruments	(0.6)	2.8
Net change in pension and other postretirement related items	1.9	6.2
Foreign currency translation adjustments	(3.5)	2.2
Total comprehensive loss	$ (76.1)	$ (56.7)

XML

Summary of Activities Related to Liabilities Associated with Restructuring and Other Charges (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]
Amounts reserved for restructuring and other charges at September 30, 2011	$ 29.6
Restructuring and other charges	2.6
Payments and other	(5.6)
Amounts reserved for restructuring and other charges at December 31, 2011	$ 26.6

XML

Major Classes of Assets and Liabilities (Detail) (USD $) In Millions, unless otherwise specified	Jan. 01, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	$ 200.9
Liabilities held for sale	45.4
Global Pro
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	200.9
Liabilities held for sale	45.4
Global Pro | Cash and cash equivalents
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	1.0
Global Pro | Accounts receivable, net
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	54.9
Global Pro | Inventories
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	61.2
Global Pro | Prepaid and other assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	4.6
Global Pro | Property, plant and equipment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	12.8
Global Pro | Good-will
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	66.4
Global Pro | Accounts payable
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Liabilities held for sale	16.4
Global Pro | Other current liabilities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Liabilities held for sale	15.6
Global Pro | Other liabilities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Liabilities held for sale	$ 13.4

XML

SHAREHOLDERS' EQUITY - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		15 Months Ended
	Dec. 31, 2011	Jan. 01, 2011	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares repurchased	0.4		7.9
Value of common shares repurchased to be held in treasury	$ 17.5		$ 401.2
Total repurchase amount	700
Share-based compensation	1.6	4.3
Deferred Compensation, Share-based Payments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement, shares that may be issued	0.7
Estimated fair value of performance shares, restricted stock units and stock options awarded on the date of the grant	$ 16.7

XML

Segment Financial Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011	Sep. 30, 2011
Segment Reporting Information [Line Items]
Net sales	$ 211.2	$ 230.2
Income from continuing operations before income taxes	(115.5)	(104.0)
Assets	2,164.3	2,255.2	2,052.2
Reportable Segment
Segment Reporting Information [Line Items]
Net sales	186.7	225.9
Income from continuing operations before income taxes	(74.0)	(59.6)
Reportable Segment | Global Consumer
Segment Reporting Information [Line Items]
Net sales	149.1	188.8
Income from continuing operations before income taxes	(69.4)	(55.1)
Assets	1,723.8	1,584.2	1,552.4
Reportable Segment | Scotts LawnService
Segment Reporting Information [Line Items]
Net sales	37.6	37.1
Income from continuing operations before income taxes	(4.6)	(4.5)
Assets	162.2	155.4	184.3
Corporate and Other
Segment Reporting Information [Line Items]
Net sales	24.5	4.3
Income from continuing operations before income taxes	(20.8)	(30.9)
Assets	278.3	314.7	315.5
Intangible asset amortization
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(2.5)	(2.3)
Product registration and recall matter
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(0.3)	(1.7)
Restructuring And Other Costs
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(2.6)
Interest expenses
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(15.3)	(9.5)
Assets held for sale
Segment Reporting Information [Line Items]
Assets		$ 200.9

XML

Components of Long-Term Debt (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Debt Instrument [Line Items]
Long-term Debt	$ 1,034.2	$ 795.0	$ 855.9
Less current portions	8.1	3.2	168.5
Total long-term debt	1,026.1	791.8	687.4
Credit Facilities | Revolving loans
Debt Instrument [Line Items]
Long-term Debt	621.7	387.2	227.4
Credit Facilities | Term loans
Debt Instrument [Line Items]
Long-term Debt			208.5
Senior Notes - 7.25%
Debt Instrument [Line Items]
Long-term Debt	200.0	200.0	200.0
Senior Notes - 6.625%
Debt Instrument [Line Items]
Long-term Debt	200.0	200.0	200.0
Master Accounts Receivable Purchase Agreement
Debt Instrument [Line Items]
Long-term Debt	5.4
Foreign Borrowings (Local Facilities and Term Loans)
Debt Instrument [Line Items]
Long-term Debt	0.3	0.4	1.3
Contingent consideration
Debt Instrument [Line Items]
Long-term Debt	0.3	0.3	10.8
Other debt
Debt Instrument [Line Items]
Long-term Debt	$ 6.5	$ 7.1	$ 7.9

XML

IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES

15 Months Ended

Dec. 31, 2011

IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES

NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES

On August 8, 2011, the Company announced a restructuring plan (the “2011 restructuring plan”) designed to streamline management decision making and continue the regionalization of the Company’s operating structure, with the objective of reinvesting the savings generated in innovation and growth initiatives. During fiscal 2011, the Company incurred $24.2 million in restructuring costs related to termination benefits provided to employees who were involuntarily terminated and special termination benefits provided to certain employees upon future separation, as well as $2.3 million related to curtailment charges for its U.S. defined benefit pension and U.S. retiree medical plans. A majority of these costs that were incurred were in relation to the Global Consumer and Corporate & Other segments. In continuation of the 2011 restructuring plan, during the three months ended December 31, 2011, the Company incurred an additional $2.4 million in restructuring costs related to termination benefits provided to employees who accepted voluntary retirement and special termination benefits provided to certain employees upon future separation as well as $0.2 million related to curtailment charges for its U.S. defined benefit pension and U.S retiree medical plans. A significant portion of the amounts reserved as of September 30, 2011 and December 31, 2011 will be paid out over the course of fiscal 2012. Included in the restructuring reserves is $7.2 million that is classified as long-term. Payments against the long-term reserves will start once the employees covered by the 2011 restructuring plan retire.

The following table summarizes the activity related to liabilities associated with the restructuring and other charges during the three months ended December 31, 2011:

		September 30,
	DECEMBER 31, 2011
Amounts reserved for restructuring and other charges at September 30, 2011	$	29.6
Restructuring and other charges		2.6
Payments and other		(5.6	)
Amounts reserved for restructuring and other charges at December 31, 2011	$	26.6

XML

Condensed Consolidating Statement of Operations (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Schedule of Condensed Consolidating Statement of Operations [Line Items]
Net sales	$ 211.2	$ 230.2
Cost of sales	186.4	180.3
Cost of sales-product registration and recall matters		0.8
Gross profit	24.8	49.1
Operating expenses:
Selling, general and administrative	123.0	143.2
Impairment, restructuring and other charges	2.6
Product registration and recall matters	0.3	0.9
Other (income) loss, net	(0.9)	(0.5)
Income (loss) from operations	(100.2)	(94.5)
Interest expense	15.3	9.5
Loss from continuing operations before income taxes	(115.5)	(104.0)
Income tax benefit from continuing operations	(41.6)	(37.3)
Loss from continuing operations	(73.9)	(66.7)
Loss from discontinued operations, net of tax		(1.2)
Net loss	(73.9)	(67.9)
Parent
Operating expenses:
Other (income) loss, net	(2.8)
Income (loss) from operations	2.8
Equity loss in subsidiaries	66.2	63.6
Other non-operating income		(3.8)
Interest expense	10.8	8.7
Loss from continuing operations before income taxes	(74.2)	(68.5)
Income tax benefit from continuing operations	(0.3)	(0.6)
Loss from continuing operations	(73.9)	(67.9)
Net loss	(73.9)	(67.9)
Subsidiary Guarantors
Schedule of Condensed Consolidating Statement of Operations [Line Items]
Net sales	157.1	176.8
Cost of sales	144.8	143.3
Cost of sales-product registration and recall matters		0.8
Gross profit	12.3	32.7
Operating expenses:
Selling, general and administrative	95.5	115.1
Impairment, restructuring and other charges	2.6
Product registration and recall matters	0.3	0.9
Other (income) loss, net	(0.5)	0.2
Income (loss) from operations	(85.6)	(83.5)
Equity loss in subsidiaries	9.8	8.4
Interest expense	6.6	4.3
Loss from continuing operations before income taxes	(102.0)	(96.2)
Income tax benefit from continuing operations	(35.8)	(32.7)
Loss from continuing operations	(66.2)	(63.5)
Net loss	(66.2)	(63.5)
Non-Guarantors
Schedule of Condensed Consolidating Statement of Operations [Line Items]
Net sales	54.1	53.4
Cost of sales	41.6	37.0
Gross profit	12.5	16.4
Operating expenses:
Selling, general and administrative	27.5	28.1
Other (income) loss, net	(0.4)	(0.7)
Income (loss) from operations	(14.6)	(11.0)
Interest expense	0.7	0.3
Loss from continuing operations before income taxes	(15.3)	(11.3)
Income tax benefit from continuing operations	(5.5)	(4.0)
Loss from continuing operations	(9.8)	(7.3)
Loss from discontinued operations, net of tax		(1.2)
Net loss	(9.8)	(8.5)
Eliminations
Operating expenses:
Other (income) loss, net	2.8
Income (loss) from operations	(2.8)
Equity loss in subsidiaries	(76.0)	(72.0)
Other non-operating income		3.8
Interest expense	(2.8)	(3.8)
Loss from continuing operations before income taxes	76.0	72.0
Loss from continuing operations	76.0	72.0
Net loss	$ 76.0	$ 72.0

XML

INVENTORIES - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Inventory Disclosure [Line Items]
Reserves for excess and obsolete inventories	$ 12.2	$ 22.0	$ 27.2

XML

COMPREHENSIVE INCOME (LOSS) (Tables)

15 Months Ended

Dec. 31, 2011

Components of Other Comprehensive Income (Expense) ("OCI")

The components of other comprehensive income (loss) (“OCI”) were as follows (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net loss	$	(73.9	)	$	(67.9	)
Other comprehensive income (loss):
Net unrealized gain (loss) on derivative instruments		(0.6	)		2.8
Net change in pension and other postretirement related items		1.9			6.2
Foreign currency translation adjustments		(3.5	)		2.2
Total comprehensive loss	$	(76.1	)	$	(56.7	)

XML

DEBT (Tables)

15 Months Ended

Dec. 31, 2011

Components of Long-Term Debt

The components of long-term debt are as follows (in millions):

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Credit Facilities:
Revolving loans	$	621.7	$	227.4	$	387.2
Term loans		—		208.5		—
Senior Notes – 7.25%		200.0		200.0		200.0
Senior Notes – 6.625%		200.0		200.0		200.0
MARP Agreement		5.4		—		—
Foreign borrowings (local facilities and term loans)		0.3		1.3		0.4
Contingent consideration		0.3		10.8		0.3
Other		6.5		7.9		7.1
		1,034.2		855.9		795.0
Less current portions		8.1		168.5		3.2
Total long-term debt	$	1,026.1	$	687.4	$	791.8

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011		Sep. 30, 2011		Jan. 01, 2011
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Fair value of outstanding derivatives	$ (26.7)		$ (26.1)		$ (6.7)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Fair value of outstanding derivatives	(2.7)	[1]	2.2	[1]	5.8	[1]
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Foreign currency swap contracts
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount of outstanding foreign currency derivatives	306.3				330.7
Fair value of outstanding derivatives	3.5				5.0
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Fair value of outstanding derivatives	(29.4)		(28.3)		(12.5)
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Interest rate swap agreements
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount of outstanding interest rate derivatives	900				800
Interest rate loss amount expected to be reclassified to earnings during the next 12 months	5.2
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Urea
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Pre-tax price risk gain (loss) amount expected to be reclassified to earnings during the next 12 months	0.1
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Diesel
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Pre-tax price risk gain (loss) amount expected to be reclassified to earnings during the next 12 months	$ 0.1

[1] See discussion above for additional information regarding the Company's purpose for entering into derivatives not designated as hedging instruments and its overall risk management strategy.

XML

Inventories for Continuing Operations, net of Reserves for Excess and Obsolete Inventories (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Inventory Disclosure [Line Items]
Finished goods	$ 435.9	$ 130.7	$ 351.5
Work-in-process	52.0	34.3	37.4
Raw materials	166.9	222.0	178.1
Total inventories	$ 654.8	$ 387.0	$ 567.0

XML

RETIREMENT AND RETIREE MEDICAL PLANS (Tables)

15 Months Ended

Dec. 31, 2011

Net Periodic Benefit Cost

The following summarizes the components of net periodic benefit cost for the retirement and retiree medical plans sponsored by the Company (in millions):

		September 30,			September 30,			September 30,		September 30,			September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011								JANUARY 1, 2011
	U.S. Pension			International Pension			U.S. Medical		U.S. Pension			International Pension			U.S. Medical
Service cost	$	—		$	0.3		$	0.1	$	—		$	0.4		$	0.1
Interest cost		1.1			2.4			0.4		1.2			2.7			0.4
Expected return on plan assets		(1.4	)		(2.2	)		—		(1.3	)		(2.6	)		—
Net amortization		1.3			0.2			0.1		1.2			0.4			—
Curtailment loss		0.2			—			—		—			—			—
Net periodic benefit cost	$	1.2		$	0.7		$	0.6	$	1.1		$	0.9		$	0.5

XML

SHAREHOLDERS' EQUITY (Tables)

15 Months Ended

Dec. 31, 2011

Summary of Share-Based Compensation Awards

The following is a summary of the share-based awards granted over the periods indicated:

		September 30,		September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011		JANUARY 1, 2011
Performance shares		—		11,574
Restricted stock units (including deferred stock units)		1,134		2,721
Total share-based awards		1,134		14,295
Aggregate fair value at grant dates (in millions)	$	0.1	$	0.7

XML

PRODUCT REGISTRATION AND RECALL MATTERS

15 Months Ended

Dec. 31, 2011

PRODUCT REGISTRATION AND RECALL MATTERS

NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS

In April 2008, the Company became aware that a former associate apparently deliberately circumvented the Company’s policies and U.S. Environmental Protection Agency (“U.S. EPA”) regulations under the Federal Insecticide, Fungicide, and Rodenticide Act of 1947, as amended (“FIFRA”), by failing to obtain valid registrations for certain products and/or causing certain invalid product registration forms to be submitted to regulators. Since that time, the Company has been cooperating with both the U.S. EPA and the U.S. Department of Justice (the “U.S. DOJ”) in related civil and criminal investigations into the pesticide product registration issues as well as a state civil investigation into related allegations arising under state pesticide registration laws and regulations.

In late April 2008, in connection with the U.S. EPA’s investigation, the Company conducted a consumer-level recall of certain consumer lawn and garden products and a Scotts LawnService^® product. Subsequently, the Company and the U.S. EPA agreed upon a Compliance Review Plan for conducting a comprehensive, independent review of the Company’s product registration records. Pursuant to the Compliance Review Plan, an independent third-party firm, Quality Associates Incorporated (“QAI”), reviewed substantially all of the Company’s U.S. pesticide product registrations and associated advertisements, some of which were historical in nature and no longer related to sales of the Company’s products. The U.S. EPA investigation and the QAI review process resulted in the temporary suspension of sales and shipments of certain products. In addition, as the QAI review process or the Company’s internal review identified potential FIFRA registration issues (some of which appear unrelated to the actions of the former associate), the Company endeavored to stop selling or distributing the affected products until the issues could be resolved. QAI’s review of the Company’s U.S. pesticide product registrations and associated advertisements is now substantially complete. The results of the QAI review process did not materially affect the Company’s fiscal 2009, fiscal 2010 or fiscal 2011 sales and are not expected to materially affect the Company’s fiscal 2012 sales.

In fiscal 2008, the Company conducted a voluntary recall of certain of its wild bird food products due to a formulation issue. Certain wild bird food products had been treated with pest control additives to avoid insect infestation, especially at retail stores. While the pest control additives had been labeled for use on certain stored grains that can be processed for human and/or animal consumption, they were not labeled for use on wild bird food products. In October 2008, the U.S. Food & Drug Administration concluded that the recall had been completed and that there had been proper disposition of the recalled products. The results of the wild bird food recall did not materially affect the Company’s fiscal 2009, fiscal 2010 or fiscal 2011 financial condition, result of operations or cash flows.

Settlement discussions relating to potential fines and/or penalties are a frequent outgrowth of governmental investigations. In that regard, on or about June 30, 2011, the Company received a Notice of Intent to File Administrative Complaint (“Notice”) from the U.S. EPA Region 5 with respect to the alleged FIFRA violations. The Notice, which does not set forth a proposed penalty amount, offers the Company an opportunity to present any information that it believes the U.S. EPA should consider prior to filing the complaint and indicates that the U.S. EPA is prepared to meet with the Company to discuss the alleged violations. The Company made a timely response to the Notice and communications between the Company and the U.S. EPA are underway.

As previously disclosed, the Company has also been engaged in settlement discussions with the U.S. DOJ regarding its criminal investigation. On January 25, 2012, a plea agreement (the “Plea Agreement”), executed by both Scotts Miracle-Gro and the U.S. DOJ, was filed with the United States District Court for the Southern District of Ohio. Under the terms of the Plea Agreement, which must be approved by a federal judge, Scotts Miracle-Gro has agreed to plead guilty to 11 counts of violating FIFRA and the regulations promulgated thereunder, to pay a $4,000,000 penalty to the United States and to provide $100,000 to each of the following programs designed to enhance and protect the natural environment, particularly habitats for the bird populations that the U.S. EPA’s regulation of pesticides is designed to protect: (1) Ohio Audubon’s Important Bird Area Program; (2) Ohio Department of Natural Resources’ Urban Forestry Program; (3) Columbus Metro-Parks Bird Habitat Enhancement Program; (4) Cornell University Ornithology Laboratory; and (5) The Nature Conservancy of Ohio. In exchange for Scotts Miracle-Gro’s guilty plea and the other promises contained in the Plea Agreement, the U.S. DOJ has agreed not to criminally prosecute the Company for any other federal crimes relating to any potential FIFRA violations known to the government as of the date of the Plea Agreement. The Company’s previously established reserve covers the full amount of the proposed criminal penalty and other amounts payable under the Plea Agreement.

The U.S. EPA and related state investigations continue and the Plea Agreement between Scotts Miracle-Gro and the U.S. DOJ must still be approved by the United States District Court. In addition, the current investigations and proceedings may result in future state, federal or private rights of action as well as judgments, settlements, fines and/or penalties with respect to known or potential additional product registration issues. At this stage of the investigations, the Company cannot reasonably estimate the total scope or magnitude of all possible liabilities that could result from known or potential product registration issues. Based on the facts and circumstances known to the Company at this time (including settlement discussions that have taken place to date and the pending Plea Agreement), the Company has established what it believes to be an appropriate reserve. It is possible that any fines and/or penalties with respect to the investigations, as well as any judgments, litigation costs or other liabilities relating to such known or potential product registration issues, could exceed the amount of the reserve, possibly materially, and could have an adverse effect on the Company’s financial condition, results of operations or cash flows.

As a result of these registration and recall matters, the Company has recorded charges for affected inventory and other registration and recall-related costs. The Company expects that future charges will include costs associated with the rework of certain finished goods inventories, the potential disposal of certain products and ongoing third-party professional services related to the U.S. EPA, U.S. DOJ and state investigations. It may also be appropriate to establish additional reserves as settlement discussions continue or in connection with other actions or potential liabilities arising in connection with the product registration issues.

The following tables summarize the impact of the product registration and recall matters on the Company’s results of operations during the three months ended December 31, 2011 and January 1, 2011, and on accrued liabilities and inventory reserves as of December 31, 2011 (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Cost of sales — other charges	$	—		$	0.8
Gross loss		—			(0.8	)
Selling, general and administrative		0.3			0.9
Loss from operations		(0.3	)		(1.7	)
Income tax benefit		0.1			0.6
Net loss	$	(0.2	)	$	(1.1	)

		September 30,		September 30,		September 30,			September 30,
	RESERVES AT SEPTEMBER  30, 2011		ADDITIONAL COSTS AND CHANGES IN ESTIMATE		RESERVES USED			RESERVES AT DECEMBER  31, 2011
Inventory reserves	$	0.4	$	—	$	—		$	0.4
Other incremental costs of sales		0.3		—		—			0.3
Other general and administrative costs		7.8		0.3		(0.6	)		7.5
Accrued liabilities and inventory reserves	$	8.5	$	0.3	$	(0.6	)	$	8.2

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

15 Months Ended

Dec. 31, 2011

Outstanding Commodity Contracts that Hedge Forecasted Purchases

As of December 31, 2011 and January 1, 2011, the Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

		September 30,		September 30,
	THREE MONTHS ENDED
Commodity	DECEMBER 31, 2011		JANUARY 1, 2011
Urea		40,500 tons		39,500 tons
Diesel		5,250,000 gallons		3,570,000 gallons
Gasoline		217,000 gallons		—
Heating Oil		2,268,000 gallons		—

Fair Values of Company's Derivative Instruments

The fair values of the Company’s derivative instruments were as follows (in millions):

	September 30,		September 30,			September 30,			September 30,
		ASSETS / (LIABILITIES)
DERIVATIVES DESIGNATED AS HEDGING		DECEMBER 31, 2011			JANUARY 1, 2011			SEPTEMBER 30, 2011
INSTRUMENTS	BALANCE SHEET LOCATION	FAIR VALUE
Interest rate swap agreements	Other assets	$	—		$	2.4		$	—
	Other current liabilities		(8.4	)		(12.3	)		(10.7	)
	Other liabilities		(18.9	)		(6.2	)		(17.4	)
Commodity hedging instruments	Prepaid and other assets		—			3.6			0.1
	Other current liabilities		(2.1	)		—			(0.3	)
Total derivatives designated as hedging instruments		$	(29.4	)	$	(12.5	)	$	(28.3	)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS (1)
Foreign currency swap contracts	Prepaid and other assets	$	3.5		$	5.3		$	2.7
	Other current liabilities		(0.6	)		(0.3	)		—
Commodity hedging instruments	Prepaid and other assets		—			0.8			—
	Other current liabilities		(0.2	)		—			(0.5	)
Total derivatives not designated as hedging instruments (1)		$	(2.7	)	$	5.8		$	2.2
Total derivatives		$	(26.7	)	$	(6.7	)	$	(26.1	)

(1) See discussion above for additional information regarding the Company’s purpose for entering into derivatives not designated as hedging instruments and its overall risk management strategy.

Effect of Derivative Instruments on OCI and Condensed, Consolidated Statements of Operations

The effect of derivative instruments on OCI and the Condensed Consolidated Statements of Operations for the three months ended December 31, 2011 and January 1, 2011 was as follows (in millions):

		September 30,			September 30,
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS	AMOUNT OF GAIN / (LOSS) RECOGNIZED IN OCI
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Interest rate swap agreements	$	(2.2	)	$	2.5
Commodity hedging instruments		(1.4	)		2.1
Total	$	(3.6	)	$	4.6

	September 30,		September 30,			September 30,
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS	LOCATION OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO EARNINGS	AMOUNT OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO EARNINGS
		THREE MONTHS ENDED
		DECEMBER 31, 2011			JANUARY 1, 2011
Interest rate swap agreements	Interest expense	$	(3.1	)	$	(3.1	)
Commodity hedging instruments	Cost of sales		0.1			0.1
Total		$	(3.0	)	$	(3.0	)

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS	LOCATION OF GAIN RECOGNIZED IN EARNINGS	AMOUNT OF GAIN RECOGNIZED IN EARNINGS
		THREE MONTHS ENDED
		DECEMBER 31, 2011		JANUARY 1, 2011
Foreign currency swap contracts	Interest expense	$	6.7	$	8.8
Commodity hedging instruments	Cost of sales		0.4		0.8
Total		$	7.1	$	9.6

XML

Accrued Liabilities and Inventory reserves (Detail) (USD $) In Millions, unless otherwise specified					3 Months Ended
	Dec. 31, 2011 Inventory Valuation Reserve	Sep. 30, 2011 Inventory Valuation Reserve	Dec. 31, 2011 Other costs of sales	Sep. 30, 2011 Other costs of sales	Dec. 31, 2011 Other general and administrative costs	Dec. 31, 2011 Accrued liabilities and inventory reserves
Product Liability Contingency [Line Items]
Beginning Balance	$ 0.4	$ 0.4	$ 0.3	$ 0.3	$ 7.8	$ 8.5
Additional Costs and Changes in Estimate					0.3	0.3
Reserves Used					(0.6)	(0.6)
Ending Balance	$ 0.4	$ 0.4	$ 0.3	$ 0.3	$ 7.5	$ 8.2

XML

Summary of Share-Based Compensation Awards (Detail) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based awards	1,134	14,295
Aggregate fair value at grant dates	$ 0.1	$ 0.7
Performance Based Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted		11,574
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted	1,134	2,721

XML

Condensed Consolidated Statements of Operations (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Net sales	$ 211.2	$ 230.2
Cost of sales	186.4	180.3
Cost of sales - product registration and recall matters		0.8
Gross profit (loss)	24.8	49.1
Operating expenses:
Selling, general and administrative	123.0	143.2
Impairment, restructuring and other charges	2.6
Product registration and recall matters	0.3	0.9
Other income, net	(0.9)	(0.5)
Loss from operations	(100.2)	(94.5)
Interest expense	15.3	9.5
Loss from continuing operations before income taxes	(115.5)	(104.0)
Income tax benefit from continuing operations	(41.6)	(37.3)
Loss from continuing operations	(73.9)	(66.7)
Loss from discontinued operations, net of tax		(1.2)
Net loss	$ (73.9)	$ (67.9)
Basic loss per common share:
Loss from continuing operations	$ (1.21)	$ (1.00)
Loss from discontinued operations		$ (0.02)
Basic loss per common share	$ (1.21)	$ (1.02)
Weighted-average common shares outstanding during the period	60.9	66.3
Diluted loss per common share:
Loss from continuing operations	$ (1.21)	$ (1.00)
Loss from discontinued operations		$ (0.02)
Diluted loss per common share	$ (1.21)	$ (1.02)
Weighted-average common shares outstanding during the period plus dilutive potential common shares	60.9	66.3
Dividends declared per common share	$ 0.30	$ 0.25

XML

MARKETING AGREEMENT - Additional Information (Detail) (Monsanto Marketing Agreement, USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011
Marketing Agreement [Line Items]
Annual contribution payment	$ 20
Initial consideration for marketing rights	32
Useful life of Marketing Agreement	20 years
Termination provision	Monsanto may also be able to terminate the Marketing Agreement within a given region, including North America, without paying a termination fee if unit volume sales to consumers in that region decline (1) over a cumulative three-fiscal-year period; or (2) by more than 5% for each of two consecutive years.
Minimum
Marketing Agreement [Line Items]
Termination fee received except in an event of default by the Company	$ 16
Contingency, A
Marketing Agreement [Line Items]
Termination criteria period	3 years
Contingency, B
Marketing Agreement [Line Items]
Termination criteria period	2 years
Contingency, B | Minimum
Marketing Agreement [Line Items]
Percentage of unit volume sales	5.00%
European Union
Marketing Agreement [Line Items]
Expiration of current term	Sep. 30, 2013
European Union | Automatic Renewal
Marketing Agreement [Line Items]
Final renewal term	2 years
European Union | Additional Renewal
Marketing Agreement [Line Items]
Final renewal term	3 years

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

15 Months Ended

Dec. 31, 2011

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of consumer branded products for lawn and garden care. The Company’s primary customers include home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers and food and drug stores. The Company’s products are sold primarily in North America and the European Union. The Company also operates the Scotts LawnService^® business, which provides residential and commercial lawn care, tree and shrub care and limited pest control services in the United States.

On February 28, 2011, the Company completed the sale of a significant majority of the assets of its Global Professional business (excluding the non-European professional seed business, “Global Pro”) to Israel Chemicals Ltd. (“ICL”). As a result of the then-pending sale, effective in the Company’s first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations. See “NOTE 2. DISCONTINUED OPERATIONS” for additional details regarding the sale of Global Pro.

Organization and Basis of Presentation

The Company’s unaudited condensed consolidated financial statements for the three months ended December 31, 2011 and January 1, 2011 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this report should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

RECENT ACCOUNTING PRONOUNCEMENTS

Fair Value Measurement

In May 2011, the Financial Accounting Standards Board (the “FASB”) issued amended accounting guidance to improve comparability of fair value measures between GAAP and the International Financial Reporting Standards. The amended guidance clarifies how to apply the existing fair value measurement and disclosure requirements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

Comprehensive Income

In June 2011, the FASB issued amended accounting guidance on the presentation of comprehensive income. The amended guidance requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

Testing for Goodwill Impairment

In September 2011, the FASB issued new accounting guidance that permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. The entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that the reporting unit’s fair value is less than its carrying value. The guidance will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the guidance may have on its financial statements and related disclosures.

XML

Effect of Derivative Instruments on OCI and Condensed, Consolidated Statements of Operations (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ (3.6)	$ 4.6
Amount of (Loss) Reclassified From AOCI Into Earnings	(3.0)	(3.0)
Cash Flow Hedging | Interest rate swap agreements
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	(2.2)	2.5
Cash Flow Hedging | Interest rate swap agreements | Interest expenses
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Reclassified From AOCI Into Earnings	(3.1)	(3.1)
Cash Flow Hedging | Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	(1.4)	2.1
Cash Flow Hedging | Commodity hedging instruments | Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Reclassified From AOCI Into Earnings	0.1	0.1
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Recognized in Earnings	7.1	9.6
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Recognized in Earnings	0.4	0.8
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Foreign currency swap contracts | Interest expenses
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Recognized in Earnings	$ 6.7	$ 8.8

XML

DISCONTINUED OPERATIONS - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011 Product Supply Agreements Maximum	Sep. 30, 2011 Global Pro	Feb. 28, 2011 Global Pro
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contract amount to Sale of Global Pro amount				$ 270
Proceeds from sale of business			270.9
Gain on sale of discontinued business			39.5
Proceeds from sale of business, net of transaction costs			253.6
Proceed utilization period	360 days
Minimum Unutilized proceed before making note repurchase offer	50
Line of credit facility potential loss to borrowing capacity	45
Scotts LLC estimates that it will supply ICL with product, per year	50
Scotts LLC estimates that it will purchase ICL product, per year	$ 15
Scotts LLC and ICL agreement, terms		5 years

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

15 Months Ended

Dec. 31, 2011

Nature of Operations

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of consumer branded products for lawn and garden care. The Company’s primary customers include home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers and food and drug stores. The Company’s products are sold primarily in North America and the European Union. The Company also operates the Scotts LawnService^® business, which provides residential and commercial lawn care, tree and shrub care and limited pest control services in the United States.

On February 28, 2011, the Company completed the sale of a significant majority of the assets of its Global Professional business (excluding the non-European professional seed business, “Global Pro”) to Israel Chemicals Ltd. (“ICL”). As a result of the then-pending sale, effective in the Company’s first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations. See “NOTE 2. DISCONTINUED OPERATIONS” for additional details regarding the sale of Global Pro.

Organization and Basis of Presentation

Organization and Basis of Presentation

The Company’s unaudited condensed consolidated financial statements for the three months ended December 31, 2011 and January 1, 2011 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this report should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.

Use of Estimates

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

Fair Value Measurement

In May 2011, the Financial Accounting Standards Board (the “FASB”) issued amended accounting guidance to improve comparability of fair value measures between GAAP and the International Financial Reporting Standards. The amended guidance clarifies how to apply the existing fair value measurement and disclosure requirements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

Comprehensive Income

In June 2011, the FASB issued amended accounting guidance on the presentation of comprehensive income. The amended guidance requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

Testing for Goodwill Impairment

In September 2011, the FASB issued new accounting guidance that permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. The entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that the reporting unit’s fair value is less than its carrying value. The guidance will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the guidance may have on its financial statements and related disclosures.

XML

Results of Global Pro within Discontinued Operations (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Jan. 01, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	$ 46.9
Operating costs	42.2
Other expense, net	5.3
Interest expense	1.0
Loss from discontinued operations before income taxes	(1.6)
Income tax benefit from discontinued operations	(0.4)
Loss from discontinued operations	$ (1.2)

XML

PRODUCT REGISTRATION AND RECALL MATTERS (Tables)

15 Months Ended

Dec. 31, 2011

Impact of Product Registration and Recall Matters on Company's Results of Operations

The following tables summarize the impact of the product registration and recall matters on the Company’s results of operations during the three months ended December 31, 2011 and January 1, 2011, and on accrued liabilities and inventory reserves as of December 31, 2011 (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Cost of sales — other charges	$	—		$	0.8
Gross loss		—			(0.8	)
Selling, general and administrative		0.3			0.9
Loss from operations		(0.3	)		(1.7	)
Income tax benefit		0.1			0.6
Net loss	$	(0.2	)	$	(1.1	)

		September 30,		September 30,		September 30,			September 30,
	RESERVES AT SEPTEMBER  30, 2011		ADDITIONAL COSTS AND CHANGES IN ESTIMATE		RESERVES USED			RESERVES AT DECEMBER  31, 2011
Inventory reserves	$	0.4	$	—	$	—		$	0.4
Other incremental costs of sales		0.3		—		—			0.3
Other general and administrative costs		7.8		0.3		(0.6	)		7.5
Accrued liabilities and inventory reserves	$	8.5	$	0.3	$	(0.6	)	$	8.2

XML

DISCONTINUED OPERATIONS

15 Months Ended

Dec. 31, 2011

DISCONTINUED OPERATIONS

NOTE 2. DISCONTINUED OPERATIONS

On February 28, 2011, the Company completed the sale of Global Pro to ICL for $270 million. After agreed upon adjustments (including post-closing adjustments), the Company received $270.9 million net proceeds, or $253.6 million after transaction costs. Results from discontinued operations for fiscal 2011 include an after-tax gain on the sale of Global Pro of $39.5 million, which includes transaction costs.

Pursuant to the terms of the indenture governing the Company’s 7.25% Senior Notes due 2018 and the indenture governing the Company’s 6.625% Senior Notes due 2020, the Company has a period of 360 days to apply an amount equal to the net proceeds received from the sale of Global Pro to repay indebtedness, acquire equity interests in certain entities, make capital expenditures, acquire other assets useful in a related business and/or make investments in certain joint ventures. Any amount not so applied must be used to make an offer to repurchase the Senior Notes, provided that such repurchase offer may be deferred until such time as the unutilized proceeds exceed $50 million. As of December 31, 2011, the Company had applied all but approximately $45 million of the net proceeds to one or more of the uses permitted by the indentures.

The Company’s decision to exit the professional ornamental horticulture, turf and specialty agriculture markets and sell Global Pro was another step in its strategy to evolve its business portfolio to better leverage growth opportunities within its Global Consumer and Scotts LawnService^® business segments.

In conjunction with the transaction, The Scotts Company LLC (“Scotts LLC”), a wholly owned subsidiary of Scotts Miracle-Gro, and ICL entered into several product supply agreements which are generally up to five years in duration, as well as various trademark and technology licensing agreements with varying durations. The purpose of these agreements is to allow each party to continue leveraging existing production capabilities and intellectual property to meet customer demand for their respective products. Scotts LLC estimates that it will supply ICL with approximately $50 million of product under these agreements, as well as purchase approximately $15 million of materials from ICL, each on an annualized basis.

The Company’s continuing cash inflows and outflows related to these agreements are not considered to be significant in relation to the overall cash flows of Global Pro. Furthermore, none of these agreements permit the Company to influence the operating or financial policies of Global Pro under the ownership of ICL. Therefore, Global Pro met the criteria for presentation as discontinued operations. As such, effective in the first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations for all periods presented. The Global Pro results from discontinued operations include an allocation of interest expense relating to the amount of our then existing credit facilities that was required to be repaid from the sale proceeds.

The following table summarizes the results of Global Pro within discontinued operations for the three months ended January 1, 2011 (in millions):

		September 30,
Net sales	$	46.9
Operating costs		42.2
Other expense, net		5.3
Interest expense		1.0
Loss from discontinued operations before income taxes		(1.6	)
Income tax benefit from discontinued operations		(0.4	)
Loss from discontinued operations	$	(1.2	)

The major classes of assets and liabilities of Global Pro as held for sale at January 1, 2011 were as follows (in millions):

		September 30,
Cash and cash equivalents	$	1.0
Accounts receivable, net		54.9
Inventories		61.2
Prepaid and other assets		4.6
Property, plant and equipment, net		12.8
Goodwill		66.4
Assets held for sale	$	200.9
Accounts payable	$	16.4
Other current liabilities		15.6
Other liabilities		13.4
Liabilities held for sale	$	45.4

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
OPERATING ACTIVITIES
Net loss	$ (73.9)	$ (67.9)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense	1.6	4.3
Depreciation	12.9	12.2
Amortization	2.7	2.5
Loss on sale of long-lived assets	0.1
Changes in assets and liabilities, net of acquired businesses:
Accounts receivable	141.8	139.5
Inventories	(269.2)	(225.3)
Prepaid and other assets		(8.7)
Accounts payable	76.4	80.0
Other current liabilities	(90.4)	(113.7)
Restructuring reserves	(3.0)
Other non-current items	(0.7)	11.6
Other, net	0.6	(4.2)
Net cash used in operating activities	(201.1)	(169.7)
INVESTING ACTIVITIES
Investments in property, plant and equipment	(16.4)	(28.1)
Net cash used in investing activities	(16.4)	(28.1)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	447.0	258.2
Repayments under revolving and bank lines of credit and term loans	(205.7)	(234.0)
Proceeds from issuance of 6.625% Senior Notes		200.0
Dividends paid	(18.9)	(16.8)
Purchase of common shares	(17.5)	(25.0)
Financing and issuance fees		(4.1)
Excess tax benefits from share-based payment arrangements	3.8	1.5
Cash received from the exercise of stock options	5.6	6.5
Net cash provided by financing activities	214.3	186.3
Effect of exchange rate changes on cash	0.1	2.2
Net decrease in cash and cash equivalents	(3.1)	(9.3)
Cash and cash equivalents, beginning of period	130.9	88.1
Cash and cash equivalents, end of period	127.8	78.8
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	(13.0)	(4.8)
Income taxes paid	$ (10.0)	$ (2.9)

XML

CONTINGENCIES

15 Months Ended

Dec. 31, 2011

CONTINGENCIES

NOTE 12. CONTINGENCIES

Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, its assessment of contingencies is reasonable and related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. The following are the more significant of the Company’s identified contingencies:

FIFRA Compliance and the Corresponding Governmental Investigations

For a description of the Company’s ongoing FIFRA compliance efforts and the corresponding governmental investigations, see “NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS.”

Other Regulatory Matters

At December 31, 2011, $4.0 million was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheet for non-FIFRA compliance-related environmental actions, the majority of which is for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.

Other

The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. The complaints in these cases are not specific about the plaintiffs’ contacts with the Company or its products. The Company in each case is one of numerous defendants and none of the claims seek damages from the Company alone. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no reserves have been recorded in the Company’s condensed consolidated financial statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

XML

Document and Entity Information	3 Months Ended
	Dec. 31, 2011	Feb. 01, 2012
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2011
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q1
Trading Symbol	SMG
Entity Registrant Name	SCOTTS MIRACLE-GRO CO
Entity Central Index Key	0000825542
Current Fiscal Year End Date	--09-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		60,827,981

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

15 Months Ended

Dec. 31, 2011

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

NOTE 13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

Exchange Rate Risk Management

The Company periodically uses foreign currency swap contracts to manage the exchange rate risk associated with intercompany loans with foreign subsidiaries that are denominated in local currencies. At December 31, 2011, the notional amount of outstanding foreign currency swap contracts was $306.3 million, with a fair value of $3.5 million. At January 1, 2011, the notional amount of outstanding foreign currency swap contracts was $330.7 million with a fair value of $5.0 million. The fair value of foreign currency swap contracts is determined based on changes in spot rates. The unrealized gain on the foreign currency swap contracts approximates the unrealized loss on the intercompany loans recognized by the Company’s lending subsidiaries. The contracts will mature over the next fiscal year.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. The fair values are reflected in the Company’s Condensed Consolidated Balance Sheets. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded as elements of accumulated other comprehensive loss (“AOCI”) within the Condensed Consolidated Balance Sheets. The fair value of the swap agreements is determined based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date.

At December 31, 2011 and January 1, 2011, the Company had outstanding interest rate swap agreements with major financial institutions that effectively converted a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a total U.S. dollar equivalent notional amount of $900 million and $800 million at December 31, 2011 and January 1, 2011, respectively. Included in the AOCI balance at December 31, 2011 was a loss of $5.2 million related to interest rate swap agreements that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

Commodity Price Risk Management

The Company had outstanding hedging arrangements at December 31, 2011 designed to fix the price of a portion of its projected future urea requirements. The contracts are designated as hedges of the Company’s exposure to future cash flow fluctuations associated with the cost of urea. The objective of the hedges is to mitigate the earnings and cash flow volatility attributable to the risk of changing prices. Unrealized gains or losses in the fair value of these contracts are recorded to the AOCI component of shareholders’ equity. Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at December 31, 2011 was a loss of $0.1 million related to urea derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

Periodically, the Company also uses derivatives to partially mitigate the effect of fluctuating diesel and gasoline costs on operating results. Any such derivatives that do not qualify for hedge accounting treatment in accordance with GAAP are recorded at fair value, with unrealized gains and losses on open contracts and realized gains or losses on settled contracts recorded as an element of cost of sales. Unrealized gains or losses in the fair value of contracts that do qualify for hedge accounting are recorded in OCI except for any ineffective portion of the change in fair value, which is immediately recorded in earnings. For the effective portion of the change in fair value, realized gains or losses remain as a component of AOCI until the related fuel is consumed. Upon consumption of the fuel, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at December 31, 2011 was a loss of $0.1 million related to fuel derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

As of December 31, 2011 and January 1, 2011, the Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

		September 30,		September 30,
	THREE MONTHS ENDED
Commodity	DECEMBER 31, 2011		JANUARY 1, 2011
Urea		40,500 tons		39,500 tons
Diesel		5,250,000 gallons		3,570,000 gallons
Gasoline		217,000 gallons		—
Heating Oil		2,268,000 gallons		—

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments were as follows (in millions):

	September 30,		September 30,			September 30,			September 30,
		ASSETS / (LIABILITIES)
DERIVATIVES DESIGNATED AS HEDGING		DECEMBER 31, 2011			JANUARY 1, 2011			SEPTEMBER 30, 2011
INSTRUMENTS	BALANCE SHEET LOCATION	FAIR VALUE
Interest rate swap agreements	Other assets	$	—		$	2.4		$	—
	Other current liabilities		(8.4	)		(12.3	)		(10.7	)
	Other liabilities		(18.9	)		(6.2	)		(17.4	)
Commodity hedging instruments	Prepaid and other assets		—			3.6			0.1
	Other current liabilities		(2.1	)		—			(0.3	)
Total derivatives designated as hedging instruments		$	(29.4	)	$	(12.5	)	$	(28.3	)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS (1)
Foreign currency swap contracts	Prepaid and other assets	$	3.5		$	5.3		$	2.7
	Other current liabilities		(0.6	)		(0.3	)		—
Commodity hedging instruments	Prepaid and other assets		—			0.8			—
	Other current liabilities		(0.2	)		—			(0.5	)
Total derivatives not designated as hedging instruments (1)		$	(2.7	)	$	5.8		$	2.2
Total derivatives		$	(26.7	)	$	(6.7	)	$	(26.1	)

(1) See discussion above for additional information regarding the Company’s purpose for entering into derivatives not designated as hedging instruments and its overall risk management strategy.

The effect of derivative instruments on OCI and the Condensed Consolidated Statements of Operations for the three months ended December 31, 2011 and January 1, 2011 was as follows (in millions):

		September 30,			September 30,
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS	AMOUNT OF GAIN / (LOSS) RECOGNIZED IN OCI
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Interest rate swap agreements	$	(2.2	)	$	2.5
Commodity hedging instruments		(1.4	)		2.1
Total	$	(3.6	)	$	4.6

	September 30,		September 30,			September 30,
DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS	LOCATION OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO EARNINGS	AMOUNT OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO EARNINGS
		THREE MONTHS ENDED
		DECEMBER 31, 2011			JANUARY 1, 2011
Interest rate swap agreements	Interest expense	$	(3.1	)	$	(3.1	)
Commodity hedging instruments	Cost of sales		0.1			0.1
Total		$	(3.0	)	$	(3.0	)

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS	LOCATION OF GAIN RECOGNIZED IN EARNINGS	AMOUNT OF GAIN RECOGNIZED IN EARNINGS
		THREE MONTHS ENDED
		DECEMBER 31, 2011		JANUARY 1, 2011
Foreign currency swap contracts	Interest expense	$	6.7	$	8.8
Commodity hedging instruments	Cost of sales		0.4		0.8
Total		$	7.1	$	9.6

XML

Condensed Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Current assets:
Cash and cash equivalents	$ 127.8	$ 130.9	$ 78.8
Accounts receivable, less allowances of $12.4, $6.2 and $12.9, respectively	166.5	323.5	213.2
Accounts receivable pledged	14.3
Inventories	654.8	387.0	567.0
Assets held for sale			200.9
Prepaid and other current assets	148.8	151.1	136.1
Total current assets	1,112.2	992.5	1,196.0
Property, plant and equipment, net of accumulated depreciation of $520.1, $471.8 and $510.5 respectively	391.4	394.7	391.1
Goodwill	309.1	309.1	305.8
Intangible assets, net	316.2	319.6	326.7
Other assets	35.4	36.3	35.6
Total assets	2,164.3	2,052.2	2,255.2
Current liabilities:
Current portion of debt	8.1	3.2	168.5
Accounts payable	220.4	150.0	208.5
Liabilities held for sale			45.4
Other current liabilities	220.6	315.4	244.8
Total current liabilities	449.1	468.6	667.2
Long-term debt	1,026.1	791.8	687.4
Other liabilities	224.9	232.0	222.0
Total liabilities	1,700.1	1,492.4	1,576.6
Commitments and contingencies (notes 3 and 12)
Shareholders' equity:
Common shares and capital in excess of $.01 stated value per share, 60.8, 66.5 and 60.8 shares issued and outstanding, respectively	410.3	427.1	428.6
Retained earnings	511.6	599.2	414.2
Treasury shares, at cost: 7.4 million shares, 1.9 million shares and 7.5 million shares, respectively	(377.5)	(388.5)	(98.3)
Accumulated other comprehensive loss	(80.2)	(78.0)	(65.9)
Total shareholders' equity	464.2	559.8	678.6
Total liabilities and shareholders' equity	$ 2,164.3	$ 2,052.2	$ 2,255.2

XML

DEBT

15 Months Ended

Dec. 31, 2011

DEBT

NOTE 7. DEBT

The components of long-term debt are as follows (in millions):

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Credit Facilities:
Revolving loans	$	621.7	$	227.4	$	387.2
Term loans		—		208.5		—
Senior Notes – 7.25%		200.0		200.0		200.0
Senior Notes – 6.625%		200.0		200.0		200.0
MARP Agreement		5.4		—		—
Foreign borrowings (local facilities and term loans)		0.3		1.3		0.4
Contingent consideration		0.3		10.8		0.3
Other		6.5		7.9		7.1
		1,034.2		855.9		795.0
Less current portions		8.1		168.5		3.2
Total long-term debt	$	1,026.1	$	687.4	$	791.8

As of December 31, 2011, there was $1.05 billion of availability under the Company’s senior secured credit facility, including availability under letters of credit. Under the credit facility, the Company has the ability to issue letter of credit commitments up to $75 million. At December 31, 2011, the Company had letters of credit in the aggregate face amount of $26.3 million outstanding.

The Company was in compliance with the terms of all debt covenants at December 31, 2011. The credit facility contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio, calculated as average total indebtedness, as described in the Company’s credit facility, relative to the Company’s EBITDA, as adjusted pursuant to the terms of the credit facility (“Adjusted EBITDA”). Under the terms of the credit facility, the maximum leverage ratio was 3.50 as of December 31, 2011. The Company’s leverage ratio was 2.09 at December 31, 2011. The Company’s credit facility also includes an affirmative covenant regarding its interest coverage ratio. Interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the credit facility, and excludes costs related to refinancings. Under the terms of the credit facility, the minimum interest coverage ratio was 3.50 for the twelve months ended December 31, 2011. The Company’s interest coverage ratio was 6.79 for the twelve months ended December 31, 2011.

On September 21, 2011, the Company entered into a new Master Accounts Receivable Purchase Agreement (the “MARP Agreement”), with an initial stated termination date of September 21, 2012, or such later date as may be mutually agreed by the Company and the banks party thereto. The MARP Agreement, which is uncommitted, provides for the discretionary sale by the Company, and the discretionary purchase by the banks, on a revolving basis, of accounts receivable generated by sales to two specified account debtors in an aggregate amount not to exceed $325 million, with debtor sublimits ranging from $120 million to $250 million. Under the terms of the MARP Agreement, the banks have the opportunity to purchase those accounts receivable offered by the Company at a discount (from the agreed base value thereof) effectively equal to the greater of 7-day or 3-month LIBOR plus 1.05%. The MARP Agreement replaced the Company’s previous Master Accounts Receivable Purchase Agreement, which provided for the discounted sale, on an uncommitted, revolving basis, of accounts receivable generated by a single specified account debtor, with aggregate limits not to exceed $80 million and an interest rate that approximated the 7-day LIBOR rate plus 1.25%. The previous Master Accounts Receivable Purchase Agreement was scheduled to expire on September 30, 2011.

The Company accounts for the sale of receivables under the MARP Agreement as short-term debt and continues to carry the receivables on its Consolidated Balance Sheet, primarily as a result of the Company’s right to repurchase receivables sold. There were $5.4 million in borrowings under the MARP Agreement as of December 31, 2011.

Estimated Fair Values

A description of the methods and assumptions used to estimate the fair values of the Company’s debt instruments is as follows:

Credit Facility

The interest rate currently available to the Company fluctuates with the applicable LIBOR rate, prime rate or Federal Funds Effective Rate, and thus the carrying value is a reasonable estimate of fair value.

7.25% Senior Notes

The fair value of Scotts Miracle-Gro’s 7.25% Senior Notes due 2018 (the “7.25% Senior Notes”) can be determined based on the trading of the 7.25% Senior Notes in the open market. The difference between the carrying value and the fair value of the 7.25% Senior Notes represents the premium or discount on that date. Based on the trading value on or around December 31, 2011, the fair value of the 7.25% Senior Notes was approximately $212.0 million.

6.625% Senior Notes

The fair value of Scotts Miracle-Gro’s 6.625% Senior Notes due 2020 (the “6.625% Senior Notes”) can be determined based on the trading of the 6.625% Senior Notes. The difference between the carrying value and the fair value of the 6.625% Senior Notes represents the premium or discount on that date. Based on the trading value on or around December 31, 2011, the fair value of the 6.625% Senior Notes was approximately $203.3 million.

Accounts Receivable Pledged

The interest rate on the short-term debt associated with accounts receivable pledged under the MARP Agreement fluctuates with the applicable LIBOR rate, and thus the carrying value is a reasonable estimate of fair value.

XML

MARKETING AGREEMENT

15 Months Ended

Dec. 31, 2011

MARKETING AGREEMENT

NOTE 6. MARKETING AGREEMENT

The Company is Monsanto’s exclusive agent for the marketing and distribution of consumer Roundup^® herbicide products (with additional rights to new products containing glyphosate or other similar non-selective herbicides) in the consumer lawn and garden market within the United States and other specified countries, including Australia, Austria, Belgium, Canada, France, Germany, the Netherlands and the United Kingdom. Under the terms of the Marketing Agreement, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The annual gross commission under the Marketing Agreement is calculated as a percentage of the actual earnings before interest and income taxes (EBIT) of the consumer Roundup^® business in the markets covered by the Marketing Agreement and is based on the achievement of two earnings thresholds, as defined in the Marketing Agreement. The Marketing Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of the consumer Roundup^® business. The annual contribution payment is defined in the Marketing Agreement as $20 million.

In consideration for the rights granted to the Company under the Marketing Agreement for North America, the Company was required to pay a marketing fee of $32 million to Monsanto. The Company has deferred this amount on the basis that the payment will provide a future benefit through commissions that will be earned under the Marketing Agreement. The economic useful life over which the marketing fee is being amortized is 20 years, with a remaining amortization period of seven years as of December 31, 2011.

Under the terms of the Marketing Agreement, the Company performs certain functions, primarily manufacturing conversion, distribution and logistics, and selling and marketing support, on behalf of Monsanto in the conduct of the consumer Roundup^® business. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred under the Marketing Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in “Cost of sales” and the reimbursement of these costs in “Net sales,” with no effect on gross profit dollars or net income.

The gross commission earned under the Marketing Agreement, the contribution payments to Monsanto and the amortization of the initial marketing fee paid to Monsanto are included in the calculation of net sales in the Company’s Consolidated Statements of Operations. The elements of the net commission and reimbursements earned under the Marketing Agreement and included in “Net sales” are as follows (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Gross commission	$	—		$	—
Contribution expenses		(5.0	)		(5.0	)
Amortization of marketing fee		(0.2	)		(0.2	)
Net commission expense		(5.2	)		(5.2	)
Reimbursements associated with Marketing Agreement		17.9			15.2
Total net sales associated with Marketing Agreement	$	12.7		$	10.0

The Marketing Agreement has no definite term except as it relates to the European Union countries (the “EU term”). The EU term extends through September 30, 2013, with an automatic renewal period of two years, subject to non-renewal only upon the occurrence of certain performance defaults. Thereafter, the Marketing Agreement provides that the parties may agree to renew the EU term for an additional three years.

The Marketing Agreement provides Monsanto with the right to terminate the Marketing Agreement upon an event of default (as defined in the Marketing Agreement) by the Company, a change in control of Monsanto or the sale of the consumer Roundup^® business. The Marketing Agreement provides the Company with the right to terminate the Marketing Agreement in certain circumstances, including an event of default by Monsanto or the sale of the consumer Roundup^® business. Unless Monsanto terminates the Marketing Agreement due to an event of default by the Company, Monsanto is required to pay a termination fee to the Company that varies by program year. The termination fee is calculated as a percentage of the value of the Roundup^® business exceeding a certain threshold, but in no event will the termination fee be less than $16 million. If Monsanto were to terminate the Marketing Agreement for cause, the Company would not be entitled to any termination fee. Monsanto may also be able to terminate the Marketing Agreement within a given region, including North America, without paying a termination fee if unit volume sales to consumers in that region decline: (1) over a cumulative three-fiscal-year period; or (2) by more than 5% for each of two consecutive years. If the Marketing Agreement was terminated for any reason, the Company would also lose all, or a substantial portion, of the significant source of earnings and overhead expense absorption the Marketing Agreement provides.

Under the Marketing Agreement, Monsanto must provide the Company with notice of any proposed sale of the consumer Roundup business, allow the Company to participate in the sale process and negotiate in good faith with the Company with respect to any such proposed sale. In the event the Company acquires the consumer Roundup^® business in such a sale, the Company would receive as a credit against the purchase price the amount of the termination fee that would have been paid to the Company if Monsanto had exercised its right to terminate the Marketing Agreement in connection with a sale to another party. If Monsanto decides to sell the consumer Roundup^® business to another party, the Company must let Monsanto know whether the Company intends to terminate the Marketing Agreement and forfeit any right to a termination fee or whether it will agree to continue to perform under the Marketing Agreement on behalf of the purchaser.

XML

DISCONTINUED OPERATIONS (Tables)

15 Months Ended

Dec. 31, 2011

Classes of Assets and Liabilities, and Results of Discontinued Operations

The following table summarizes the results of Global Pro within discontinued operations for the three months ended January 1, 2011 (in millions):

		September 30,
Net sales	$	46.9
Operating costs		42.2
Other expense, net		5.3
Interest expense		1.0
Loss from discontinued operations before income taxes		(1.6	)
Income tax benefit from discontinued operations		(0.4	)
Loss from discontinued operations	$	(1.2	)

The major classes of assets and liabilities of Global Pro as held for sale at January 1, 2011 were as follows (in millions):

		September 30,
Cash and cash equivalents	$	1.0
Accounts receivable, net		54.9
Inventories		61.2
Prepaid and other assets		4.6
Property, plant and equipment, net		12.8
Goodwill		66.4
Assets held for sale	$	200.9
Accounts payable	$	16.4
Other current liabilities		15.6
Other liabilities		13.4
Liabilities held for sale	$	45.4

XML

FAIR VALUE MEASUREMENTS

15 Months Ended

Dec. 31, 2011

FAIR VALUE MEASUREMENTS

NOTE 14. FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

Derivatives

Derivatives consist of foreign currency, interest rate and commodity derivative instruments. Foreign currency swap contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Commodity contracts are measured using observable commodity exchange prices in active markets.

These derivative instruments are classified within Level 2 of the valuation hierarchy and are included within other assets and other liabilities in the Company’s Condensed Consolidated Balance Sheets, except for derivative instruments expected to be settled within the next 12 months, which are included within prepaid and other assets and other current liabilities.

Cash equivalents

Cash equivalents consist of highly liquid investments purchased with a maturity of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

Other

Other financial assets consist of investment securities in non-qualified retirement plan assets. These securities are valued using observable market prices in active markets.

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at December 31, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Cash equivalents	$	83.5	$	—		$	—	$	83.5
Derivatives
Foreign currency swap contracts		—		3.5			—		3.5
Other		6.5		—			—		6.5
Total	$	90.0	$	3.5		$	—	$	93.5
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(27.3	)	$	—	$	(27.3	)
Foreign currency swap contracts		—		(0.6	)		—		(0.6	)
Commodity hedging instruments		—		(2.3	)		—		(2.3	)
Total	$	—	$	(30.2	)	$	—	$	(30.2	)

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at January 1, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Derivatives
Interest rate swap agreements	$	—	$	2.4		$	—	$	2.4
Foreign currency swap contracts		—		5.3			—		5.3
Commodity hedging instruments		—		4.4			—		4.4
Other		7.8		—			—		7.8
Total	$	7.8	$	12.1		$	—	$	19.9
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(18.5	)	$	—	$	(18.5	)
Foreign currency swap contracts		—		(0.3	)		—		(0.3	)
Total	$	—	$	(18.8	)	$	—	$	(18.8	)

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at September 30, 2011 (in millions):

		September 30,		September 30,			September 30,		September 30,
	Quoted Prices in  Active Markets for Identical Assets (Level 1)		Significant Other Observable  Inputs (Level 2)			Unobservable Inputs (Level 3)		Total
Assets
Cash equivalents	$	83.6	$	—		$	—	$	83.6
Derivatives
Commodity hedging instruments		—		0.1			—		0.1
Foreign currency swap contracts		—		2.7			—		2.7
Other		6.3		—			—		6.3
Total	$	89.9	$	2.8		$	—	$	92.7
Liabilities
Derivatives
Interest rate swap agreements	$	—	$	(28.1	)	$	—	$	(28.1	)
Commodity hedging instruments		—		(0.8	)		—		(0.8	)
Total	$	—	$	(28.9	)	$	—	$	(28.9	)

XML

SHAREHOLDERS' EQUITY

15 Months Ended

Dec. 31, 2011

SHAREHOLDERS' EQUITY

NOTE 10. SHAREHOLDERS’ EQUITY

During the three months ended December 31, 2011, Scotts Miracle-Gro repurchased 0.4 million of its common shares (the “Common Shares”) for $17.5 million. These repurchases were made pursuant to the $700 million share repurchase program approved by the Scotts Miracle-Gro Board of Directors. Since the inception of the program in the fourth quarter of fiscal 2010 through December 31, 2011, Scotts Miracle-Gro has repurchased approximately 7.9 million Common Shares for $401.2 million to be held in treasury.

Share-based awards

The following is a summary of the share-based awards granted over the periods indicated:

		September 30,		September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011		JANUARY 1, 2011
Performance shares		—		11,574
Restricted stock units (including deferred stock units)		1,134		2,721
Total share-based awards		1,134		14,295
Aggregate fair value at grant dates (in millions)	$	0.1	$	0.7

Total share-based compensation was $1.6 million and $4.3 million for the three months ended December 31, 2011 and January 1, 2011, respectively.

Subsequent to December 31, 2011, Scotts Miracle-Gro awarded stock options, performance share units, restricted stock units and deferred stock units covering 0.7 million Common Shares to employees and members of the Board of Directors with an estimated fair value of $16.7 million on the date of the grant.

XML

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (Fair Value, Measurements, Recurring, USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 83.5	$ 83.6
Other	6.5	6.3	7.8
Total	93.5	92.7	19.9
Total	(30.2)	(28.9)	(18.8)
Interest rate swap agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets			2.4
Derivative liabilities	(27.3)	(28.1)	(18.5)
Foreign currency swap contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	3.5	2.7	5.3
Derivative liabilities	(0.6)		(0.3)
Commodity hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets		0.1	4.4
Derivative liabilities	(2.3)	(0.8)
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	83.5	83.6
Other	6.5	6.3	7.8
Total	90.0	89.9	7.8
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	3.5	2.8	12.1
Total	(30.2)	(28.9)	(18.8)
Significant Other Observable Inputs (Level 2) | Interest rate swap agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets			2.4
Derivative liabilities	(27.3)	(28.1)	(18.5)
Significant Other Observable Inputs (Level 2) | Foreign currency swap contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	3.5	2.7	5.3
Derivative liabilities	(0.6)		(0.3)
Significant Other Observable Inputs (Level 2) | Commodity hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets		0.1	4.4
Derivative liabilities	$ (2.3)	$ (0.8)

XML

COMPREHENSIVE INCOME (LOSS)

15 Months Ended

Dec. 31, 2011

COMPREHENSIVE INCOME (LOSS)

NOTE 8. COMPREHENSIVE INCOME (LOSS)

The components of other comprehensive income (loss) (“OCI”) were as follows (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net loss	$	(73.9	)	$	(67.9	)
Other comprehensive income (loss):
Net unrealized gain (loss) on derivative instruments		(0.6	)		2.8
Net change in pension and other postretirement related items		1.9			6.2
Foreign currency translation adjustments		(3.5	)		2.2
Total comprehensive loss	$	(76.1	)	$	(56.7	)

XML

RETIREMENT AND RETIREE MEDICAL PLANS

15 Months Ended

Dec. 31, 2011

RETIREMENT AND RETIREE MEDICAL PLANS

NOTE 9. RETIREMENT AND RETIREE MEDICAL PLANS

The following summarizes the components of net periodic benefit cost for the retirement and retiree medical plans sponsored by the Company (in millions):

		September 30,			September 30,			September 30,		September 30,			September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011								JANUARY 1, 2011
	U.S. Pension			International Pension			U.S. Medical		U.S. Pension			International Pension			U.S. Medical
Service cost	$	—		$	0.3		$	0.1	$	—		$	0.4		$	0.1
Interest cost		1.1			2.4			0.4		1.2			2.7			0.4
Expected return on plan assets		(1.4	)		(2.2	)		—		(1.3	)		(2.6	)		—
Net amortization		1.3			0.2			0.1		1.2			0.4			—
Curtailment loss		0.2			—			—		—			—			—
Net periodic benefit cost	$	1.2		$	0.7		$	0.6	$	1.1		$	0.9		$	0.5

XML

INCOME TAXES

15 Months Ended

Dec. 31, 2011

INCOME TAXES

NOTE 11. INCOME TAXES

The effective tax rate related to continuing operations for the three months ended December 31, 2011 was 36.0%, compared to 35.9% for the three months ended January 1, 2011. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year. An allocation of the income tax expense has been separately determined to report the discontinued operations, net of tax. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year end.

Scotts Miracle-Gro and/or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. With few exceptions, which are discussed below, the Company is no longer subject to examinations by these tax authorities for fiscal years prior to 2008. The Company is currently under examination by certain foreign and U.S. state and local tax authorities. In regard to the local German audit, the tax periods under investigation are limited to fiscal years 2004 through 2008. In regard to the U.S. state and local audits, the tax periods under investigation are limited to fiscal years 1997 through 2009. In addition to these aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company currently anticipates that few of its open and active audits will be resolved within the next 12 months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

XML

Condensed Consolidating Balance Sheet (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011	Oct. 01, 2010
Current assets:
Cash and cash equivalents	$ 127.8	$ 130.9	$ 78.8	$ 88.1
Accounts receivable, net	166.5	323.5	213.2
Accounts receivable, pledged	14.3
Inventories	654.8	387.0	567.0
Assets held for sale			200.9
Prepaid and other current assets	148.8	151.1	136.1
Total current assets	1,112.2	992.5	1,196.0
Property, plant and equipment, net	391.4	394.7	391.1
Goodwill	309.1	309.1	305.8
Intangible assets, net	316.2	319.6	326.7
Other assets	35.4	36.3	35.6
Total assets	2,164.3	2,052.2	2,255.2
Current liabilities:
Current portion of debt	8.1	3.2	168.5
Accounts payable	220.4	150.0	208.5
Liabilities held for sale			45.4
Other current liabilities	220.6	315.4	244.8
Total current liabilities	449.1	468.6	667.2
Long-term debt	1,026.1	791.8	687.4
Other liabilities	224.9	232.0	222.0
Total liabilities	1,700.1	1,492.4	1,576.6
Shareholders' equity	464.2	559.8	678.6
Total liabilities and shareholders' equity	2,164.3	2,052.2	2,255.2
Parent
Current assets:
Other assets	32.1	33.1	13.6
Equity investment in subsidiaries	699.2	794.3	919.3
Intercompany assets	788.3	553.7	578.1
Total assets	1,519.6	1,381.1	1,511.0
Current liabilities:
Current portion of debt			164.7
Other current liabilities	15.3	17.2	7.3
Total current liabilities	15.3	17.2	172.0
Long-term debt	1,021.7	787.2	657.4
Other liabilities	18.4	16.9	3.0
Total liabilities	1,055.4	821.3	832.4
Shareholders' equity	464.2	559.8	678.6
Total liabilities and shareholders' equity	1,519.6	1,381.1	1,511.0
Subsidiary Guarantors
Current assets:
Cash and cash equivalents	10.0	4.3	10.8	5.1
Accounts receivable, net	92.7	248.2	137.0
Accounts receivable, pledged	14.3
Inventories	543.6	313.7	474.0
Prepaid and other current assets	102.2	107.9	97.9
Total current assets	762.8	674.1	719.7
Property, plant and equipment, net	343.2	347.3	344.5
Goodwill	308.4	308.4	305.1
Intangible assets, net	269.6	270.3	273.9
Other assets	13.3	13.3	23.1
Intercompany assets	207.7	115.4
Total assets	1,905.0	1,728.8	1,666.3
Current liabilities:
Current portion of debt	7.8	2.8	2.4
Accounts payable	165.6	103.9	161.0
Other current liabilities	118.6	202.5	142.4
Total current liabilities	292.0	309.2	305.8
Long-term debt	547.4	261.3	230.0
Other liabilities	200.5	205.6	198.1
Equity investment in subsidiaries	336.1	328.7	173.3
Intercompany liabilities			10.0
Total liabilities	1,376.0	1,104.8	917.2
Shareholders' equity	529.0	624.0	749.1
Total liabilities and shareholders' equity	1,905.0	1,728.8	1,666.3
Non-Guarantors
Current assets:
Cash and cash equivalents	117.8	126.6	68.0	83.0
Accounts receivable, net	73.8	75.3	76.2
Inventories	111.2	73.3	93.0
Assets held for sale			200.9
Prepaid and other current assets	46.6	43.2	38.2
Total current assets	349.4	318.4	476.3
Property, plant and equipment, net	48.2	47.4	46.6
Goodwill	0.7	0.7	0.7
Intangible assets, net	46.6	49.3	52.8
Other assets	27.6	27.6	28.8
Total assets	472.5	443.4	605.2
Current liabilities:
Current portion of debt	0.3	0.4	1.4
Accounts payable	54.8	46.1	47.5
Liabilities held for sale			45.4
Other current liabilities	86.7	95.7	95.1
Total current liabilities	141.8	142.2	189.4
Long-term debt	78.7	130.5	13.7
Other liabilities	43.6	47.2	50.8
Intercompany liabilities	374.3	281.9	354.4
Total liabilities	638.4	601.8	608.3
Shareholders' equity	(165.9)	(158.4)	(3.1)
Total liabilities and shareholders' equity	472.5	443.4	605.2
Eliminations
Current assets:
Other assets	(37.6)	(37.7)	(29.9)
Equity investment in subsidiaries	(699.2)	(794.3)	(919.3)
Intercompany assets	(996.0)	(669.1)	(578.1)
Total assets	(1,732.8)	(1,501.1)	(1,527.3)
Current liabilities:
Long-term debt	(621.7)	(387.2)	(213.7)
Other liabilities	(37.6)	(37.7)	(29.9)
Equity investment in subsidiaries	(336.1)	(328.7)	(173.3)
Intercompany liabilities	(374.3)	(281.9)	(364.4)
Total liabilities	(1,369.7)	(1,035.5)	(781.3)
Shareholders' equity	(363.1)	(465.6)	(746.0)
Total liabilities and shareholders' equity	$ (1,732.8)	$ (1,501.1)	$ (1,527.3)

XML

Condensed Consolidating Statement of Cash Flows (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
Schedule of Condensed Consolidating Statement of Cash Flows [Line Items]
NET CASH USED IN OPERATING ACTIVITIES	$ (201.1)	$ (169.7)
INVESTING ACTIVITIES
Investments in property, plant and equipment	(16.4)	(28.1)
Net cash used in investing activities	(16.4)	(28.1)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit	447.0	258.2
Repayments under revolving and bank lines of credit	(205.7)	(234.0)
Proceeds from issuance of 6.625% Senior Notes		200.0
Dividends paid	(18.9)	(16.8)
Purchase of common shares	(17.5)	(25.0)
Financing and issuance fees		(4.1)
Excess tax benefits from share-based payment arrangements	3.8	1.5
Cash received from the exercise of stock options	5.6	6.5
Net cash provided by financing activities	214.3	186.3
Effect of exchange rate changes on cash	0.1	2.2
Net increase (decrease) in cash and cash equivalents	(3.1)	(9.3)
Cash and cash equivalents, beginning of period	130.9	88.1
Cash and cash equivalents, end of period	127.8	78.8
Parent
Schedule of Condensed Consolidating Statement of Cash Flows [Line Items]
NET CASH USED IN OPERATING ACTIVITIES	(8.0)	(0.6)
FINANCING ACTIVITIES
Proceeds from issuance of 6.625% Senior Notes		200.0
Dividends paid	(18.9)	(16.8)
Purchase of common shares	(17.5)	(25.0)
Financing and issuance fees		(4.1)
Cash received from the exercise of stock options	5.6	6.5
Intercompany financing	38.8	(160.0)
Net cash provided by financing activities	8.0	0.6
Subsidiary Guarantors
Schedule of Condensed Consolidating Statement of Cash Flows [Line Items]
NET CASH USED IN OPERATING ACTIVITIES	(144.7)	(125.0)
INVESTING ACTIVITIES
Investments in property, plant and equipment	(13.3)	(25.2)
Net cash used in investing activities	(13.3)	(25.2)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit	321.9	205.2
Repayments under revolving and bank lines of credit	(30.7)	(94.0)
Excess tax benefits from share-based payment arrangements	3.8	1.5
Intercompany financing	(131.3)	43.2
Net cash provided by financing activities	163.7	155.9
Net increase (decrease) in cash and cash equivalents	5.7	5.7
Cash and cash equivalents, beginning of period	4.3	5.1
Cash and cash equivalents, end of period	10.0	10.8
Non-Guarantors
Schedule of Condensed Consolidating Statement of Cash Flows [Line Items]
NET CASH USED IN OPERATING ACTIVITIES	(48.4)	(44.1)
INVESTING ACTIVITIES
Investments in property, plant and equipment	(3.1)	(2.9)
Net cash used in investing activities	(3.1)	(2.9)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit	125.1	53.0
Repayments under revolving and bank lines of credit	(175.0)	(140.0)
Intercompany financing	92.5	116.8
Net cash provided by financing activities	42.6	29.8
Effect of exchange rate changes on cash	0.1	2.2
Net increase (decrease) in cash and cash equivalents	(8.8)	(15.0)
Cash and cash equivalents, beginning of period	126.6	83.0
Cash and cash equivalents, end of period	$ 117.8	$ 68.0

XML

SEGMENT INFORMATION (Tables)

15 Months Ended

Dec. 31, 2011

Segment Financial Information

The following tables present summarized financial information concerning the Company’s reportable segments for the periods indicated (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net sales:
Global Consumer	$	149.1		$	188.8
Scotts LawnService®		37.6			37.1
Segment total		186.7			225.9
Corporate & Other		24.5			4.3
Consolidated	$	211.2		$	230.2
Loss from continuing operations before income taxes:
Global Consumer	$	(69.4	)	$	(55.1	)
Scotts LawnService®		(4.6	)		(4.5	)
Segment total		(74.0	)		(59.6	)
Corporate & Other		(20.8	)		(30.9	)
Intangible asset amortization		(2.5	)		(2.3	)
Product registration and recall matters		(0.3	)		(1.7	)
Restructuring and other charges		(2.6	)		—
Interest expense		(15.3	)		(9.5	)
Consolidated	$	(115.5	)	$	(104.0	)

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Total assets:
Global Consumer	$	1,723.8	$	1,584.2	$	1,552.4
Scotts LawnService®		162.2		155.4		184.3
Corporate & Other		278.3		314.7		315.5
Assets held for sale		—		200.9		—
Consolidated	$	2,164.3	$	2,255.2	$	2,052.2

XML

Net Periodic Benefit Cost (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Dec. 31, 2011	Jan. 01, 2011
U.S. Pension
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 1.1	$ 1.2
Expected return on plan assets	(1.4)	(1.3)
Net amortization	1.3	1.2
Curtailment loss	0.2
Net periodic benefit cost	1.2	1.1
International Pension
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.3	0.4
Interest cost	2.4	2.7
Expected return on plan assets	(2.2)	(2.6)
Net amortization	0.2	0.4
Net periodic benefit cost	0.7	0.9
U.S. Medical
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.1	0.1
Interest cost	0.4	0.4
Net amortization	0.1
Net periodic benefit cost	$ 0.6	$ 0.5

XML

FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS

15 Months Ended

Dec. 31, 2011

FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS

NOTE 16. FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS

The 7.25% and 6.625% Senior Notes (collectively, the “Senior Notes”) issued by Scotts Miracle-Gro on January 14, 2010 and December 16, 2010, respectively, are guaranteed by certain of its domestic subsidiaries and, therefore, the Company has disclosed condensed consolidating financial information in accordance with SEC Regulation S-X Rule 3-10, Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered. The following 100% directly or indirectly owned subsidiaries fully and unconditionally guarantee the Senior Notes on a joint and several basis: EG Systems, Inc., dba Scotts LawnService^®; Gutwein & Co., Inc.; Hyponex Corporation; Miracle-Gro Lawn Products, Inc.; OMS Investments, Inc.; Rod McLellan Company; Sanford Scientific, Inc.; Scotts Temecula Operations, LLC; Scotts Manufacturing Company; Scotts Products Co.; Scotts Professional Products Co.; Scotts-Sierra Investments, Inc.; SMG Brands, Inc.; SMG Growing Media, Inc.; Swiss Farms Products, Inc.; and The Scotts Company LLC (collectively, the “Guarantors”). SMG Brands, Inc. was added as a Guarantor of the Senior Notes on September 28, 2011. Accordingly, SMG Brands, Inc. has been classified as a Guarantor for all periods presented in the condensed consolidating financial information accompanying this Note 16.

The following information presents condensed consolidating Statements of Operations for the three months ended December 31, 2011 and January 1, 2011, condensed consolidating Statements of Cash Flows for the three months ended December 31, 2011 and January 1, 2011, and condensed consolidating Balance Sheets as of December 31, 2011, January 1, 2011 and September 30, 2011. The condensed consolidating financial information presents, in separate columns, financial information for: Scotts Miracle-Gro on a Parent-only basis, carrying its investment in subsidiaries under the equity method; Guarantors on a combined basis, carrying their investments in subsidiaries which do not guarantee the debt (collectively, the “Non-Guarantors”) under the equity method; Non-Guarantors on a combined basis; and eliminating entries. The eliminating entries primarily reflect intercompany transactions, such as interest expense, accounts receivable and payable, short and long-term debt, and the elimination of equity investments and income in subsidiaries. Because the Parent is obligated to pay the unpaid principal amount and interest on all amounts borrowed by the Guarantors or Non-Guarantors under the credit facility (and was obligated to pay the unpaid principal amount and interest on all amounts borrowed by the Guarantors and Non-Guarantors under the previous senior secured five-year revolving loan facility), the borrowings and related interest expense for the loans outstanding of the Guarantors and Non-Guarantors are also presented in the accompanying Parent-only financial information, and are then eliminated.

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Operations

for the three months ended December 31, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,			September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations			Consolidated
Net sales	$	—		$	157.1		$	54.1		$	—		$	211.2
Cost of sales		—			144.8			41.6			—			186.4
Gross profit		—			12.3			12.5			—			24.8
Operating expenses:
Selling, general and administrative		—			95.5			27.5			—			123.0
Impairment, restructuring and other charges		—			2.6			—			—			2.6
Product registration and recall matters		—			0.3			—			—			0.3
Other income, net		(2.8	)		(0.5	)		(0.4	)		2.8			(0.9	)
Income (loss) from operations		2.8			(85.6	)		(14.6	)		(2.8	)		(100.2	)
Equity loss in subsidiaries		66.2			9.8			—			(76.0	)		—
Interest expense		10.8			6.6			0.7			(2.8	)		15.3
Loss from continuing operations before income taxes		(74.2	)		(102.0	)		(15.3	)		76.0			(115.5	)
Income tax benefit from continuing operations		(0.3	)		(35.8	)		(5.5	)		—			(41.6	)
Loss from continuing operations		(73.9	)		(66.2	)		(9.8	)		76.0			(73.9	)
Loss from discontinued operations, net of tax		—			—			—			—			—
Net loss	$	(73.9	)	$	(66.2	)	$	(9.8	)	$	76.0		$	(73.9	)

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Cash Flows

for the three months ended December 31, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,		September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations		Consolidated
NET CASH USED IN OPERATING ACTIVITIES	$	(8.0	)	$	(144.7	)	$	(48.4	)	$	—	$	(201.1	)
INVESTING ACTIVITIES
Investments in property, plant and equipment		—			(13.3	)		(3.1	)		—		(16.4	)
Net cash used in investing activities		—			(13.3	)		(3.1	)		—		(16.4	)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit		—			321.9			125.1			—		447.0
Repayments under revolving and bank lines of credit		—			(30.7	)		(175.0	)		—		(205.7	)
Dividends paid		(18.9	)		—			—			—		(18.9	)
Purchase of common shares		(17.5	)		—			—			—		(17.5	)
Excess tax benefits from share-based payment arrangements		—			3.8			—			—		3.8
Cash received from the exercise of stock options		5.6			—			—			—		5.6
Intercompany financing		38.8			(131.3	)		92.5			—		—
Net cash provided by financing activities		8.0			163.7			42.6			—		214.3
Effect of exchange rate changes on cash		—			—			0.1			—		0.1
Net increase (decrease) in cash and cash equivalents		—			5.7			(8.8	)		—		(3.1	)
Cash and cash equivalents, beginning of period		—			4.3			126.6			—		130.9
Cash and cash equivalents, end of period	$	—		$	10.0		$	117.8		$	—	$	127.8

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Balance Sheet

As of December 31, 2011

(in millions)

		September 30,		September 30,		September 30,			September 30,			September 30,
			Subsidiary		Non-
	Parent		Guarantors		Guarantors			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	10.0	$	117.8		$	—		$	127.8
Accounts receivable, net		—		92.7		73.8			—			166.5
Accounts receivable pledged		—		14.3		—			—			14.3
Inventories		—		543.6		111.2			—			654.8
Prepaid and other current assets		—		102.2		46.6			—			148.8
Total current assets		—		762.8		349.4			—			1,112.2
Property, plant and equipment, net		—		343.2		48.2			—			391.4
Goodwill		—		308.4		0.7			—			309.1
Intangible assets, net		—		269.6		46.6			—			316.2
Other assets		32.1		13.3		27.6			(37.6	)		35.4
Equity investment in subsidiaries		699.2		—		—			(699.2	)		—
Intercompany assets		788.3		207.7		—			(996.0	)		—
Total assets	$	1,519.6	$	1,905.0	$	472.5		$	(1,732.8	)	$	2,164.3
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	—	$	7.8	$	0.3		$	—		$	8.1
Accounts payable		—		165.6		54.8			—			220.4
Other current liabilities		15.3		118.6		86.7			—			220.6
Total current liabilities		15.3		292.0		141.8			—			449.1
Long-term debt		1,021.7		547.4		78.7			(621.7	)		1,026.1
Other liabilities		18.4		200.5		43.6			(37.6	)		224.9
Equity investment in subsidiaries		—		336.1		—			(336.1	)		—
Intercompany liabilities		—		—		374.3			(374.3	)		—
Total liabilities		1,055.4		1,376.0		638.4			(1,369.7	)		1,700.1
Shareholders’ equity		464.2		529.0		(165.9	)		(363.1	)		464.2
Total liabilities and shareholders’ equity	$	1,519.6	$	1,905.0	$	472.5		$	(1,732.8	)	$	2,164.3

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Operations

for the three months ended January 1, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,			September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations			Consolidated
Net sales	$	—		$	176.8		$	53.4		$	—		$	230.2
Cost of sales		—			143.3			37.0			—			180.3
Cost of sales—product registration and recall matters		—			0.8			—			—			0.8
Gross profit		—			32.7			16.4			—			49.1
Operating expenses:
Selling, general and administrative		—			115.1			28.1			—			143.2
Product registration and recall matters		—			0.9			—			—			0.9
Other (income) loss, net		—			0.2			(0.7	)		—			(0.5	)
Loss from operations		—			(83.5	)		(11.0	)		—			(94.5	)
Equity loss in subsidiaries		63.6			8.4			—			(72.0	)		—
Other non-operating income		(3.8	)		—			—			3.8			—
Interest expense		8.7			4.3			0.3			(3.8	)		9.5
Loss from continuing operations before income taxes		(68.5	)		(96.2	)		(11.3	)		72.0			(104.0	)
Income tax benefit from continuing operations		(0.6	)		(32.7	)		(4.0	)		—			(37.3	)
Loss from continuing operations		(67.9	)		(63.5	)		(7.3	)		72.0			(66.7	)
Loss from discontinued operations, net of tax		—			—			(1.2	)		—			(1.2	)
Net loss	$	(67.9	)	$	(63.5	)	$	(8.5	)	$	72.0		$	(67.9	)

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Statement of Cash Flows

for the three months ended January 1, 2011

(in millions)

		September 30,			September 30,			September 30,			September 30,		September 30,
				Subsidiary			Non-
	Parent			Guarantors			Guarantors			Eliminations		Consolidated
NET CASH USED IN OPERATING ACTIVITIES	$	(0.6	)	$	(125.0	)	$	(44.1	)	$	—	$	(169.7	)
INVESTING ACTIVITIES
Investments in property, plant and equipment		—			(25.2	)		(2.9	)		—		(28.1	)
Net cash used in investing activities		—			(25.2	)		(2.9	)		—		(28.1	)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans		—			205.2			53.0			—		258.2
Repayments under revolving and bank lines of credit and term loans		—			(94.0	)		(140.0	)		—		(234.0	)
Proceeds from issuance of 6.625% Senior Notes		200.0			—			—			—		200.0
Dividends paid		(16.8	)		—			—			—		(16.8	)
Purchase of common shares		(25.0	)		—			—			—		(25.0	)
Financing and issuance fees		(4.1	)		—			—			—		(4.1	)
Excess tax benefits from share-based payment arrangements		—			1.5			—			—		1.5
Cash received from the exercise of stock options		6.5			—			—			—		6.5
Intercompany financing		(160.0	)		43.2			116.8			—		—
Net cash provided by financing activities		0.6			155.9			29.8			—		186.3
Effect of exchange rate changes on cash		—			—			2.2			—		2.2
Net increase (decrease) in cash and cash equivalents		—			5.7			(15.0	)		—		(9.3	)
Cash and cash equivalents, beginning of period		—			5.1			83.0			—		88.1
Cash and cash equivalents, end of period	$	—		$	10.8		$	68.0		$	—	$	78.8

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Balance Sheet

As of January 1, 2011

(in millions)

		September 30,		September 30,		September 30,			September 30,			September 30,
			Subsidiary		Non-
	Parent		Guarantors		Guarantors			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	10.8	$	68.0		$	—		$	78.8
Accounts receivable, net		—		137.0		76.2			—			213.2
Inventories		—		474.0		93.0			—			567.0
Assets held for sale		—		—		200.9			—			200.9
Prepaid and other current assets		—		97.9		38.2			—			136.1
Total current assets		—		719.7		476.3			—			1,196.0
Property, plant and equipment, net		—		344.5		46.6			—			391.1
Goodwill		—		305.1		0.7			—			305.8
Intangible assets, net		—		273.9		52.8			—			326.7
Other assets		13.6		23.1		28.8			(29.9	)		35.6
Equity investment in subsidiaries		919.3		—		—			(919.3	)		—
Intercompany assets		578.1		—		—			(578.1	)		—
Total assets	$	1,511.0	$	1,666.3	$	605.2		$	(1,527.3	)	$	2,255.2
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	164.7	$	2.4	$	1.4		$	—		$	168.5
Accounts payable		—		161.0		47.5			—			208.5
Liabilities held for sale		—		—		45.4			—			45.4
Other current liabilities		7.3		142.4		95.1			—			244.8
Total current liabilities		172.0		305.8		189.4			—			667.2
Long-term debt		657.4		230.0		13.7			(213.7	)		687.4
Other liabilities		3.0		198.1		50.8			(29.9	)		222.0
Equity investment in subsidiaries		—		173.3		—			(173.3	)		—
Intercompany liabilities		—		10.0		354.4			(364.4	)		—
Total liabilities		832.4		917.2		608.3			(781.3	)		1,576.6
Shareholders’ equity		678.6		749.1		(3.1	)		(746.0	)		678.6
Total liabilities and shareholders’ equity	$	1,511.0	$	1,666.3	$	605.2		$	(1,527.3	)	$	2,255.2

THE SCOTTS MIRACLE-GRO COMPANY

Condensed Consolidating Balance Sheet

As of September 30, 2011

(in millions)

		September 30,		September 30,		September 30,			September 30,			September 30,
			Subsidiary		Non-
	Parent		Guarantors		Guarantors			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	4.3	$	126.6		$	—		$	130.9
Accounts receivable, net		—		248.2		75.3			—			323.5
Inventories		—		313.7		73.3			—			387.0
Prepaid and other current assets		—		107.9		43.2			—			151.1
Total current assets		—		674.1		318.4			—			992.5
Property, plant and equipment, net		—		347.3		47.4			—			394.7
Goodwill		—		308.4		0.7			—			309.1
Intangible assets, net		—		270.3		49.3			—			319.6
Other assets		33.1		13.3		27.6			(37.7	)		36.3
Equity investment in subsidiaries		794.3		—		—			(794.3	)		—
Intercompany assets		553.7		115.4		—			(669.1	)		—
Total assets	$	1,381.1	$	1,728.8	$	443.4		$	(1,501.1	)	$	2,052.2
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of debt	$	—	$	2.8	$	0.4		$	—		$	3.2
Accounts payable		—		103.9		46.1			—			150.0
Other current liabilities		17.2		202.5		95.7			—			315.4
Total current liabilities		17.2		309.2		142.2			—			468.6
Long-term debt		787.2		261.3		130.5			(387.2	)		791.8
Other liabilities		16.9		205.6		47.2			(37.7	)		232.0
Equity investment in subsidiaries		—		328.7		—			(328.7	)		—
Intercompany liabilities		—		—		281.9			(281.9	)		—
Total liabilities		821.3		1,104.8		601.8			(1,035.5	)		1,492.4
Shareholders’ equity		559.8		624.0		(158.4	)		(465.6	)		559.8
Total liabilities and shareholders’ equity	$	1,381.1	$	1,728.8	$	443.4		$	(1,501.1	)	$	2,052.2

XML

INVENTORIES (Tables)

15 Months Ended

Dec. 31, 2011

Inventories for Continuing Operations

Inventories, net of reserves of $12.2 million, $27.2 million and $22.0 million as of December 31, 2011, January 1, 2011 and September 30, 2011, respectively, consisted of the following (in millions):

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Finished goods	$	435.9	$	351.5	$	130.7
Work-in-process		52.0		37.4		34.3
Raw materials		166.9		178.1		222.0
Total inventories	$	654.8	$	567.0	$	387.0

XML

DEBT - Additional Information (Detail) (USD $)	3 Months Ended
	Dec. 31, 2011	Jun. 27, 2009
Debt Disclosure [Line Items]
Senior secured credit facilities, available borrowing capacity	$ 1,050,000,000
Aggregate face amount of letters of credit outstanding	26,300,000
Debt, covenant compliance	The Company was in compliance with the terms of all debt covenants at December 31, 2011.
Leverage ratio	2.09
Interest coverage ratio	6.79
Minimum
Debt Disclosure [Line Items]
Interest coverage ratio	3.50
Maximum
Debt Disclosure [Line Items]
Leverage ratio	3.50
Letter of Credit
Debt Disclosure [Line Items]
Senior secured credit facilities, maximum borrowing capacity	75,000,000
Senior Notes - 7.25%
Debt Disclosure [Line Items]
Long-term debt, fair value	212,000,000
Senior Notes - 6.625%
Debt Disclosure [Line Items]
Long-term debt, fair value	203,300,000
Master Accounts Receivable Purchase Agreement
Debt Disclosure [Line Items]
Agreement entry date	Sep. 21, 2011
Stated termination date	September 21, 2012
Receivables purchase agreement capacity	325,000,000	80,000,000
Interest rate paid, over LIBOR	1.05%	1.25%
Collateralized short-term debt	5,400,000
Master Accounts Receivable Purchase Agreement | Minimum
Debt Disclosure [Line Items]
Receivables purchase agreement capacity	120,000,000
Master Accounts Receivable Purchase Agreement | Maximum
Debt Disclosure [Line Items]
Receivables purchase agreement capacity	$ 250,000,000

XML

IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011 Involuntary Termination	Sep. 30, 2011 Voluntary Retirement
Restructuring Cost and Reserve [Line Items]
Restructuring costs		$ 24.2	$ 2.4
Plan curtailment charges		2.3	0.2
Restructuring reserves	$ 7.2

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011	Jan. 01, 2011
Accounts receivable, allowances	$ 12.4	$ 12.9	$ 6.2
Property, plant and equipment, accumulated depreciation	$ 520.1	$ 510.5	$ 471.8
Common shares, stated value per share	$ 0.01	$ 0.01	$ 0.01
Common shares, shares issued	60.8	60.8	66.5
Common shares, shares outstanding	60.8	60.8	66.5
Treasury shares, at cost, shares	7.4	7.5	1.9

XML

INVENTORIES

15 Months Ended

Dec. 31, 2011

INVENTORIES

NOTE 5. INVENTORIES

Inventories, net of reserves of $12.2 million, $27.2 million and $22.0 million as of December 31, 2011, January 1, 2011 and September 30, 2011, respectively, consisted of the following (in millions):

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Finished goods	$	435.9	$	351.5	$	130.7
Work-in-process		52.0		37.4		34.3
Raw materials		166.9		178.1		222.0
Total inventories	$	654.8	$	567.0	$	387.0

XML

Fair Values of Company's Derivative Instruments (Detail) (USD $) In Millions, unless otherwise specified	Dec. 31, 2011		Sep. 30, 2011		Jan. 01, 2011
Derivatives, Fair Value [Line Items]
Total derivatives instruments	$ (26.7)		$ (26.1)		$ (6.7)
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS
Derivatives, Fair Value [Line Items]
Total derivatives instruments	(29.4)		(28.3)		(12.5)
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Interest rate swap agreements | Other Asset
Derivatives, Fair Value [Line Items]
Derivative asset					2.4
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Interest rate swap agreements | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(8.4)		(10.7)		(12.3)
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Interest rate swap agreements | Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(18.9)		(17.4)		(6.2)
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(2.1)		(0.3)
DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Prepaid and other assets
Derivatives, Fair Value [Line Items]
Derivative asset			0.1		3.6
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Derivatives, Fair Value [Line Items]
Total derivatives instruments	(2.7)	[1]	2.2	[1]	5.8	[1]
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(0.2)	[1]	(0.5)	[1]
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Commodity hedging instruments | Prepaid and other assets
Derivatives, Fair Value [Line Items]
Derivative asset					0.8	[1]
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Foreign currency swap contracts
Derivatives, Fair Value [Line Items]
Total derivatives instruments	3.5				5.0
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Foreign currency swap contracts | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(0.6)	[1]			(0.3)	[1]
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS | Foreign currency swap contracts | Prepaid and other assets
Derivatives, Fair Value [Line Items]
Derivative asset	$ 3.5	[1]	$ 2.7	[1]	$ 5.3	[1]

[1] See discussion above for additional information regarding the Company's purpose for entering into derivatives not designated as hedging instruments and its overall risk management strategy.

XML

MARKETING AGREEMENT (Tables)

15 Months Ended

Dec. 31, 2011

Net Commission Earned Under Marketing Agreement

The elements of the net commission and reimbursements earned under the Marketing Agreement and included in “Net sales” are as follows (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Gross commission	$	—		$	—
Contribution expenses		(5.0	)		(5.0	)
Amortization of marketing fee		(0.2	)		(0.2	)
Net commission expense		(5.2	)		(5.2	)
Reimbursements associated with Marketing Agreement		17.9			15.2
Total net sales associated with Marketing Agreement	$	12.7		$	10.0

XML

PRODUCT REGISTRATION AND RECALL MATTERS - Additional Information (Detail) (USD $)	Dec. 31, 2011 LegalMatter
Loss Contingencies [Line Items]
Number of potential claims	11
DOJ
Loss Contingencies [Line Items]
Accrual loss contingencies	4,000,000
Ohio Audubons Important Bird Area Program
Loss Contingencies [Line Items]
Accrual loss contingencies	100,000
Ohio Department Of Natural Resources Urban Forestry Program
Loss Contingencies [Line Items]
Accrual loss contingencies	100,000
Columbus Metro Parks Bird Habitat Enhancement Program
Loss Contingencies [Line Items]
Accrual loss contingencies	100,000
Cornell University Ornithology Laboratory
Loss Contingencies [Line Items]
Accrual loss contingencies	100,000
Nature Conservancy Of Ohio
Loss Contingencies [Line Items]
Accrual loss contingencies	100,000

XML

SEGMENT INFORMATION

15 Months Ended

Dec. 31, 2011

SEGMENT INFORMATION

NOTE 15. SEGMENT INFORMATION

The Company divides its business into the following segments—Global Consumer and Scotts LawnService^®. This division of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company.

Segment performance is evaluated based on several factors, including income from continuing operations before amortization, product registration and recall costs, and impairment, restructuring and other charges, which is not a GAAP measure. Senior management of the Company uses this measure of operating profit to gauge segment performance because the Company believes this measure is the most indicative of performance trends and the overall earnings potential of each segment.

Corporate & Other consists of the Company’s non-European professional seed business, revenues and expenses associated with the Company’s supply agreements with ICL and the amortization related to the Roundup^® Marketing Agreement, as well as corporate, general and administrative expenses and certain other income/expense items not allocated to the business segments. Corporate & Other assets primarily include deferred financing and debt issuance costs and corporate intangible assets, as well as deferred tax assets. For capital expenditures and total assets, Corporate & Other also includes Smith & Hawken, which is classified as discontinued operations on the Consolidated Statements of Operations.

The following tables present summarized financial information concerning the Company’s reportable segments for the periods indicated (in millions):

		September 30,			September 30,
	THREE MONTHS ENDED
	DECEMBER 31, 2011			JANUARY 1, 2011
Net sales:
Global Consumer	$	149.1		$	188.8
Scotts LawnService®		37.6			37.1
Segment total		186.7			225.9
Corporate & Other		24.5			4.3
Consolidated	$	211.2		$	230.2
Loss from continuing operations before income taxes:
Global Consumer	$	(69.4	)	$	(55.1	)
Scotts LawnService®		(4.6	)		(4.5	)
Segment total		(74.0	)		(59.6	)
Corporate & Other		(20.8	)		(30.9	)
Intangible asset amortization		(2.5	)		(2.3	)
Product registration and recall matters		(0.3	)		(1.7	)
Restructuring and other charges		(2.6	)		—
Interest expense		(15.3	)		(9.5	)
Consolidated	$	(115.5	)	$	(104.0	)

		September 30,		September 30,		September 30,
	DECEMBER 31, 2011		JANUARY 1, 2011		SEPTEMBER 30, 2011
Total assets:
Global Consumer	$	1,723.8	$	1,584.2	$	1,552.4
Scotts LawnService®		162.2		155.4		184.3
Corporate & Other		278.3		314.7		315.5
Assets held for sale		—		200.9		—
Consolidated	$	2,164.3	$	2,255.2	$	2,052.2